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SUMMARY
The OXA-2 bla gene as specified by the R factor R46 was 
cloned into the plasmid vector pMB9 to produce the chimaeric 
plasmid pSU3 in order to increase the gene copy number and 
concurrently the level of beta-lactamase production. The 
pSU3 plasmid was transformed into a high cell yielding Porton 
strain (E. coli CA265 ) which was then utilised for a 400 
litre batch culture fermentation. The total yield of the OXA-2 
beta-lactamase v/as approximately 78-fold greater than that from 
an E. coli strain carrying the R46 plasmid, as reported by 
Dale and Smith (1971).
The conditions necessary for the large scale purification 
of the OXA-2 beta-lactamase were investigated. The large 
scale purification protocol was capable of processing 2.25 
litres of crude cell extract (22.5 litres of original 400 
litre culture ) containing! 116 g of cell protein. The yield 
of purified enzyme from each 2.25 litres was 90mg and the 
recovery of enzyme activity was 15%. Sufficient purified 
enzyme was therefore available to fulfill the needs of this 
project and those of future research.
Various techniques were performed in order to characterise 
the OXA-2 enzyme. A short NH2~terminal sequence of the OXA-2 
enzyme was determined. The occurrence of a leucine-glutamate 
sequence at positions 5 and 6 in the sequence may indicate 
some homology with the class A beta-lactamases. The interaction 
of the OXA-2 enzyme with a range of beta-lactamase inhibitors 
was investigated with particular emphasis on the mechanism 
of clavulanate-mediated inhibition. The features of this 
interaction were correlated into a minimal scheme for the 
interaction of clavulanic acid with the OXA-2 beta lactamase.
The OXA-2 and OXA-3 beta lactamases were shown to be 
related via immunological cross-neutralisation. The OXA-2 
enzyme showed no relationship to any of the other plasmid- 
mediated beta-lactamases tested.Presumably if the OXA-2 
enzyme is a class A beta-lactamase; then in view of the 
relationship between the OXA-2 and OXA-3 enzymes, the OXA 
beta-lactamase may also be assigned to this class.
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LITERATURE SURVEY
Section 1 Beta-lactam antibiotics
Beta-lactam antibiotics including penicillins,cephalosporins 
and related compounds, are small molecular weight substances 
that each contain a beta-lactam ring in their molecular 
structure. Benzylpenicillin (Penicillin G) was isolated 
from PeniciIlium notatum in 1928 by Alexander Fleming*. It 
was, however, not until 1940 that the properties of the 
compound were investigated and its therapeutic potential 
was realised (Chain et al., 1940). Penicillin G proved to 
be bacteriocidal and non toxic in laboratory tests and it 
was subsequently used for the successful treatment of several 
human diseases, particularly staphylococcal and streptococcal 
infections. Several of these conditions had been clinically 
untreatable before the development of penicillins. Prior 
to the isolation of the penicillin nucleus 6-aminopenicillanic 
acid (6-APA) in 1959 (Batchelor et al.,1959), the only 
penicillins available were penicillin G and penicillin V 
(Phenoxymethyl-penicillin). Both compounds have certain 
chemotherapeutic disadvantages. Penicillin G cannot be 
administered orally and neither compound is particularly 
active against (aram-negative bacteria due to their poor 
penetration through the cell's outer membrane. The use 
of both antibiotics was further complicated by the 
development of resistance particularly in staphylococcal 
strains. Resistance was mediated by the production of 
hydrolytic enzymes designated penicillinases. These 
enzymes have now been regrouped under the collective term 
of beta-lactamase to include both penicillinases and 
cephalosporinases. The overall disadvantages of both 
penicillins G and V necessitated a search for derivatives 
with a greater therapeutic potential. The availability . 
of 6-APA enabled the synthesis and testing of a large 
number of compounds in which the beta-lactam side chain 
had been modified. An intact beta-lactam/thiazolidine
* A.Fleming(1928) cited by Selwyn(1980).
fused ring system (figure 1 .1) was originally thought to be 
essential for antibiotic activity. Consequently, the 
search was based primarily on derivatives of 6-APA which 
exhibited the following properties; a broader spectrum 
of activity than penicillin G, resistance to microbial 
beta-lactamases, stability to acids and an acceptable 
level of binding to serum proteins.
The search for compounds which were effective against 
gram-positive bacteria, particularly Staphylococci, resulted 
in the development of a group of antibiotics in which a 
carbocyclic or heterocyclic ring was attached directly to 
the carbonyl group substituting the amino group of 6-APA 
at C6 in the beta-lactam ring. This is in contrast to 
penicillin G or V where the heterocyclic ring is fused to 
the carbonyl group of 6-APA via an intermediate linkage 
group. The parent member of this group of antibiotics is 
phenylpenicillin (figure 1.5), which is less active than 
penicillin G. Introduction, however, of substituents at 
the ortho-position in the heterocyclic or carbocyclic 
rings, resulted in derivitives which were both effective 
antibiotics and resistant to several beta-lactamases.
The first member of this group of penicillins to be 
produced commercially was methicillin which contains two 
methoxy substituents in the ring system (Rolinson et al.,1960). 
Other effective derivitives were subsequently patented 
but none,however , was particularly effective against the 
gram-negative bacteria due to impermeability of the outer 
membrane.
The problem of penetration into gram-negative cells was 
partially solved by simple substitution on the cx-carbon 
atom of the hydrophobic side chain of benzylpenicillin, 
with either an amino (ampicillin) or carboxyl (carbenicillin) 
group. Both compounds are more stable to beta-lactamase 
action than benzylpenicillin but only ampicillin can be 
taken orally. Since the introduction of ampicillin and
2
carbenicillin in the early 1970's, several effective 
derivitives have been developed. Ticarcillin, a derivitive 
of carbenicillin, is an extremely potent antibiotic with 
a broad spectrum of activity and a high level of resistance 
to several common beta-lactamases. Pivampicillin and 
amoxycillin are effective and useful derivitives of 
ampicillin.
The cephalosporins contain a fused beta-lactam/ 
dihydrothiazine ring system which distinguishes them from 
penicillins (figure 1.7). Cephalosporins were discovered 
by G. Brotzu*in 1945, who identified a fungus similar to 
Cephalosporium acrenomium which produces a substance 
capable of inhibiting the growth of pathogenic gram-positive 
and gram-negative organisms. The cephalosporin 
development programme was, however, not initiated until the 
1960's when their potential as alternatives to the semi­
synthetic penicillins was realised. All commercially 
available cephalosporins, except the cephamycins, are 
derived from cephalosporin C (figure 1.8). The potential 
of this compound, which itself has little intrinsic activity, 
is based on the removal of the aminoadipic side chain to 
produce 7-aminocephalosporonic acid or 7-ACA (figure 1.7), 
analogous to the 6-APA of penicillin. The 7-ACA nucleus 
provides a greater potential for variation than its 6-APA 
counterpart since the dihydrothiazine ring at the C3 position 
can carry substitutions, in addition to the C7 position in 
the beta-lactam ring. Modifications of the side chain on 
the left side of the nucleus at Cl essentially effect 
the compounds antibacterial properties, while modifications 
on the right at C3 alter its pharmacological properties.
An extensive range of cephalosporins are now available 
which vary in their relative antibacterial spectrum. In 
general, cephalosporins are more effective against gram- 
negative bacteria due to their greater permeability through 
the cell's outer membrane than penicillins. Cephalosporins
•* G.Brotzu (1945) cited by Selwyn (1980).
are relatively popular since they have a broad activity 
spectrum, are generally free from side effects and are 
effective in the prophylactic treatment of surgical cases. 
They do suffer from certain disadvantages in that they are 
expensive and tend to provide a wide spectrum of selective 
pressure for the emergence of antibiotic resistance. On 
account of their popularity, cephalosporins suffer from 
some misuse. They are not always the drug of choice 
particularly when the use of a cheaper penicillin will 
suffice. In 1974, cephalosporins accounted for approximately 
30% of the total pharmacy budget in an average American 
hospital (Holloway,1976). This situation probably does 
not occur today particularly in view of the strict 
antibiotic policies in operation in both the community 
and hospital environments. A recent survey of forty three 
hospitals in England indicated that cephalosporins 
contributed 8% of the total antimicrobial agents in use 
accounting for 17% of the annual cost of antimicrobial 
chemotherapy (Leigh, 1982).
Since 1976, a number of novel beta-lactams have been 
isolated from culture filtrates of Streptomyces which differ 
from the classic penicillin and cephalosporin structure. 
These compounds exhibit little intrinsic activity but act 
as highly potent active site-directed inhibitors of 
several beta-lactamases. Representatives of this group 
include clavulanic acid (Howarth et al., 1976), and the 
olivanic acids (Brown et al. , 1976). Thienamycin, produced 
by Streptomyces cattleya, is a 1-carba-2-penam-3-carboxylic 
acid similar to the olivanic acids (figure 1.9). It is 
a broad spectrum antibiotic which is stable to several 
beta-lactamases. The compounds chemotherapeutic potential 
is reduced by its chemical instability. This problem has 
been overcome in N-amidine derivitives of thienamycin 
in which the parent compounds antibacterial activity has 
been coupled with chemical stability. Nocardicins are
4
naturally * occuring monocyclic beta-lactams which lack the 
fused ring system, containing only a substituted beta- 
lactam ring (Aoki et al.,1976). Nocardicin A (figure 1.10), 
the major component of a mixture of seven related compounds 
produced by a species of Nocardia uniformis, is active 
against a broad range of gram-negative bacteria. Recently, 
a new class of monocyclic beta-lactams of bacterial 
origin have been identified. These compounds designated 
the monobactams (Sykes et al.,1981), are N-acyl derivitives 
of 3-amino monobactamic acid. Investigation into structure 
activity relationships has led to the development of 
synthetic monobactam derivitives such as azthreonam 
(Sykes et al.,1982). Azthreonam (figure 1.12) is specifically 
active against aerobic gram-negative bacteria including 
Pseudomonas aeruginosa.
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Section 2 ' Beta-lactamases
2.1 General properties
Beta-lactamases (penicillin/cephalosporin beta-lactam 
amidohydrolase, EC3.5.2.6) are enzymes which hydrolyse the 
amide bond in the beta-lactam ring of penicillins, 
cephalosporins and related beta-lactam compounds, rendering 
them antibacterially inactive. The enzyme was first 
identified in Escherichia coli in 1940, coincidental with 
the development of penicillin as a chemotherapeutic drug 
(Abraham and Chain, 1940). The importance of beta- 
lactamases as a resistance mechanism has grown in parallel 
with the increased use of beta-lactam antibiotics which 
now represent the most widely prescribed antibiotic in 
Britain today. Beta-lactamases constitute a heterogenous 
group of enzymes with molecular weights ranging from 
12,000 - 50,000. They are produced in both gram-positive 
and gram-negative bacteria and contribute significantly 
to resistance in each case. The beta-lactamase structural 
(bla) gene can be either chromasomally or plasmid-mediated; 
certain enzymes such as the TEM group may be able to 
utilise both locations (Curtis et al.,1972; Richmond and 
Sykes, 1972). Enzyme production in gram-positive bacteria 
is usually extracellular and inducible. Induction is 
generally-mediated by a beta-lactam compound (Hennessey,1967). 
Gram-negative beta-lactamases can be either constitutive 
or inducible, however enzyme production tends to be cell- 
bound (Richmond and Sykes, 1973). Simultaneous production - 
of two enzyme types has been reported (Letarte et al.,1978).
In these cases, one enzyme tends to be chromosomally and 
the other plasmid-mediated. The consensus of opinion is 
that all bacteria can produce a chromosomal beta-lactamase.
If this is the case, then dual enzyme production is probably 
a common occurance. To date, no beta-lactamase has been 
described which acts exclusively on penicillins or on 
cephalosporins. Penicillinases which show preferential 
activity towards penicillin substrates always exhibit 
some cephalosporin activity. Conversely, the cephalosporinases
8
show some•activity towards penicillins. Beta-lactamases 
tend to be grouped together according to their 
preferential activity towards certain substrates.
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2.2 The Classification of Beta-lactamases
The isolation of different types of beta-lactamases 
prompted the development of several classification systems, 
designed mainly to accommodate gram-negative enzymes.
The beta-lactamases produced by gram-positive bacteria 
represent an homogenous enzyme group, varying little in 
biochemical and physical parameters (Pollock,1971). The 
popular theory at that time was that the classification 
of beta-lactamases would reflect the evolutionary pattern 
of the group of organisms from which the enzymes were 
derived. Classification also provides a means for assessing 
large amounts of data, where those data are compartmentalised 
into distinct groups. The system most commonly quoted is 
that devised by Richmond and Sykes (1973). It is composed 
of five main categories, based on substrate profile and 
the interaction of the enzymes with various inhibitors.
Data collected by Matthew and Harris (1976) , suggested 
that beta-lactamases were genus, species and subspecies 
specific and therefore constituted a group of enzymes 
probably as diverse as the bacteria themselves. Sykes 
and Matthew (1976) therefore realised that a formally 
divided system of classification had become unrealistic. 
Consequently, they devised a system geared primarily 
towards clinical purposes, based principally on the 
location of the beta-lactamase gene. Subdivisions within 
the system were then based on parameters such as substrate 
profile, molecular weight, isoelectric point and 
immunological cross reactivity.
Any classification system relies on data collected from 
different laboratories. Methods for the determination of 
even the simplest parameter vary from place to place and 
are not always comparable. Consideration of such variation 
must be taken into account. Systems based on sequencing 
data are the most reliable since amino acid sequences 
are unique in that they are digital in nature, whereas 
.most other biological information is analogue. Sequence
10
data is a 'prerequisite for high resolution tertiary 
structure investigations by X-ray crystallography.
Structural information is, in turn, necessary for elucidation 
of mechanisms of enzyme action and can also indicate 
evolutionary relationships not recognised by sequence 
similarity (Rosmann et al.,1974). Amino acid sequencing 
of beta-lactamases is a difficult task simply due to the 
size of the enzymes. Nevertheless, the sequences of four 
beta-lactamases are virtually complete and several partial 
sequences are known (Ambler,1980). Consequently, Ambler 
has devised a system of beta-lactamase classification 
based primarily on amino acid sequences but also including 
mechanistic and structural data. The system encompasses 
both gram-positive and gram-negative enzymes and, to date 
is composed of three groups A, B and C. Group A are 
serine enzymes with a molecular weight of approximately 
30,000. The designation as a serine enzyme is due to the 
identification of a serine residue at the enzyme active 
site. To date, Group B contains only the Bacillus cereus II 
beta-lactamase which differs in its hydrolytic mechanism 
from group A enzymes by its requirement for a metal 
cofactor for catalytic activity. Group C are serine 
cephalosporinases which show little active site sequence 
homology to the group A enzymes. The C group was added to 
Ambler's classification system following DNA sequencing 
studies on the AmpC beta-lactamase (Jaurin and Grundstrom, 
1981). Table 1 lists some of the common and more unusual 
beta-lactamases. It is not meant to be an exhaustive 
survey, but merely a representative study. The enzymes 
have been grouped according to the classification system 
devised by Ambler. The oxacillin-hydrolysing enzymes 
have been classed as presumptive group A enzymes.
11
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2.3 The oxacillin-hydrolysing beta-lactamases
Enzymes which hydrolyse oxacillin at a higher rate than 
benzylpenicillin are classified as oxacillin-hydrolysing 
beta-lactamases (Hedges et al.,1974). Oxacillin and the 
other isoxazoyl penicillins were originally introduced 
to combat penicillin resistance particularly in strains 
of Staphylococcus aureus (Leduc,1966). Interest in this 
group of beta-lactamases obviously derives from its unusual 
substrate profile. Initially, investigations were based 
on two enzymes specified by the R-factors R-GN238 
(Yamagishi et al.,1969) and R46 (Anderson and Datta,1965) 
also known as R-1818 or R-Brighton. A comparison of their 
biochemical and physical parameters indicated that these 
two enzymes were sufficiently different as to constitute 
two subgroups (Dale and Smith,1972). Characterisation of 
oxacillin-hydrolysing enzymes specified by 14 different 
R factors, in fact, revealed that this enzyme class could 
be seperated into 2 major and 1 minor subgroups (Dale 
and Smith,1974). The divisions between the groups are 
not distinct since internal variation does occur. The 
three groups were designated OXA-1, 2 and 3 by Matthew 
and Hedges (1976), OXA-1 and OXA-2 corresponding to groups 
Va and Vb in the Richmond and Sykes classification system. 
No comparable group to OXA-3 is found in that system.
The OXA enzyme group were always thought to be plasmid- 
mediated. Some doubt concerning the location of the 
structural gene has been introduced, due to the isolation 
of an OXA-enzyme from Aeromonas hydrophila 67-P-24 which 
may have a chromosomally-located beta-lactamase (bla)gene 
(Sawai et al., 1976). The OXA beta-lactamases are confined 
to a small number of incompatibility groups which reflect 
their conservative distribution. Nevertheless, they 
represent the second most commonly occuring type of beta- 
lactamse in a survey of clinical isolates conducted by 
Matthew (1979). Their isolation frequency is, however,
16
still low when compared with the TEM beta-lactamase group 
which are promiscuously distributed among plasmids of a 
wide variety of incompatability groups.
The R-Factor R46 specifies production of the OXA-2 
beta-lactamase and, in addition, mediates resistance to 
streptomycin, sulphonamide and tetracycline. The plasmid 
was originally isolated from a strain of Salmonella 
tymphimurium in 1962 following the introduction of the 
isoxazoyl penicillins the previous year. The properties 
of the OXA-2 enzyme as specified by R46, listed in Table 2 
are those determined by Dale (1971), The molecular weights 
of both the OXA-2 and OXA-3 enzymes (as determined by 
Sephadex gel Filtration) are significantly higher than 
most other beta-lactamases. OXA-2/OXA-3 hybrid studies, 
in conjunction with molecular weight data, suggests that 
both enzymes may be dimeric in nature (Dale and Smith,1976). 
All other beta-lactamases to date, appear to be monomers.
The OXA-1 enzyme is transposable in a recA independent 
background (Yamamoto, Tanaka, Nohara et al.,1981). The 
OXA-2 (bla) gene is not thought to be part of a transposon, 
at least when carried by the R46 plasmid (N. Willetts, 
unpublished data).
17
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Section 3' The location and secretion of beta-lactamases
3.1 The location of beta-lactamases in gram-negative cells
Biochemical and electron microscopic data indicate that the 
cell envelope in gram-negative bacteria is composed of two 
distinct membranes, the outer membrane and the inner or 
cytoplasmic membrane. The cell wall peptidoglycan layer 
is located between the two. The existence of a region 
between the two membranes containing certain soluble 
enzymes has been postulated in order to explain the 
selective release of these enzymes by osmotic shock, a 
technique which disturbs the outer membrane but leaves the 
cytoplasmic membrane intact (Neu and Heppel,1964; Neu and 
Chou, 1967). This region is known as the periplasmic 
space (Mitchell,1961), and in certain conditions can be 
visualised in electron micrographs as a relatively electron 
transparent zone between the two membranes. Periplasmic 
enzymes were originally thought to be unbound to any 
structural component (Heppel,1969), but concentrated in 
polar caps where the periplasmic space is enlarged 
(Wetzel et al.., 1970) Alkaline phosphatase has been 
located in the periplasm using Ferritin-coupled antibodies 
(MacAlister et al.,1972), the enzyme associates with 
lipopolysaccharides in the periplasmic space (Lindsay et al. , 
1973). The current opinion is that the location of certain 
enzymes within the periplasm may be more dependent on 
its association with periplasmic components than on any 
physical limitation.
The release of an enzyme by osmotic shock treatment 
is thought to be an indication of its location within the 
periplasm of the cell. Studies concerning the release 
of plasmid and chromosomally-mediated beta-lactamases 
prompted the hypothesis that the location of beta-lactamases 
within the cell was dependent on the genetic location of 
the enzymes structural gene (Neu,1968). It therefore
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became generally accepted that plasmid-mediated beta- 
lactamases which were released by osmotic shock, were 
periplasmic, whereas chromosomal enzymes which were not 
released, were therefore more tightly bound. Exceptions 
to this generalisation have been recorded (Curtis et al.,1972) 
and it is now thought that the location of the enzyme's 
structual gene has no bearing on the location of that 
enzyme in the cell. Smith and Wyatt (1974) have in fact 
shown that the release of beta-lactamases by osmotic 
shock is apparently dependent on the molecular weight of 
the enzyme itself. Enzymes less than or equal to a 
molecular weight of 30,000 are released whereas those 
above that size are retained. The equivalence of a 
molecular sieve and the outer membrane of gram-negative 
bacteria has been established. It seems likely that, 
although the outer membrane is damaged by osmotic shock 
treatment, it retains some of its sieving properties. 
Presumably, enzymes below a particular exclusion limit are 
released by the treatment depending upon the level of 
membrane damage, and enzymes above that size are retained.
The nature of the component to which a periplasmic enzyme 
may be bound, would influence its release. The 
classification of an enzyme as non-periplasmic if it is 
not released by osmotic shock, is probably invalid.
20
3.2 The -Secretion of proteins across membranes
Secretory proteins are synthesized within the cytoplasm 
and transported across the cytoplasmic membrane to their 
final destination within the cell. In gram-negative 
bacteria, three classes of protein require membrane 
translocation. These are the outer membrane proteins, 
the periplasmic proteins and the cytoplasmic membrane 
proteins. The cell-bound and exo-cellular beta-lactamases 
of both gram-positive and gram-negative bacteria can be 
classed as secretory proteins. The precise mechanism of 
secretion across the cytoplasmic membrane is still unclear, 
however, evidence supports the involvement of a short 
peptide chain designated the signal sequence (Milstein 
et al.,1972). Several secretory- proteins are known to be 
synthesized in a precursor form which has a higher molecular 
weight than the mature protein due to the presence of a 
short peptide extension; the signal sequence (Sugimoto et al., 
1977 ; Sutcliffe, 1978). Amino acid sequencing data have 
indicated that signal regions from different proteins 
share several common properties. Each sequence contains a 
basic section adjacent to the NH2 - terminus and a hydrophobic 
region between the basic section and the cleavage site 
(i.e. site at which the signal region is removed, from the 
mature protein). The amino acid residues at the cleavage 
site show a marked specificity and the hydrophobic region 
is subdivided into three sections by proline or glycine 
residues. The three subsections decrease in hydrophobicity 
as the cleavage site is approached. Figure 2 indicates a 
typical signal region from a secretory protein.
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Figure 2 : The general structure of a signal sequence
composed of 25 amino acids in length
R E S ID U E  NUMBER 
16 11 6
......  H
1
a f = f
CLEAVAGE
SITE
V
b
2
1 = basic region, 2 = hydrophobic region,
3 = recognition site for the cleavage of the signal sequence.
Section 2 is divided into 3 subsections a, b and c by 
proline or glycine at positions 6 and 11.
There are currently two theories of membrane transport, 
namely the loop model (Inouye et al.,1979), and the linear 
or signal model of Blobel and Dobberstein (1975). Only 
the loop model accounts for the various properties of the 
signal region. In this model, the basicity of the NH2 ~ 
terminal region permits the initial attachment of the 
precursor protein to the inner surface of the cytoplasmic 
membrane. Insertion of the protein into the membrane 
proceeds, via hydrophobic interactions, between the 
appropriate sections in the signal region and the lipid 
bilayer. The protein extends through the membrane in a
22
loop configuration with the NH2 - terminus of the signal 
region still attached to the inner surface of the cytoplasmic 
membrane. The role of the proline or glycine residues 
within Section II of the signal region (figure 2), may 
be important in the bending of the peptide at these 
positions to form the loop. Eventually, the cleavage 
site is exposed to proteases within the periplasm which 
cleave off the signal region. The mature protein is 
thereby released outside the cytoplasmic membrane. In 
the loop model processing of the precursor (ie. removal 
of the signal region) seems to be a prerequisite for 
membrane transport. In the linear model, the signal 
region is believed to lead the precursor protein through 
a transmembrane hydrophilic channel. The channel is 
thought to be formed in response to the activation of a 
receptor protein following interaction with the NH2“terminal 
region of the signal sequence. Processing of the signal 
region is not necessary for the transport of a protein 
■across the cytoplasmic membrane using the linear model.
Figure 3 illustrates the differences between the loop 
and the linear models of membrane transport.
Figure 3 : Loop and linear models for the translocation of
secretary proteins across membranes
outside
jCSTi
I
LOOP MODEL LINEAR MODEL
inside
This area represents the basic regions of the f i r s t  several 
amino acid residues of the signal sequence
t^ % ^ This area represents the hydrophobic region and the
cleavage site  of the signal sequence
I I t h is  area represents the mature protein
Arrows mark the cleavage s ite  of the signal sequence
The precise role of the signal sequence and its removal 
is still unclear. It appears to be necessary for transport 
in most cases since mutuational changes in its amino 
acid sequence eliminate translocation (Bedouelle et al.,1980). 
The carboxy-terminal region is necessary for the transport 
of the TEM-1 beta-lactamase across the cytoplasmic 
membrane (Koshland and Botstein,1980). Experiments 
utilising mutants which cause premature termination of 
the polypeptide chain indicate that deletion of even a 
small section of the carboxy-terminal region from the 
TEM-1 enzyme resulted in the failure of enzyme secretion 
into the periplasm. Abortive transportation resulted 
in spite of the normal processing of the signal sequence. 
Furthermore, experiments utilising fused proteins 
constructed from the signal region of the E.coli maltose- 
binding protein joined to the Beta-galactosidase protein, 
have shown that transport of this enzyme does not occur in the 
E.coli system (Bassford et al.,1979). Together, these results 
suggest that the presence and also.probably the removal of the 
signal region is not sufficient to ensure secretion. 
Beta-lactamases utilise different transport mechanisms.
The B.licheniformis enzyme is secreted via a co-translation 
vectorial system where the enzyme is transported as a 
growing chain still attached to the ribosome (Davis and 
Tai,1980), whereas the secretion of the TEM-1 beta- 
lactamase requires that the synthesis of the protein chain 
be complete. Activation of transport systems may be 
confined to the recognition of certain parts of the protein 
molecule particularly the signal region and in the case 
of the TEM enzyme the carboxy terminal sequence. It 
has been suggested, however, that the conformation of 
the whole molecule is involved (Ito et al.,1979). Beta- 
lactamases have provided a useful model for the study of 
processing and secretion in both eucaryotic and procaryotic 
systems. The TEM-1 bla gene has been cloned into a
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suitable vector and transformed into Saccharomyces 
cerevisiae. The enzyme is expressed in a precursor from which 
is correctly processed to the mature enzyme in the eucaryotic 
cell (Roggenkamp et al.,1980). Conversely, eucaryotic, 
procaryotic or hybrid signal sequences can direct the 
secretion of rat insulin in E.coli (Talmadge et al.,1980).
This indicates that some aspects of protein secretion are 
common to both the eucaryotic and procaryotic systems.
B. licheniformis produces different forms of a single 
type of beta-lactamase including a 36,000 molecular weight 
precursor, a 33,000 hydrophobic membrane-bound enzyme and 
several hydrophilic exo-enzymes of variable molecular weight 
(Smith et al.,1981). DNA sequence studies have indicated 
that the enzyme is produced as a precursor form which contains 
a 34 amino acid residue extension at the Nf^-terminus of 
the mature protein. This extension is believed to be the 
target for all processing reactions which produce the 
different catalytically-active forms of the enzyme(Neugebauer 
et al.,1981). The precursor extension is significantly 
larger than most signal regions which usually range from 
1 8 — > 25 residues in length (Inouye and Halegoua, 1980) . 
Consequently, Nielson and his coworkers (Nielson et al.,1981) 
have suggested that the precursor extension consists of both 
a standard signal region and a membrane attachment site.
Removal of the signal sequence would produce an enzyme form 
which had already been, or subsequently could be, modified 
for membrane attachment. The membrane-bound form contains 
a cysteinyl, fatty acid and glycerol residues at or near 
its Nf^-terminus. Similar Nl^-terminal modification has 
been observed in several membrane lipoproteins of E.coli 
(Hantke and Braun,1973; Ichihara et al.,1981). The 
presence of glycerol and fatty acids may be a common phenomenon 
which provides proteins with a hydrophobic region sufficient 
for membrane attachment. The presence of a lipid extension,
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however, is not a prerequisite for the membrane attachment 
of beta-lactamases. Mantsala and Suominen (1981) have 
isolated a membrane-bound form of the TEM-1 beta-lactamase 
which accounts for only 2% of the periplasmic enzyme.
In this case, membrane attachment is maintained by 
hydrophobic association without concomitant lipid attachment 
at the NH2"" terminal region. Two exoenzyme forms of the 
B .licheniformis beta-lactamase have been identified.
The exo-large form (Izui .et al.,1980)contains an additional 
8 residues when compared with the 256 residues of the exo­
small form (Meadway,1969; Ambler and Meadway,1969).
The exo-enzymes can be produced via the removal of the 
hydrophobic region from the membrane-bound form. Cleavage 
is catalysed by a serine protease (Aiyappa et al.,1976; 
Aiyappa and Lampen, 1977). The membrane-bound form, however, 
is not an obligate intermediate in the production of the 
exo-enzymes (Lampen,1978).
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Section 4 Molecular basis for the mode of action of
beta-lactam antibiotics
The rational development of novel beta-lactams which are 
resistant to beta-lactamase attack, necessitates an 
understanding of the mode of action of these compounds.
The concept that beta-lactamases interfere with the structural 
integrity and hence cell wall biosynthesis, was introduced 
in the 1940's and was based on the morphological changes 
induced by penicillin (Gardner, 1940). Cell wall 
peptidoglycan is composed of alternating units of 
N-acetylmuramic acid and N-acetylglucosamine intermittently 
cross-linked via peptide bonds formed between amino acid 
residues in the pentapeptide chains attached to the 
muramic acid moiety (figures 4 and 5). Three enzymes have 
been described which are implicated in cell wall biosynthesis. 
These are the transpeptidases, the D-alanine (D-ala) 
carboxypeptidases and the endopeptidases. Multiple 
molecular forms of these enzymes have been identified that 
differ with respect to their penicillin sensitivity 
(Ghussen,1977). Transpeptidases catalyse the cross-linking 
between the pentapeptide chains in cell wall peptidoglycan; 
the cross-links serve to stabilise and strengthen the cell 
wall. D-ala carboxypeptidases cause the release of the 
C-terminal D-alanine from the pentapeptide without 
concomitant transpeptidation (Izaki et al.,1966). In view of 
their 'in vitro' activity, it has been suggested that they 
function 'in vivo' to regulate the level of peptidoglycan 
cross-linkage. Regulation being achieved via the conversion 
of some of the pentapeptide side chains to tetrapeptides, 
thereby preventing them from acting as peptide donors in 
the cross-linking reaction (Blumberg and Strominger,1974).
The autolytic endopeptidases cleave the peptide bond 
between the cross-linked dimers 'in vitro' to produce 
disaccharide-peptide monomers (Bogdanovsky et al.,1969)
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Figure 4 Structure of the basic subunit of cell wall
peptidoglycan
N-acety|glucosamine N-acetylmuramic acid
c h 2o h  c h 2o h
■CHCH, NHCOCHNHCOCH3
L— alanine
D-isoglutam ine
penta - L - ly s in e
p eptide  |
D -a la n in e
D-Jlanine
Figure 5 : Structure of the peptidoglycan of Escherichia coli
'Q/u a la
9/u’ys
9/u
ys
a laNAG = N-acetylglucosamine , N A M A -N -a c e ty lm u ra m ic  acid
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Weidel and Pelzer (1964) suggested that autolysins which 
include the endopeptidases may have a physiological role 
during normal cell wall synthesis in that their controlled 
activity may open up parts of the peptidoglycan, at which 
new units could be added by the action of synthetases.
The precise physiological roles of both the D-ala 
carboxypeptidases and endopeptidases in cell wall 
biosynthesis is obscure since in some cases synthesis 
can proceed normally in their absence ( Matsuhashi et aj.. ,
19 77). The consequence of beta-lactams binding to these 
enzymes is also unknown since no particular morphological 
effect can be attributed to them. This proves particularly 
puzzling in the case of the D-ala carboxypeptidases, since 
they represent the major cell wall penicillin-sensitive 
enzyme (PSEs). The allocation of a specific function to each 
of the PSEs is further complicated by the demonstration 
that they each catalyse several different reactions 
'in vitro1. For example, the D-ala carboxypeptidases of 
B .stearothermophilus (Yocum et al.,19 74) and Streptomyces 
species (Leyh-Bouille et al.,1972) catalyse endopeptidase 
reactions. Furthermore the two purified proteins from Salmonella 
typhimurium catalyse transpeptidase, D-alanine 
carboxypeptidase and endopeptidase reactions (Shepherd et 
al.,1977). The three cell wall PSEs may function 
synergistically 'in vivo' to maintain a complex balance 
in enzyme concentration which is necessary to control 
peptidoglycan synthesis and maintain the structural 
integrity of the cell wall.
Beta-lactams inhibit the final transpeptidation reaction 
of peptidoglycan synthesis. Tipper and Strominger (1965) 
proposed that beta-lactams act as substrate or transition 
state analogues of acyl-D-alanyl-D-alanine, the normal 
substrate of the transpeptidase enzyme. As such, they bind 
to and subsequently acylate an active site serine residue 
in the transpeptidase enzyme (Yocum et al.,1979; Waxman
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and Strominger,1980). The covalent penicilloyl-enzyme 
is relatively stable. The transpeptidase is inactivated 
and can no longer catalyse transpeptidation. This results 
in a blockage in peptidoglycan synthesis. The concept 
of structural analogy, as proposed by Tipper and Strominger, 
is not so simple. Analysis of stereomodels of beta-lactams 
and acyl-D-alanyl-D-alanine substrates has indicated 
several discrepancies. Consequently, Rando (1975 a, and 
b) has designed a model in which the reactivity of the 
beta-lactam is more important to its inhibitory antibiotic 
activity than isoterism. In this model, the antibiotic 
requires catalytic conversion by the target enzyme to an 
active form with a conformation similar to that of the 
normal substrate of the transpeptidase. Rando argues that 
the active site of the enzyme binds the antibiotic in such 
a way that the beta-lactam nitrogen is forced to approach 
planarity. In this way, the strain energy applied by the 
enzyme would be transferred to the already reactive carbonyl- 
nitrogen bond in the beta-lactam ring. In comparison with 
the free antibiotic, the enzyme-bound form would be in a 
higher energy state. Cleavage of the carbonyl-nitrogen 
bond would release the strain which would be manifested 
as an increase in the chemical reactivity of the compound.
The net result of these changes would be to increase the 
probability of a reaction between the antibiotic and the 
active site serine residue. This model also explains the 
requirement for the presence of certain substituents in 
the beta-lactam nucleus for inhibitory activity, particularly 
in relation to free amino and carboxylic acid moieties.
These groups are thought to act as handles by which the 
enzyme distorts the conformation of the antibiotic thereby 
further increasing the chemical reactivity of the beta- 
lactam amide bond. Similar interactions between the side 
chain of the third amino acid residue in the pentapeptide 
chain and the transpeptidase enzyme might result in the 
similar distortion of the D-ala-D-ala portion of the
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substrate'. Once these conformational changes have 
occurred, the serine residue in the enzyme active site is 
more prone to acylation by the penicilloyl or acyl-D-ala 
moieties.
The exposure of a bacterial cell to beta-lactam 
antibiotics can result in three different effects, a 
cessation of bacterial growth, a decrease in cell viability 
or cell lysis. The cytocidal and cytolytic effects were 
originally thought to be a direct result of inhibition of 
cell wall biosynthesis. Inhibition of synthesis in the 
presence of a normally growing cytoplasmic mass would lead 
to the mechanical rupture of the cell followed by cell 
lysis due to osmotic stress. The concept that lysis is 
a passive osmotic effect now seems invalid due to several 
recent observations which clearly indicate that lysis is 
an enzyme catalysed process. Furthermore, the cytocidal 
and cytolytic effects do not occur invariably. For example, 
within the Streptococci, penicillin induces several 
responses; S.pneumoniae is killed and lysed, S.pyogenes 
(group A) is killed but not lysed, while S .sanguis is 
neither killed nor lysed (Horne and Tomasz,1977). As 
summarised by Tomasz and Holtje (1977), penicillin - 
induced lysis is apparently mediated by endogenous 
peptidoglycan hydrolases (autolysins) secondary to the 
primary biochemical effects of the antibiotic on murein 
biosynthesis. The exact interrelationship of these primary 
biochemical and secondary physiological disturbances is 
unknown. It has, however, been established that autolysins 
are under a negative control system (Tomasz and Waks,1975; 
Tomasz and Holtje,1977). The interaction of beta-lactams 
with their target enzymes, results in the loss of an autolytic 
inhibitor, which in turn triggers autolytic activity and 
hence cell lysis. More specifically Tomasz (1979) postulates 
that, as a result of one or more signals generated by 
penicillin interference in cell wall synthesis, an inactive 
complex of murein hydrolase-lipoteichoic acid (enzyme-
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inhibitor' complex) dissociates, thereby releasing active 
hydrolase molecules and inhibitor (which is secreted into 
the medium).
Identification of the precise cellular targets of 
.beta-lactams is complicated by the presence of multiple 
forms of the cell wall PSEs. One implication of the 
structural analogue hypothesis is that PSEs can be detected 
as those proteins that covalently bind radio-active 
penicillin (Blumberg and Strominger,1974) and can be 
visualised by scintillation radioautography after formation 
on SDS-polyacrylamide slab gels (Spratt and Pardee,1975).
PSEs detected in this way are called penicillin binding 
proteins or PBPs. Each bacterial species has a characteristic 
set of PBPs of which seven have been identified in E.coli 
(Table 3). Examination of the properties of PBP temperature- 
sensitive mutants, in conjunction with studies on the 
binding of beta-lactams which are specific or relatively 
specific in producing a single morphological effect, have 
provided an understanding of the role of each PBP in the 
killing effects of beta-lactams. Mecillinam over a wide 
concentration range results in the conversion of gram- 
negative bacteria into osmotically-stable oval cells 
(Spratt,1975). Mecillinam binds preferentially to PBP2. 
Consequently, this protein is implicated in some aspect 
of shape determination presumably involving synthesis and 
remodelling of peptidoglycan (Spratt,1977). Similarly, 
cephalexin, which inhibits cell division, binds 
preferentially to PBP3. This protein is, therefore, 
involved in some aspect of septum formation. The three 
PBPs, 1B, 2 and 3, have been identified as the primary 
killing targets of beta-lactam antibiotics (Spratt, 1979) . 
Inactivation of any one is potentially lethal. PBP1 is 
composed of two units, 1A and 1B. Temperature sensitive 
mutants of 1B which are deficient in peptidoglycan synthesis, 
suggest that this enzyme is the major cell wall
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transpept'idase (Tamaki et al.,1977). Several of the other 
PBPs catalyse natural transpeptidase reactions 'in vitro’• 
Whether or not they contribute to transpeptidation 'in vivo' 
is unknown. PBP 1A is dispensable to the cell but 1A 
and 1B can however,substitute for each other, with 1A 
acting as a detour enzyme in the absence of 1B (Suzuki 
et al.,1978).
Three carboxypeptidases, 1A, 1B and 1C have been 
purified from E.coli (Tamura et al.,1976). Mutants lacking 
enzyme 1B/C (1C is the soluble form of the membrane- 
bound enzyme 1B) lack PBP4. Mutants deficient in PBP4 
are more stable to penicillin-induced lysis, suggesting 
that the role of this protein (in Vivo1 may be as an 
endopeptidase rather than a carboxypeptidase (Iwaya and 
Strominger,1977) .
Purified carboxypeptidase 1A on SDS-PAGE runs as a 
doublet of molecular weight 40,000 and 42,000 which 
corresponds exactly to PBP5 and 6 (Spratt and Strominger,
1976). Initially, it was unclear whether or not the doublet 
represented modifications of the same polypeptide. It has 
since been established that they are different polypeptides 
coded for by separate genes (Matsuhashi et al.,1979).
The precise physiological roles of PBPs 1A, 4 , 5  and 6 
remain unclear since the binding of beta-lactams to these 
proteins seems to induce no visible response. Little is 
known about the enzymatic functions of PBP1A and the 
killing targets 2 and 3. Presumably, these PBPs catalyse 
one or more of the known penicillin-sensitive reactions 
involved in cell wall biosynthesis but make too minor a 
contribution to the total activity of the cell to be 
readily detected. In view of the involvement of PBB3 in 
cell division, there are several possibilities for the 
role of this protein. Thus, it may itself be a transpeptidase 
directly responsible for initiating cross-wall synthesis,
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coupled in some way to the termination of a round of DNA 
replication. Alternatively, it may act to alter the 
direction of insertion of new peptidoglycan chains such 
that septum formation is initiated rather than peripheral 
cell wall synthesis.
Although beta-lactams can kill by the inactivation of 
a single target protein, many have similar affinities for 
2 or 3 of these targets. As discussed earlier in this 
section, the statement that beta-lactams kill bacteria by 
inhibiting peptidoglycan transpeptidation, is only part 
of the picture, at least for E.coli. Inactivation of the 
major cell wall transpeptidase 1B is usually fatal to the 
cell. Many beta-lactams, however, produce cytocidal and 
cytolytic effects without concomitant inhibition of this 
enzyme. The morphological response of bacterial cells 
to beta-lactam antibiotics reflects the preferential 
binding to, and consequent inhibition of, one or more of 
the target proteins corresponding to several enzymatic 
performances that together produce the three dimensional 
cell wall structure.
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Section 5' The functions of beta-lactamases
5.1 The role of beta-lactamses in resistance
From a theoretical standpoint, resistance to beta- 
lactam antibiotics can be achieved through a variety of 
mechanisms. These include modification of the target 
enzymes to prevent interaction with the beta-lactam whilst 
retaining the enzymes catalytic activity, tolerance due to 
the alteration of the cells autolytic activity, acquisition 
of a broad-spectrum highly active beta-lactamase and 
modification of the cells outer surface so as to limit the 
access of the antibiotic to its cellular target. In 
clinical practise, beta-lactamase - mediated hydrolysis 
of beta-lactam antibiotics is by far the most important 
resistance mechanism since it is difficult for modification 
of an important target to be achieved without deleterious 
effects on bacterial growth rate, alteration of the outer 
membrane permeability almost certainly effecting the rate 
of uptake of essential metabolites.
Tolerance can be distinguished from the more well 
characterised forms of resistance when the typical 
bacteriocidal response of a cell becomes bacteriostatic.
The cells retain their low minimal inhibitory concentration 
values but show increased viability during prolonged 
antibiotic treatment and are resistant to lysis. Despite 
modification of the cells autolytic system, the cell wall 
biosynthetic enzymes previously discussed remain sensitive 
to inhibition. Tolerance represents a clinically important 
form of resistance in Gram-positive bacteria (Sabath et ajL. ,
1977) and may contribute to the clinical phenomenon known 
as bacterial persistence. Tolerance has also been 
demonstrated in mutant strains of E.coli (Ayusawa et al.,1975) . 
Resistance in E.coli due to an alteration in the cells 
PBPs has been recorded. Mecillinam binds preferentially to 
PBP2 resulting in the production of large spherical
36
osmotically-stable cells. Spratt (1978) isolated a 
temperature-sensitive mecillinam resistant mutant in which 
resistance was due to the modification of PBP2. The PBP2 
protein was less thermostable than parental PBP2 and 
its affinity for C 14 benzylpenicillin was significantly 
reduced. The fact that alteration of a PBP can affect the 
cells sensitivity, even though the protein may not be a 
vital cellular target, is illustrated by mutants of E.coli 
which lack the D-ala carboxypeptidase 1A activity. Although 
this enzyme is not considered essential for growth, its 
loss results in the supersensitivity of the mutant to a 
number of beta-lactams (Tamaki et al.,1978).
The gram-negative cell envelope contains an outer 
membrane proximal to the peptidoglycan layer. Gram-positive 
cells do not possess this outer membrane. This difference 
in structure may account for the different beta-lactamase 
locations in each case and for the different strategies that 
both cell types have evolved to produce resistance to 
beta-lactam antibiotics. In general, the beta-lactamases 
of Gram-positive cells are extracellular, are produced in 
large quantities when induced and have a strong substrate affinity 
(Citri and Pollock, 1966). Induction commits a large 
proportion of the cells synthetic machinery to enzyme 
production which, if prolonged, can prove detrimental. The 
efficiency of induction as a process lies in its ability 
to control enzyme production in response to environmental 
stimulation. Resistance in Gram-positive bacteria is based 
on the destruction of the antibiotic outside the cell by 
externally secreted beta-lactamases since the cell lacks 
any back-up system of resistance. Beta-lactamase production 
is therefore the primary mechanism by which Gram-positive 
bacteria mediate resistance to beta-lactam antibiotics.
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The situation with gram-negative bacteria is more 
complex. Enzymes are usually cell-bound, exceptions seemingly 
being the beta-lactamases produced by strains of Bacteroides 
fragilis, Hemophilus influenzae and Neisseria gonorrheae 
(Sykes and Percival,1978). Attempts to correlate 
resistance with enzyme production have indicated some 
discrepancies. In the case of some plasmid-mediated enzymes, 
a good correlation between gene copy number, enzyme 
production and resistance has been demonstrated (Uhlin and 
Nordstrom,1977). Certain gram-negative strains however 
express resistance without concomitant enzyme production.
This 'intrinsic' resistance is due to the outer membrane 
permeability of the cell. The outer membrane of gram- 
negative cells acts as a barrier to hydrophilic compounds 
of a certain molecular size and each species seems to have 
a characteristic exclusion limit (Nakae and Nickaido,1975). 
Penetration is thought to occur through aqeous pores formed 
by outer membrane proteins known as porins (Nakae,1976) .
In general hydrophobic compounds do not pass through these 
pores easily even though they are well within the size limit. 
Zimmerman and Rosselet(1977) established that an increase in 
the lipophilic nature of the antibiotic tended to decrease 
its rate of diffusion. In summary, resistance in gram-negative 
bacteria results from the interplay between the outer 
membrane permeability and the concentration and kinetic 
parameters of the beta-lactamase located within the periplasm. 
This synergistic interaction is known as crypticity.
38
5.2 The- Physiological function of beta-lactamases
Certain beta-lactamases are among some of the most active 
enzymes known. The concept that their only physiological 
role is to protect the cell from the cytocidal effects of 
beta-lactam antibiotics has met with some scepticism.
The relationship between resistance and enzyme production 
can be very loosely based particularly in ^ Tram-negative 
bacteria. In some cases the level of enzyme production 
is so low as to seem insufficient to serve as a protective 
mechanism. Beta-lactamases have been demonstrated in 
strains isolated prior to the introduction of beta-lactam 
antibiotics as chemotherapeutic agents. In terms of 
conservation the cell favours the evolutionary stability 
of any function which provides a selective advantage.
The maintenance of beta-lactamases prior to the clinical 
introduction of beta-lactams must have been mediated by 
the operation of an unknown selection pressure or by the 
fact that the enzyme has some other physiological function.
The production of beta-lactams by soil and skin saphrophytes 
can be demonstrated 'in vitro1 but it is not known to occur 
'in vivo'. It therefore seems unlikely that environmental 
beta-lactams could have provided the necessary selective 
pressure for the maintenance of beta-lactamases. Other 
functions of beta-lactamases are not readily forthcoming.
Both beta-lactam compounds and peptidoglycan can induce 
enzyme production. In some strains of B.cereus, the onset 
of enzyme synthesis corresponds to the availability of 
peptidoglycan. Enzyme and peptidoglycan concentrations 
are high at cell germination and sporulation but low in 
vegetative log phase cells. These observations led Ozer 
and Saz (1970), to suggest that beta-lactamases are involved 
in cell wall and spore coat metabolism. Furthermore,
Sykes and Matthews (1976), have subsequently proposed that 
beta-lactamase may function in the breakdown of a beta- 
lactam structure which is a transitory cell wall intermediate.
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Beta-lactamases may have a common evolutionary origin 
and good candidates for their common ancestors are the cell 
wall synthetic enzymes. Pollock (1967) has suggested that 
beta-lactamases may have evolved from its*common ancestor 
via gene duplication followed by separate evolution in 
-response to environmental stimulation. Alternatively, theyJ 
may be direct line step mutations from a cell wall synthetic 
enzyme, the activity of which has been retained. Concurrent 
with Pollock's proposal, is that beta-lactamases and cell 
wall synthetic enzymes would share some common regions of 
amino acid sequence. The amino acid sequence from the 4 
group A beta-lactamses (Ambler,1980) and the two D-ala 
carboxypeptidases (Yocum et al.,1979 ; Waxman and Strominger, 
1980) from B .subtilis and B .stereothermophilus show 
significant homology in their NH2”terminal and active site 
regions. The two enzyme types share the same acyl-enzyme 
catalytic mechanism and can both be classed as serine 
enzymes. Furthermore, sequence data from PBP5 (D-alanine 
carboxypeptidase) of, E.coli, has indicated that this enzyme 
shows significant homology to the TEM betar-lactamases. in its 
Nf^-terminaT region (Waxman et al.,1982j Broome-Smith and 
Spratt, 1983)*. Within the last 65 amino acid NH2“terminal 
residues, 23% of the residues are in identical positions to 
those of TEM. The remainder of the protein sequence shows 
little similarity. In particular a region from residues 
2 6 - 3 1  in both proteins shows extensive homology with 5 
out of the 6 residues showing identity. This region is 
highly conserved in the PBP5 from other strains including 
the two Bacillus enzymes. Certain D-ala carboxypeptidases are 
able to hydrolyse both their own normal substrate, acyl- 
D-alanyl-D-alanine, and beta-lactam antibiotics; in fact 
the staphylococcal enzyme has equal carboxypeptidase and 
beta-lactamase activity (Kozarich and Strominger,1978).
The evidence that the group A serine beta-lactamases and 
D-ala carboxypeptidases are evolutionary related is strong
*BFOOME-SMITH, J.K, and SPRATT, B.G.(1983). The sequence of the penicillin 
binding protein 5 of Escherichia coli. Society for General Microbiology,
. 96th Ordinary Meeting, Newcastle, 4-6th January. Abstracts published 
in Society for General Microbiology Quarterly, vol.9, Part 4.
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but by no means conclusive. The completion of structural 
studies currently in progress is awaited to either prove 
or refute this similarity. If true, however, it would 
explain why beta-lactamases utilise the acyl-enzyme 
catalytic mechanism in preference to a much simpler acid/ 
base catalysis.
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Section 6 The interaction of Beta-lactamases with substrates
and inhibitors
6.1 The mechanism of action of Beta-lactamases
Acyl-enzyme intermediates in enzyme-catalyzed hydrolytic 
pathways are common to several enzyme/substrate interactions. 
Recent evidence suggests that beta-lactamase - catalyzed 
hydrolysis of beta-lactam antibiotics proceeds via a general 
reaction pathway which is characterised by the formation of 
an acyl-enzyme intermediate. The enzyme acts as a 
nucleophile, attacking the substrate at the susceptible 
carbonyl-amide bond to form an acyl-enzyme complex via an 
ester linkage between the beta-lactam carbonyl and a 
functional group at the enzyme’s active site. Deacylation of 
the complex proceeds following hydrolysis of the newly formed 
ester bond releasing active enzyme and the degradation 
products of beta-lactam-hydrolysis. Support for this 
mechanistic pathway comes from three separate lines of evidence. 
The first line of evidence is based on the interaction of 
several beta-lactamases with active-site directed inactivators. 
In each case the enzyme in question forms a covalent complex 
(acyl-enzyme intermediate) with the inactivator (Charnas et 
al.,1978a; Cartwright and Coulson,1979; Loosemore et al. ,1980). 
The second and third lines of evidence are derived from 
studies on the interaction of the Pseudomonas enzyme and the 
Amp C beta-lactamase with cloxacillin (Knott-Hunziker,
Petursson, Jayatilake et al.,1982; Knott-Hunziker, Petursson, 
Waley et al.,1982), and the RTEM-2 enzyme with cefoxitin 
(Fisher et al.,1980). In both cases kinetic, spectroscopic 
and chemical data substantiate the formation of an acyl- 
enzyme intermediate. The respective acyl-enzyme complexes 
have been isolated following the interaction of the 
enzymes with radio-active labelled substrate and 
subsequent denaturation. Furthermore, in the case of the 
Pseudomonas enzyme and the Amp C beta-lactamase from
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E. coli K-12 (Boman et al.,1974) the acyl-enzymes have been 
degraded in order to determine the residue labelled and 
the sequence around it. The labelled active-site residue 
was in each case identified as serine. A minimal kinetic 
scheme for the interaction of beta-lactamases with their 
substrates is shown in Figure 6.
Figure 6:- Possible scheme for the hydrolytic pathway of 
beta-lactamases.
K- K ? K-
E + S  s ES    => ES* ---— ± E + P(s)
E = Enzyme, S = Substrate, ES = Michaelis Menten complex, 
ES* = Acyl-enzyme intermediate,P(s) = product(s) of 
the hydrolytic breakdown of the substrate
Beta-lactamase mediated hydrolysis of penicillins 
produces the corresponding penicilloic acid in stoichiometric 
proportions. Penicilloic acid has two acidic groups relative 
to the parent compounds one, permitting the progress of the 
catalytic reaction to be assessed. The situation with 
cephalosporins is more complex. The breakdown products of 
hydrolysis are dependent on the nature of the substituents 
at the 3C position of the dihydrothiazine ring. It is 
assumed that a cephalosporoic acid is produced analogous to 
the penicillin situation. With few exceptions, however, 
the cephalosporoic acid is unstable and undergoes rapid 
decomposition. Hydrolytic cleavage of the beta-lactam ring 
is often accompanied by expulsion of the 3C substituent, 
provided that the cephalosporin in question contains a good 
leaving group at this position. The product formed following 
expulsion takes the general form shown in figure 7. The 
loss of a leaving group at C3 in certain cephalosporins, is 
a consequence of but not a prerequisite for hydrolysis of 
the beta-lactam ring (O'Callaghan et al.,1972).
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Figure 7:* Product from the hydrolytic cleavage of those 
cephalosporins containing a leaving group at C-3
H
R — C — N -
° A  NvNO NHR, 
COO
CH-
44
6.2 Beta-lactamase Assay Methods
The methods available for assaying beta-lactamase activity 
are relatively numerous but can, however, be divided into 
two categories depending upon which detection method they 
are based. The?first group includes all the methods which 
detect the concentration of unhydrolysed substrate, for 
example, the hydroxylamine assay of Boxer and Everett 
(1949), and the microbiological assay (prstravik and pdegaard 
19 71). The second category relies on the detection of the 
hydrolytic breakdown products and includes the acidimetric/ 
alkalimetric methods (Hou and Poule,1972), the iodometric 
methods and the spectrophotometric assay of Samuni (1975).
No one method is suitable for all purposes. The method of 
choice must take into account the material to be assayed, 
the sensitivity required and the substrate to be utilised.
The diversity of the assay techniques has meant that a 
comparison of data collected from different laboratories 
is difficult.
The iodometric assay method is a popular technique 
which is particularly useful for kinetic analysis. The assay 
is based on the reduction of iodine by the breakdown 
products of beta-lactam hydrolysis. The level of reduced 
iodine is measured either by back titration with sodium 
thiosulphate (Macroiodometric technique : Perret,1954), or 
more sensitively by following the decolourisation of a 
starch-iodine complex spectrophotometrically (Microiodometric 
technique : Novick,1962). Cephalosporin substrates are less 
suitably adapted to this assay technique than their 
penicillin counterparts, due to the complexity of their 
hydrolytic pathway. New assay techniques are currently 
being developed. Yamabe (1980) has recently introduced 
a rapid spectrophotometric assay which is based on the 
reduction of cytochrome C in the presence of copper sulphate.
The current limited use of the technique probably stems 
from the fact that it seems to offer no distinct advantage 
over existing methods.
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Many•hospitals now screen routinely for beta-lactamase 
producers. Here the method of choice must be quick, simple 
and extremely sensitive, since the pretreatment of gram- 
negative bacteria to render the enzymes more accessible 
for assay is often impracticable. The methods currently 
employed utilise a filter paper strip, impregnated with an 
indicator, which undergoes a colour change as a result of 
beta-lactamase-mediated hydrolysis. The indicators fall 
into two categories; chromogenic cephalosporins and pH 
indicators. The chromogenic cephalosporins which include 
nitrocefin (Russell,1972; Gibbs and Thornsberry,1979), and 
pyridinium-2-Azo-p-Dimethylaniline chromophore (Jorgensen 
et al..,1982), act as substrates in the assay technique and 
undergo a colour change in response to the hydrolysis of 
their beta-lactam rings. The pH indicators, including 
phenol red (Tu et cil.,1980) and bromescol purple, require 
the addition of a substrate to the assay. Hydrolysis of 
the substrate releases gxtra acidic groups producing a pH 
change which is detected by the pH indicator. The 
identification of beta-lactamase producers is often a 
necessary prerequisite for effective clinical treatment. 
Consequently, a radio isotope assay has now been developed 
in order to detect the enzyme in biological fluids and 
permit the rapid diagnosis of bacterial infections 
(Yolken et al.,1980). The assay is 100-fold more sensitive 
than conventional methods.
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6,3 Substrate induced conformational response
The binding of specific ligands (substrates, coenzymes) 
may be accompanied by conformational changes in certain enzymes. 
These reversible transitions are known as the conformational 
response (Citri ?and Zyk, 1967). Several beta-lactamases
exhibit a substrate - induced response in terms of a specific 
change in the conformation of their active sites (Citri and 
Garber,1961). The nature of the penam side chain 
influences the nature of the response and, consequently, 
the rate of the catalytic reaction (Citri and Zyk,1965).
Class S substrates induce a compact conformation favourable 
to catalysis (e.g. ampicillin, and benzylpenicillin).
Class A substrates induce an open conformation that limits 
hydrolysis (e.g. oxacillin). The conformational response 
exhibited during hydrolysis of a class A substrate is 
manifested kinetically as a biphasic pathway, where an 
initial phase of decelerating kinetics is followed by a 
second linear rate (Citri et al.,1976). Enzymes which show 
biphasic kinetics are said to display hysteric behaviour.
A typical conformational response is manifested by altered 
physical and chemical parameters which include altered 
reactivity to iodine, p-chlormecuribenzoate, heat stability, 
photo-oxidation and proteolysis. Homologous antibodies 
prevent the conformational response and resulting kinetic 
shift, by stabilising the native conformation of the enzyme 
(Zyk and Citri,1968). Although enzymatic hysteric behaviour 
has only been demonstrated in a limited number of cases, 
this conformational adjustment may be a general phenomenon 
which, in most enzyme reactions, is usually too rapid to be 
observed. Evidence consistent with this theory derives from 
a demonstration that so called non-hysteric enzymes display 
an antibody induced catalytic acceleration of class A 
substrates. Koshland (1960) proposed that the specificity 
of an enzyme is based on its conformational response pattern. 
Recent evidence pertaining to the B.cereus I beta-lactamase
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supports this theory (Samuni and Citri,1979). Samuni and 
Citri gauged the effect of different beta-lactams on the 
conformation of the enzyme by examining the kinetics of 
deceleration of class A-type substrates, using the postulate 
that different kinetics would reflect different 
conformational responses. They concluded that the 
specificity of the catalytic parameters is matched by and, 
therefore, may derive from the conformational response of 
the enzyme.
Class A substrates induce a conformational response 
in certain 'floppy' beta-lactamases which is unfavourable 
to catalysis. Kiernerand his co-workers (Kierner et al.,1980) 
have proposed that this substrate-induced inactivation of 
certain beta-lactamases is due to the unfolding of an acyl- 
enzyme intermediate in the normal hydrolytic reaction pathway. 
Presumably, substrate - induced inhibition is a form of 
competitive inhibition in which the poor class-A substrate 
can compete with the good class-S substrates for the enzyme 
active site. In this case inhibition is produced by a 
competitive substrate rather than a competitive inhibitor, 
since limited hydrolysis of the inhibitory compound does 
take place.
48
6.4 The interaction of beta-lactamases with inhibitors
The proliferation of beta-lactamase producing bacteria 
provides a continual obstacle to effective antimicrobial 
chemotherapy. This problem has been approached in two ways. 
Research has, a) .concentrated on the development of effective 
antibiotics which are also resistant to hydrolysis and 
b) on the use of beta-lactamase inhibitors. Traditionally, 
resistance to the action of beta-lactamases, combined with 
antibacterial potency, was obtained by the development of 
semi-synthetic beta-lactam derivitives. Several of these 
derivitives show beta-lactamase inhibitory activity towards 
certain enzymes. In each case, inhibition is generally of 
a competitive and reversible nature. The inhibitory activity 
of semi-synthetic penicillins was first reported in 1964 
(Hamilton - Miller et al.,1964). A survey of more than 1000 
semi-synthetic beta-lactams conducted by Cole et al.,1972 
indicated that the most effective inhibitors of the beta- 
lactamase produced by E.coli B11 were the alkoxy and halogen 
substituted phenyl, napthyl or quionolyl penicillins. The 
concept of combining an inhibitor with a susceptible antibiotic 
in order to protect the labile beta-lactam from inactivation 
and allow it to achieve its antibacterial potency, was first 
explored by Sabath and his co-workers (Sabath et al.,1967). 
Although a therapeutically attractive principle, the concept 
met with little clinical success. This failure stemmed, 
primarily, from the competitive nature of inhibition and the 
lack of a broad-spectrum inhibitor. O'Callaghan and Morris 
(1972) reported that, of the inhibitors available at that 
time, no single compound was active against a broad range 
of enzymes. The inhibitor/substrate concept proved to be 
ineffective even when applied to the treatment of urinary 
tract infections where the possibility of exploiting the 
high beta-lactam concentrations might be expected to offer 
a greater chance of success (Greenwood and O'Gr'ady, 1975).
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Recently, several effective beta-lactamase inhibitors 
have been isolated which act synergistically in combination 
with certain beta-lactam antibiotics. As mentioned in 
section 1, clavulanic acid and the olivanic acids are 
naturally occuring examples of such potent, active-site 
directed inhibitors. Recognition of their powerful inhibitory 
activity has prompted a surveillance of soil isolates for 
related compounds such as PS-5 (Okamura et al.,1978); and 
mode of action studies have led to the development of 
synthetic derivitives such as Penicillanic acid sulphone 
(English et al.,1978) and 6 beta-bromopenicillanic acid 
(Knott-Hunziker, Orlek et al.,1979). Investigations into the 
interaction of these various inhibitors with certain 
beta-lactamases (Charnas et al.,1978a; Loosemore et al.,1980) 
have led to the proposal that this novel group of compounds 
function as Kcat or suicide inactivators (Rando,1975a?Abeles 
and Maycock,1976). Suicide inactivators are compounds which 
are structurally related "to the natural substrates of the 
enzyme and, as such, they can interact with the enzyme at 
its active site. The inactivator is converted to a reactive 
species which can covalently bind to one or several active 
site functional groups which results in inhibition.
The level of inhibitory activity displayed by such an 
inactivator is dependent on its ability to undergo an 
enzyme-catalyzed conversion to a reactive species which can 
covalently modify the enzyme.
Beta-lactamase-mediated hydrolysis of a substrate is 
thought to proceed via the formation of an acyl-enzyme 
intermediate which subsequently undergoes deacylation, 
releasing active enzyme and an inactive reaction product 
(Fisher et al.,1980 ), (Section 6.1). Inhibition by a Kcat 
inactivator is also thought to follow a similar mechanistic 
pathway via formation of an acyl-enzyme complex (Fisher et al. , 
1980 ). It is proposed that inhibition results from the
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structural rearrangement of the acyl-enzyme complex into 
a series of derivitives which are more stabilised to 
normal hydrolysis. The concept of reversible or irreversible 
inhibition is then dependent on the relative stabilities 
of these rearranged derivitives. The interaction of the 
.TEM-2 beta-lactamase with clavulanate leads to enzyme- 
catalyzed depletion of the inhibitor, transient inhibition 
and irreversible inactivation (Fisher et al.,1978).
Three irreversible inactive species have been identified by 
isoelectric focusing (Charnas et al.,1978a). The multiplicity 
of these reaction products suggests a) that the inhibitor 
may have multiple attachment sites at the active site of 
the TEM enzyme or b) that the enzyme may generate a series 
of acylating or alkylating agents from the inhibitor which 
can each inactivate the enzyme or c) both. Several possible 
pathways for the interaction of clavulanic acid with beta- 
lactamases are shown in figure 8. The enzyme may be 
acylated (at 'X*, though from the multiplicity of inactivated 
enzyme species produced in the TEM reaction, there may be 
more than one 'X' group in this case) by reaction either of 
the intact beta-lactam ring of clavulanic acid or of a 
ketene clavulanate - derived derivitive (I ). Following 
its formation, the acyl-enzyme complex may undergo a series 
of structural rearrangements which generates a series of 
alkylating agents (Michael acceptors, V andVI). These 
rearranged derivitives are more stabilised to the normal 
deacylation reaction and therefore result in enzyme 
inhibition. The rearrangement is thought to involve a 
beta-elimination reaction across the C5-C6 bond of the 
clavulanate-enzyme complex which, in turn, leads to the 
opening of the 5-membered heteroazolidine ring. The 
derivitives formed following such a beta-elimination reaction 
are believed to be consistent with the formation of ene- 
amino carbonyl derivitives such as structures . V, VI VIIand 
V 131 in figure 8, which absorb strongly at 280nm (Fisher et 
al.,1980 ). Evidence in support of this postulate derives
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FIGURE 8 . POSSIBLE PATHWAYS FOR THE INTERACTION OF CLAVULANIC
ACID WITH B E T A -L A C T A M A S E S
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I V =  C l a v u l a n a t e - d e r i v e d  product  from hydro lyt ic  turnover  
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from the fact that both the transient and irreversibly 
inactivated species produced during the TEM/clavulanate 
interaction show an increased absorbtion at this wavelength. 
Further covalent modification of the enzyme may then result 
from the interaction of the Michael acceptors with an enzyme 
nucleophile Y (structure VH5. Fisher et al.,(1978) have 
suggested that an enzymatic base assists in proton removal 
from the 6 oc C atom which provides the driving force for 
the beta-elimination reaction and the subsequent opening 
of the ring system. Cohen and Pratt (1980) , in their 
studies on the interaction of the B.cereus I enzyme with 
6 beta-bromopenicillanic acid, see no requirement for base- 
catalysed opening of the ring system which, they suggest, 
is prone to automatic opening. The interaction of 6 beta- 
bromopenicillanic acid with the B.cereus I enzyme shows 
several other different features from that of the clavulanate/ 
TEM-1 system. In the former interaction, acylation of the 
enzyme at a unique serine residue is followed by rapid 
irreversible enzyme inactivation, presumably via structural 
rearrangement of the acyl-enzyme intermediate analogous to 
the clavulanate/TEM system. Spectroscopic and chemical 
data have indicated that the bound inhibitor species 
represents a dihydrothiazine moiety (Knott-Hunziker, Waley 
et al.,1979;. Orlek et a^.,1980). This structure is 
illustrated in figure 9.
The interaction of the TEM-1 enzyme with Penicillanic acid 
sulphone has also been shown to proceed via acylation of 
an active-site serine residue. The involvement of an 
active site serine during the interaction of beta-lactamases 
with both substrates (6.1) and inhibitors, indicates its 
prime importance to the catalytic activity of this enzyme.
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Figure 9: Dihydrothiazine derivitive of 6beta-bromopenicillanic 
acid which binds to and consequently inhibits beta-lactamase I 
from Bacillus cereus
ROoG
COoH
H
R = BETA-LACTAMASE
In conclusion, the interaction of beta-lactamases 
with Kcat inhibitors proceeds via an acyl-enzyme intermediate 
which undergoes a structural rearrangement to derivitives 
which are stabilised to normal hydrolysis. This structural 
rearrangement involves a beta-elimination reaction across 
the C5-C6 bond of the enzyme/clavulanate complex which leads 
to the opening of the heterazolidine ring. Whether or not 
this ring opening is base-catalyzed, is unknown at present. 
Within this basic interaction pathway, variations will 
obviously occur depending upon which inhibitor/enzyme 
system is involved. Inactivation of the B.cereus I 
beta-lactamase by 6 beta-bromopenicillanic acid involves 
the covalent modification of a unique serine residue 
whereas the clavulanate/TEM system may involve the 
modification of several active site functional groups.
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Section 7 • The Spread of Antibiotic Resistance
7.1 Transposable genetic elements (TGE)
TGEs are discreet DNA units which facilitate gene 
transfer due to .their ability to move freely between the 
chromosome and plasmid or phage replicons. They function 
as biological switches, inactivating the genes into which 
they are inserted and controlling the function of adjacent 
genes. They are also involved in the structural 
organisation of the genome, directing deletions both 
proximal and distal to the insertion site (Cohen,1976).
The simplest TGEs are the insertion (IS) elements which 
only carry genes specifying insertion functions and 
occasionally promotor-like sequences (Saedler et al.,1974).
IS elements range from approximately 800 - 1400 base pairs 
in length. They can function as a control mechanism or 
promote the transposition of a DNA region. Two IS sequences 
at either side of a segment of DNA can mediate the 
translocation of that intervening DNA region (Reif,1980). 
Transposons constitute a second class of TGE and carry 
genes which specify a particular phenotype. The first 
transposons identified, mediated antibiotic resistance 
(Hedges and Jacob,1974). Transposons are generally larger 
than IS elements and sometimes have known IS sequences at 
their ends. Both IS elements and transposons are flanked 
by short inverted DNA repeats. These so called 'inverted 
repeats' are sequences with rotational symmetry, that is, 
the sequence at one end of the transposon is identical to 
the sequence at the other end read in the opposite direction. 
Electron microscopic heteroduplex analysis has shown that 
following DNA denaturation and strand separation, transposons 
may form hairpin loop structures. The inverted repeats 
form the stalk due to intrastrand annealing and the 
non-duplicated intervening sequence forms the actual loop.
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Episomes have been classed as TGEs due to their ability 
to integrate into the chromosome (Cohen,1976). Certain 
large R factors are,under appropriate conditions, able 
to dissociate into discrete units. One segment consists of 
a transfer region which mediates transfer functions; this 
region was formerly called the resistance transfer factor.
The other segment, designated as the R-determinant zone, 
mediates antibiotic resistance. Heteroduplex mapping of 
several phenotypically distinct plasmids, has indicated 
that their transfer regions show a significant degree of 
homology (Sharp et al.,1973). The structure and genetic 
diversity of plasmids may, therefore, be partly due to the 
linkage of antibiotic resistance determinants to common 
transfer regions. Furthermore, the non-essential 
R-determinants may provide a pool of transposable DNA segments 
which can associate and dissociate freely with the transfer 
region, depending on the prevalent selection pressure 
(Heffron et al.,1976). IS elements have been identified 
at the junction between the transfer region and the R- 
determinant zone on several plasmids (Hu et al.,1975).
They may provide the mechanism for reversible dissociation 
of cointegrate plasmids (Ptashne and Cohen,1975) and may 
also be involved in the amplification of antibiotic 
resistance via the formation of plasmids consisting of 
polygenic R-determinants.
The precise mechanisms of transposition are unclear. 
General recombination involves the rec A gene product and 
it is commonly dependent on the physical breakage and 
reciprocal exchange of DNA sequences in regions of extensive 
homology. Transposition can proceed via 'illegitimate 
recombination1, a process which requires little or no DNA 
homology and is independent of the rec A protein. A model 
for transposition between two replicons has been described 
by Arthur and Sherratt (1979), in which transposition occurs 
via a cointegrate intermediate which is normally efficiently
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resolved into both the donor and recipient replicons, each 
with a copy of the TGE. IS sequences have been recognised 
on all classes of TGEs. They obviously represent a basic 
structural unit and, as such, they are probably closely 
inter-linked with the mechanism of transposition. More 
precisely, the a'ctual ’inverted repeats’ contained within 
the IS sequences may represent a key region involved in 
translocation, In Arthur and Sherratt’s model, an endonuclease 
initiates transposition; it is proposed that the enzyme may 
recognise a nucleotide sequence contained within the 
’inverted repeats’.
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7.2 Transposons which mediate antibiotic resistance
Transposons commonly carry genes specifying antibiotic 
resistance. Consequently, they facilitate the spread of 
antibiotic resistance and enhance the evolutionary potential 
of several resistance determinants (Bennett and Richmond,
1978). The TEM-1 beta-lactamase gene resides on a
2.7 - 3.3 kilobase transposon designated TnA. DNA hybridisation
studies indicate that the TnA I DNA sequence is common
to many plasmids of a variety of incompatibility groups
(Heffron et al.,197.6).' The TEM bla gene was originally thought
to be restricted to Enteric bacteria. It has since been
recognised however, in such diverse species as Hemophilus
and. Neisseria (Fayetet al.,1979). Transposons carry
multiple as well as single resistance determinants. The
Tn4 transposon mediates resistance to ampicillin,
sulphonamide and streptomycin (Kopecko et al. , 197.6), whilst
Tn7 (Cambell et al., 19770 encodes for trimethoprim and
streptomycin/spectinomycin resistance. It is generally
accepted that some of the smaller transposons can combine
to form the larger multiresistant elements. For example,
Tn4 may have been produced by the transposition of Tn3 into 
Tn21 (Kopecko and Cohen,1975).
Bla genes often reside on TGEs. The property of 
transposition is often directly related to the promiscuity 
of a particular beta-lactamase. Although the OXA-1 beta- 
lactamase is not widely distributed, it can reside on atransposon 
designated Tn2603 (Yamamoto, Tanaka, Nohara~et al.,1981).
This transposon is 19.6 kilobases in size and is flanked by 
inverted repeats approximately 200 kilobases long. It 
transposes by rec A independent recombination. Tn2603 is 
a multiresistant transposon which specifies resistance to 
streptomycin, sulphonamide, mecury and ampicillin. DNA 
sequence homologous to Tn2603 have been identified on other 
plasmids which produce the OXA-1 beta-lactamses, principally,
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R455 and R656a (Yamamoto, Tanaka, Baba and Yamagishi,1981). 
The reason for the conservative distribution of the OXA-1 
beta-lactamase may reflect a low selective pressure and/or 
a defective recombination system which limits the 
transposition of Tn2603.
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7.3 The .Ecology of transferable antibiotic resistance
The clinical introduction of any new antibiotic is 
invariably followed by the emergence of bacterial resistance. 
The antibiotic will select for resistance, provided that 
a gene coding for an appropriate resistance mechanism is 
available. The majority of resistance mechanisms are 
known to have existed prior to the introduction of antibiotics 
into chemotherapeutic use (Ambler,1980). The evolution of 
de novo resistance mechanisms are rare and, consequently, 
the appearance of resistance traits in populations which 
were previously sensitive must be a result of gene transfer.
The transfer of resistance genes between bacterial cells 
is facilitated by a variety of mechanisms which include 
conjugation, transduction, transfection, transformation 
and cell fusion. Of these five mechanisms of transfer, only 
conjugation is known to occur 'in vivo' (Petrocheilou et al.,
1979). The ability of resistance genes to be transferred 
between cells is greatly enhanced by the genetic location 
of the structural gene. A plasmid location favours transfer 
(Bennett and Richmond,1978). Transposition provides a 
mechanism of gene transfer from one replicon to another, 
for example, from the chromosome to a plasmid or between 
distinct plasmids. Transfer in this case is bidirectional. 
Inter-replicon gene transfer is also exhibited by transducing 
phages and F prime elements which can pick up and 
incorporate chromosomal genes. In the context of infectious 
diseases, cross infection facilitates the spread of antibiotic 
resistance. The emergence of antibiotic resistance can 
therefore be studied at three principal levels of structural 
organisation; the transposon, the extrachromosomal element 
and the infectious bacterium. Cross infection, conjugation 
and transposition all occur' 'in vivo1 to give rise to the 
spread of resistance in situations where it had not been 
prevalent before.
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Section 8' Materials
Strains: All the strains utilised in this project were
assigned a strain number and are listed in tables 4 and 5.
The relevant R factors are listed in table 6. The strains 
were maintained on nutrient agar slopes at 4°C and were 
sub-cultured every 3 months.
Antibiotics: All the antibiotics were donated by Beecham
Pharmaceuticals. Nitrocefin was obtained from Glaxo 
Research Ltd.
Media: Nutrient broth and agar were obtained from Oxoid
Ltd. L broth and L agar were prepared according to the 
following recipe:
L Broth (1 litre volume)
10g Tryptone (Oxoid)
5g Yeast extract (Oxoid)
1g Sodium chloride 
1g Glucose
The volume was made up to 1 litre with distilled water and 
the pH adjusted to 7 with sodium hydroxide. To make L agar, 
15g/litre of Davis Agar was added.
Buffers: All buffers were prepared according to the
directions given in 'Data for Biochemical Research', 2nd Ed, 
(Dawson et al. ,1969) .
Chemicals
BDH: Acrylogel, Ammonium Sulphate (Analar and Enzyme grade),
Boric acid, Caesium chloride (Analar), Dithiothreitol, 
D-glucose (Analar), glycine (Analar), D-L Histidine, 
Hydroxylammonium chloride, 2-Mercaptoethanol, Polyamide layer 
sheets, Sodium acetate, Tetramethyethylene diamine (TEMED)•
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Table 4 : Bacterial Strains
Strain
Number
Organism Plasmid
Carried
Beta-lactamase 
type specified
1 E.coli J6-2 R46
i
OX A-2
2 ED8654 - -
3 ED8654 R46 OX A-2
4 ED8654 pkM101 OX A-2
5 ED8654 pMB9 -
6 ED8654 clone A
7 ED8654 clone B
8 ED8654 clone C
9 ED8654 pSu3 OXA-2
10 K12 CA244 - -
11 K12 CA265 - -
12 MRE 600 - -
13 K12 CA244 pSu3 OXA-2
14 K12 CA265 pSu3 OXA-2
15 K12 CA265 R46 OXA-2
16 J5-3 pR997 HMS-1
17 E5-2 pRPL11 PSE-1
18 E5-2 pR1 51 PSE-2
19 E5-2 pRMS149 PSE-3
20 E5-2 pMG1 9 PSE-4
21 J5-3 p453 SHV-1
22 J6-2 RGN238 OXA-1
23 J6-2 R57B OX A-3
24 JT4 R+ TEM-1
25 J5-3 RP1 TEM-2
26 J6-2 R55 OX A-3
27 J5-3 R46/R55 OXA-2/OXA-3
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Table 6 - R Factors
R factors Derivation Resistance
determinants
References
R46(R1818) S. tymphirnur ium Ap, Tc, Su, Sm Meynell & Datta (1966)
pkM101 Derived from R46 by 
phage transudction
Ap
Iel+
Mortelmans & Stocker 
(1979)
pMB9 Cloning vector Tc, Rodriguez et al.,(1976)
pSu3 Chimaeric plasmid Ap, Tc, Iel+ This thesis
pR997 Proteus mirabilis Ap, Sm, Su Matthew et al.(1979)
pRPL11 Pseudomonas aeruginosa Gm,Cb,Sm,Tc,Su,
Cm
Korfhagen & Laper (1974)
pR151 It Ghi, Cb, Sm, Su Matthew (1978)
pRMS149 VI Gm, Cb, Sm, Su Sawada et al.,(1974)
pMG19 II Cb, Sm, Su, Tc, 
Km
Hedges. & Matthew (1979)
p453 E. coli Ap, Sm, Tc, Cm, 
Su
Roupas & Pitton (1974)
RGN238 ii Ap, Sm, Tc, Cm, 
Su
Yamagishi et al., (1974)
RP1 ii Ap* Tc, Km Hedges et al.,(1974)
R57B ) 
R55 j
Klebsiella pneumoniae Ap, Cm, Su, Gm Wichitz & Chabbert(1971)
Ap = Ampicillin, Cb = Carbenicillin, Cm = Chloramphen icol
Gm = Gentamycin, Km = Kanamycin, Sm = Streptomycin
Su = Sulphonamides, Tc = Tetracycline, Iel = Colicin El imrrunity
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Sigma: Acrylamide, Agarose, Bovine Serum Albumin,
Dansyl chloride, Ethidium bromide, Flavin mononucleotide 
(reagent grade, disodium salt), Lysozyme (grade I),
N, N'-Methylene - bis - Acrylamide, Beta-Nicotinamide adenine 
dinucleotide phosphate (Type III-tetrasodim salt),
.Ribonuclease Type 1-A, Sephadex G-50-40, Sodium dodecyl 
sulphate, Trizma base (Reagent grade), N-ethyl morpholine.
Hopkin and Williams: Ethylene diamino tetra-acetic acid -
EDTA (disodium salt, Analar).
M + B Ltd : Sodium chloride.
Restriction enzymes were obtained from Bethesda Research 
Laboratories Inc. T4 ligase and Bacteriophage lambda DNA 
were purchased from Boehringer Mannheim.
TEM-2 beta-lactamase was donated by Beecham Pharmaceuticals.
The amino acid standards for molecular weight determination 
and the dansylated amino acid standards were obtained from 
S igma.
The Ampholine Polyacrylamide gel (PAG) plates, pH3.5 - 9.5, 
were obtained from LKB.
All the amino acid sequencing reagents were donated by the 
S.E.R.C. sequencing unit (Leeds).
DE52 and CM52 ion exchange celluloses were obtained from 
Whatman Ltd. Sephadex G-100 was purchased from Pharmacia 
Fine Chemicals AB.
i 25
Carrier free I was obtained from Amersham International PLC.
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Films
Kodak :
Polaroid:
Ectrachrome 50ASA and 400ASA Films 
X-Ray film XRP5 (30 x 40cm) 
Kodalith-ortholith film type 3
positive/negative 4x5 land film type 55
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Section 9 > Methods
9.1 Measurement of protein concentration
Two methods were used routinely to measure protein 
concentration; the Lowry method (1951) and the Waddell method 
(1956). A comparison of the two methods, when used to assay 
crude enzyme extracts, indicated that the values obtained 
with the Lowry assay were consistently higher than those 
obtained with the Waddell method by a factor of approximately
1.5 - 0.12. The raised Lowry values were probably due to 
cellular components other than proteins, interfering with 
the assay. Consequently, the Waddell assay was used primarily 
to assay crude beta-lactamase preparations, whereas the 
Lowry method was applied to purified enzyme extracts.
Lowry method:- Bovine Serum Albumin (BSA) was routinely used 
as the protein standard,, It was, however, replaced with 
purified OXA-2 beta-lactamase when sufficient enzyme 
became available.
Waddell method;- The Beckman spectrophotometer (model 24) 
was calibrated using BSA as a standard. The multiplication 
factor for the calculation of protein concentration was 
calibrated to 198.75
i.e. Protein concentration = (E215 ~ E225^ x 198.75.
9.2 Beta-lactamase assay methods 
The spectrophotometric assay
Enzyme activity was measured routinely using a 
spectrophotometric assay described by Samuni (1975). 
Beta-lactamase-mediated hydrolysis was followed by measuring 
the rate of change in optical density at a wavelength which 
is characteristic of the substrate in question. This optimal 
wavelength is determined by comparing the relative absorption 
spectra from hydrolysed and unhydrolysed substrate. The
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actual wavelength chosen represents the differential peak 
between the two spectra. Table 7 lists the optimal 
wavelengths for a range of beta-lactam compounds.
Procedure
The assay was carried out using a Beckman model 24 
U.V. spectrophotometer linked to a Beckman strip chart 
recorder and a Haake circulator for temperature regulation. 
For a typical assay, 1.9ml and 2.4ml aliquots of 0.025M 
sodium phosphate buffer at pH7.4 were dispensed into test 
and standard spectrophotometric cells. All the reagents 
were kept at 30°C. A 0.5ml aliquot of the substrate, usually 
at a 2.5 mg/ml concentration, was added to the test cell.
The reaction was started when a 100 Ail of the beta-lactamase 
preparation was added to each cell and thoroughly mixed into 
the solution by inverting the cells. Hydrolysis of the 
substrate in question wgis followed at the appropriate 
wavelength. The reaction temperature was maintained at 30°C.
Table 7 : Optimal wavelengths for monitoring the hydrolysis 
of substrates using the spectrophotometric assay
Substrate Wavelength (nm)
amoxicillin 250
ampicillin 240
benzylpenicillin 240
carbenicillin 240
cefazolin 262
cephaloridine 305
cephalothin 305
cloxacillin 270
Methicillin 305
Oxacillin 263
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High Pressure Liquid Chromatography (HPLC)
The HPLC assay was used to measure the hydrolysis of 
several substrates (eg. ticarcillin) which could not be 
measured accurately using the spectrophotometric assay.
The HPLC assay 4-s based on monitoring the degradation of the 
substrate following hydrolysis. The enzyme and substrate 
at suitable concentrations were incubated at 30°C in 0.025M 
sodium phosphate buffer at pH7.4. At regular time intervals, 
25 Ail samples were removed and injected into the injection 
point of a Micro-Bondapak-C18 column (Waters Associates Inc.) 
with a 30-cm length and a 3.9-mm inside diameter. The 
column was pre-equilibrated in 0.1M sodium phosphate buffer 
at pH5.3 containing 15% methanol and was connected to a 
strip chart recorder (Biorad model 1310A) and a u.v. detector. 
The pump speed (Waters Associates Inc.) was set at 2.5ml/ 
minute and the column effluent was monitored at 217nm.
Monitoring column effluents: Effluents from sephadex gel
filtration, affinity chromatography and DEAE cellulose 
columns, were assayed qualitatively using a microtitre 
method and quantitatively, when appropriate, using the 
modified microiodometric assay described by Dale and Smith 
(1971).
Microtitre assay: A stock solution of nitrocefin was prepared 
at 50mg/ml in dimethyl sulphoxide. When required the stock 
solution was diluted to 500 Aig/ml in 0.1M sodium phosphate 
buffer at pH7.0. One drop of the nitrocefin solution was 
mixed with one drop of the column effluent in the well of 
a microtitre plate. A change in the colour of the indicator 
from yellow to red within 10 minutes, was indicative of 
the presence of beta-lactamase.
Enzyme units: One unit of enzyme activity is equivalent to
1 Aimole of benzylpenicillin hydrolysed per minute at 30°C 
and pH 7.4.
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9.3 Preparation of crude beta-lactamase extracts
The strain in question was innoculated into 10ml of 
prewarmed LBroth and incubated at 37°C for approximately 
4 hours. The starter culture was sub-cultured into 75ml 
of prewarmed LBroth in a 250ml conical flask and grown 
overnight at 37°C on a orbital shaker (MkV model, set at 
amplitude 5). The cells were“harvested and washed with an 
equal volume of 0.025M sodium phosphate buffer at pH7.4.
The cells were then resuspended in 7.5ml of the same buffer 
and sonicated (MSE sonicater) on ice for 75 seconds at 
amplitude 3. The disrupted cell suspension was centrifuged 
at 25g for 20 minutes and the supernatant was stored at 4°C.
9.4 Preparation of glassware
It was extremely important that the glassware used for 
protein purification, Nf^ - terminal analysis and sequencing 
studies should be free from contaminants. Therefore, all 
the glassware utilised during the course of this project, 
was subjected to the following cleaning process
The glassware was soaked overnight in a 2% solution of 
decon made up in deionised water and then scrubbed using a 
variety of wire brushes. It was then rinsed twice in 
distilled water, twice in deionised water and finally dried 
overnight at 105°C. All the glassware was covered prior 
to storage.
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9.5 Isolation of Plasmid DNA using a sheared lysate technique
Adapted from the methods described by Bazaral and 
Helinski (1968) and Barth and Grinter (1974).
Reagents ?
TES buffer:- 0.05M Tris, 0.005M EDTA, 0.05M NaCl pH 8.0 
Spheroplast mix:-Add 5mg of Ribonuclease to 10ml of TES 
buffer, heat for 10 - 15 minutes at 80°C and add 1g of 
sucrose. Cool, and add 1Omg of lysozyme.
Sarkosyl:- 2% solution in deionised water.
Procedure
The strain in question was grown overnight at 37°C in 
10ml of LBroth containing 1QAig/ml of the appropriate selective 
antibiotic. The starter broth was sub-cultured into 300ml 
of prewarmed LBroth (-fc selective antibiotic at 1QAig/ml 
concentration) and incubated at 37°C on an orbital shaker 
(amplitude 5) for approximately 3 hours until the optical 
density of the culture at 550nm was at 0.8. The culture
was then cooled on ice and the cells were pelleted by
centrifugation at 7.5g for 15 minutes. The cells were washed
twice in 100ml of cold TES buffer (4°C) and resuspended in
10ml of the spheroplast mix. The cell suspension was 
incubated at 37°C for 10 minutes and then left on ice for 
5 minutes. 5ml of sarkosyl solution was added and gently 
mixed into the suspension which was further diluted with 
10ml of TES buffer and passed through a 21 gauge syringe 
needle approximately 20 times. The sheared lysate was 
made up to 51ml in volume with TES buffer, to which was 
added 56gm of caesium chloride and 10ml of ethidium bromide 
solution (1.5 mg/ml). The sheared lysate was distributed 
into 10ml polycarbonate tubes which were spun in a 75 Ti 
rotor of a Beckman L5-65 ultracentrifuge at 40,000rpm 
for 48 hours at 20°C. The DNA bands were viewed via u.v. 
longwave illumination and the plasmid bands were removed
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and pooled. The ethidium bromide was removed from the 
plasmid DNA by three extractions with equal volumes of 
isopropanol saturated with caesium chloride. The plasmid 
DNA was dialysed against 4 x 500ml of TE buffer (0.05M Tris, 
0.025M EDTA, pH7.4), and ethanol precipitated.
9.6 Ethanol DNA precipitation
DNA was precipitated in 1.5ml polypropylene microcentrifuge 
tubes. Aliquots of 30jul of sodium acetate 3M, 30 Ail of 
magnesium acetate 0.3M and 750 Ail of absolute ethanol were 
added to 300 Ail of DNA solution. The mixture was inverted 
several times and left at -20°C overnight.' The DNA was then 
precipitated via centrifugation for 3 minutes in an 
Eppendorf centrifuge. The DNA was washed 3 times in cold 
absolute ethanol, dried under vacuum and resuspended in 50 Ail 
of TE buffer. All DNA preparations were stored at 4°C.
9.7 Agarose Gel Electrophoresis 
Buffer Systems
Tris Acetate: 40mM Tris, 20mM sodium acetate, 1mM EDTA.
The pH was adjusted to 8.2 with acetic acid. The gel system 
was run at 60Volts (constant voltage).
Tris Borate: 90mM Tris, 90mM Boric Acid, 2.5mM EDTA pH8.5.
The gel system was run at 120 Volts (constant voltage).
The Tris Acetate system will give sharper DNA bands whereas 
the Tris Borate system may produce tailing. The borate 
gels can, however, be run at a higher voltage.
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Procedure'
The gel apparatus used was a vertical gel bed system 
(Raven Scientific Ltd). The 20 x 20cm glass plates were 
washed thoroughly in decon, rinsed with distilled water 
and wiped with acetone. The spacers (3mm) were smeared with 
vaseline and clamped into position. An acrylamide plug 
was used to prevent the gel from slipping out of plate mould. 
The plug was prepared from a 10ml solution of Acrylogel 
(10% solution made up in electrophoresis buffer) to which 
was added 40 Ail of TEMED and a few crystals of ammonium 
persulphate. The agarose gel concentration generally used 
was a 0.8% solution, prepared in the appropriate buffer.
The gel solution was boiled gently for 15 minutes, cooled 
and poured into the gel mould. A comb containing the 
appropriate number of wells (8 -^20) was inserted into the 
gel which was left to polymerise. The gel was loaded with 
the DNA samples containi-ng 40 Ail of the DNA preparation 
and 10 Ail of a bromophenol blue marker (50% glycerol, 5%
SDS, 0.025% bromophenol blue). The gel was run at the 
appropriate voltage until the marker dye had entered the 
acrylamide plug. The gel was then removed from the 
apparatus and placed in a staining tray containing 250ml 
of the electrophoresis buffer. The gel was stained with 
ethidium bromide at 1Omg/ml for 30 minutes and washed with 
fresh buffer. The DNA bands within the gel were viewed 
via longwave u.v. illumination using a transilluminator 
(Ultra-violet Products Inc.). The gel was photographed 
when necessary.
9.8 Transformation of E.coli
The transformation strain commonly used was E.coli 
ED8654 (strain 2). Other strains, however, were transformed 
including the 3 Porton Strains 10, 11 and 12.
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Preparation of competent cells
The appropriate transformation strain was grown 
overnight at 37°C in 10ml of LBroth. A 1ml aliquot of the 
overnight broth was sub-cultured into 20ml of prewarmed 
LBroth and grown at 37°C with agitation for approximately 
100 minutes. The culture was cooled on ice and centrifuged 
at 6000rpm in a MSE Super Minor centrifuge for 10 minutes. 
The cells were resuspended in 20ml of ice cold calcium 
chloride (CalC^) at 0.1M concentration, spun (as above) 
and resuspended in 10 ml of 0.1M CaC^. The cell suspension 
was left on ice for 20 minutes, spun and resuspended in 
1ml of 0.1M CaCl2 « The cells were then competent.
Transformation procedure
1 volume of DNA in TEN buffer (Tris 0.05M, NaCl 0.05M 
and EDTA 0.001M, pH7.5) ..was mixed with 2 volumes of 
competent cells and heat shocked for 1 minute at 37°C.
The DNA/cell mixture was left on ice for 1 hour and then 
diluted 10 times with LBroth. The cells were left at room 
temperature for 1 hour to allow for the expression of the 
transformed DNA and then plated out onto the appropriate 
selective medium. The transformed cells were incubated 
at 37°C for 24 -> 48 hours.
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9.9 N - terminal amino acid Analysis
The most popular method of ' N - terminal amino acid 
analysis is the dansyl chloride method of Gray and Hartley 
(1965). N-N-dimethylaminonaphthalene-5-sulphonyl or dansyl 
chloride is used to label the free NH2 “ terminal residue 
of a peptide chain. The labelled residue is cleaved from 
the remaining residues in the peptide by acid hydrolysis.
The labelled residue can then be visualised by fluorescence 
on a thin layer chromatography (tic) plate and identified 
via its position relative to a set of dansylated amino 
acid standards. The principles of the method are the same 
for both proteins and individual amino acid residues, the 
practical details differing only to account for the different 
size and properties of the substrate. The dansylation 
of proteins is carried out under denaturing conditions to 
ensure the exposure of the NH2 - terminal residue.
Dansylation of proteins
10 nmoles of freeze-dried and salt free OXA-2 beta- 
lactamases was dissolved in 5 0 /il of 1% (w/v) sodium dodecyl 
sulphate (SDS) by boiling the solution for 4 minutes.
After cooling, 50 Ail of N-ethyl morpholine and 75 Ail of 
dansyl chloride (2.5 mg/ml in dimethyl formamide) were added. 
The solution was left at room temperature for 2-3 hours, 
after which, the protein was precipitated over ice with 
500 Ail of ice cold acetone and centrifuged for 5 minutes 
at 6,000 rpm in a MSE Super Minor centrifuge. This 
precipitation process was repeated. The final precipitate 
was resuspended in 50 Ail of 0.1M hydrochloric acid (HC1) 
and 200 Ail of ice cold acetone, collected by centrifugation 
(as before) and dried under vacuum. A 50 Ail aliquot of 
6M HCl containing 0.5M/litre of mercaptoethanol was added 
to the protein in a 5cm x 0.5cm glass test tube. The 
vessel was sealed under flame and the solution was incubated 
overnight at 105°C. The excess HCl was removed by drying 
the sample under vacuum over sodium hydroxide pellets and 
the dansylated protein was dissolved in 50% v/v pyridine 
solution made up in distilled water.
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Dansylation of Histidine
InMole of Histidine was dissolved in 10 Ail of 0.2M 
sodium bicarbonate solution to which was added 10 Ail of 
dansyl chloride (2.5 mg/ml in acetone). The glass 
reaction tube was sealed and incubated at 37°C for 1 hour. ■ 
Following incubation, the sample was dried under vacuum 
and dissolved in 10 ul of v/v pyridine/H20 solution.
Identification of dansylated amino acid residues by thin 
layer chromatography
Chromatography was carried out on 7.5cm square 
polyamide plates. The plates are double sided so that a 
sample can be run on one side and a sample plus standards 
on the other. The plates were loaded at 0.5cm from the 
left hand lower corner and run in an enclosed tank system. 
The position of the solvent fronts were recorded and 
dansylated samples were visualised via longwave u.v. 
illumination. Two solvent systems described by Metrione 
(1978) were utilised in order to identify the dansylated 
residues.
Solvent system A
Horizontal - H 20 : 90% Formic acid (200:3)
Vertical - Toluene : Acetic acid (9 : 1)
Solvent system B
Horizontal - H 20 : 90% Formic acid (200:3)
Vertical - H20 : Ethanol : Ammonium Hydroxide (17:2:1)
The dansylated amino acids standards utilised were as 
follows? Dansy}.-L-arginine, Dansylglycine, Dansyl-L-glutamic 
acid, Dansyl-DL-phenylanine, Dansyl-L-proline, Dansyl-L- 
threonine.
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9.10 Photography
All photographs, except the polaroids, were taken with 
a OM-2 Olympus camera fitted with an Auto-mass lens system. 
The polaroid photographs were taken with an MP4 Land Camera 
using a polaroid positive/negative 4 x 5  Land film type 
55. The tic plates from Nf^ - terminal analysis were 
photographed using a 400ASA Ektachrome Film and Wratten 
filters 81EF and 2B. The PAGE-SDS gels and autoradiographs 
were photographed using a Kodalith film at 12ASA. The 
isoelectric focusing gels were photographed using a Kodak 
Ektachrome tungsten 50 ASA film and a 22 Wratten filter.
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Section 10 Increasing the yield of the OXA-2 beta-lactamase
The R factor R4 6 carries the gene which codes for the 
production of the OXA-2 beta-lactamase. This plasmid has 
a characteristic low copy number which accounts partially 
for the low level of enzyme production in host strains.
One of the principle aims of this project was to increase 
the yield of the OXA-2 beta-lactamase for large scale 
enzyme isolation and purification. Two lines of investigation 
were adopted in order to achieve this aim. Firstly, 
attempts were made to clone the bla gene from R46 and 
pkM101 host plasmids into various high copy number vectors, 
in order to increase the gene copy number and concurrently 
the level of enzyme production. Secondly, the growth 
conditions which favoured enzyme production were investigated. 
The cloning experiments were aided considerably by the 
availability of detailed restriction maps of both R46 and 
pkMlOl (figure 10). pkM101 is a derivitive of R46 in which 
a 14 kilo base fragment of DNA has been deleted. The 
deleted region codes for resistance to streptomycin/ 
spectinomycin, sulphonamide and tetracycline. pkM101 
provides an alternative source of the OXA-2 bla gene, 
bounded by different restriction sites. The cloning 
technique involved dissecting a region of DNA containing the 
bla gene from the donor plasmid and joining it to the 
vector through complementary ends generated by restriction 
endonucleases. The hybrid plasmid or chimaera was then 
transformed into a suitable host strain.
10.1 Cloning R1* fragments of pkM101 into R1 digest of pMB9
Attempts were made to clone a segment of DNA containing 
the OXA-2 bla gene from pkM101 into the EcoR1 site of pMB9.
The plasmid pkMlOl contains only one EcoR1 site. Altering 
the EcoR1 digestion conditions by lowering the- ionic 
strength of the digestion buffer reduces the specificity
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Figure 10: Restriction map of R46 and pkMlOl
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The R4 6 EcoR1 site which corresponds to the single EcoR1 site 
in pkMlOl has been assigned the map position 'O'. For 
reference the positions of the R46 regions which code for 
resistance to ampicillin (ie. R46 bla gene), streptomycin 
and tetracycline are indicated. The R46 replication origin 
(Rep) and the uv protection zone are also indicated.
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of the R1 'enzyme from its original hexanucleotide recognition 
sequence G^AATT C to a tetranucleotide recognition sequence 
'huVTT thereby generating an R1 * digest. The single stranded
overlapping 5 1 termini generated by the R1* digest
complement the R1 generated 5 1 termini. The probability 
of the R1* tetranucleotide sequence occuring within the 
pkM101 DNA is greatly increased relative to that of the R1 
hexanucleotide recognition sequence. Consequently, the 
chances of obtaining the desired DNA fragment containing 
the OXA-2 bla gene are also improved. Clones were detected 
by selection for ampicillin and tetracycline resistance 
and colicin immunity.
Procedure
Strains: No 4 E .coli ED8654 (pkM101) - ApR
No 5 E .coli ED8654 (pMB9) - T e t ^ l e 1
Plasmid DNA was isolated from strains 4 and 5 according to 
the method described in section 9.5. Aliquots of both DNA 
samples were run on a 0.8% agarose gel to check for nuclease 
and chromosomal DNA contamination. Both samples were 
relatively clean. Restriction digests of both the pMB9 
and pkM101 DNA samples were set up as described below.
Digest buffers
R1 - 1OOmM Tris, 50mM NaCl, 5mM MgCl2 (pH7.5)
R1*- 25mM Tris, 2mM MgCl2 (pH8.5)
Restriction digests
A : R1* digest of pkM101
5 Ail pkM101 DNA + 5 Ail H20 + 10 Ail 2xR1 * digestion buffer
+ 2 Ail EcoR1
B : R1 digest of pMB9
8 Ail pMB9 + 8 Ail 2xR1 digestion buffer + 2 Ail EcoRl
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Digests A and B were incubated overnight at 37°C. 
Following incubation, both digests were heat shocked at 
60°C for 15 minutes to denature the EcoR1 enzyme. Each 
digest was checked by running a 5 jal aliquot of each on a
0.8%agarose gel. Both digests A and B were successful, 
digest A producing multiple bands following electrophoresis 
whereas digest B produced a single band indicating that 
pMB9 had been cut at its single EcoR1 site. Both digests 
were, therefore, ligated .together using the ligation 
mixtures listed in table 8. Three different ligation 
mixtures were utilised in order to optimise ligation and 
these differed in the relative concentrations of the donor 
and vector DNA. The three ligation mixes were incubated at 
10°C overnight. Each mix was dialysed against 300ml of 
TEN buffer for 2 hours at 4°C. The ligated DNA was then 
used to transform strain 2 (E.coli ED8654). The preparation 
of competent cells from strain 2 and the transformation 
procedure was carried otit in accordance with the methods 
described in section 9.8. The transformation mixtures 
that were used are listed below.
Table 8 Ligation Mixes
Ligation 
mix 1 (nl)
Ligation 
mix 2 (Ail)
Ligation 
mix 3 (Ail)
Digest A 8.0 4 2
Digest B 1.0 2 4
0.5M Tris-HCl 5.4 5.4 5.1
5mM ATP 5.0 5.0 5.0
0.4M DTT 2.5 2.5 2.5
0.4M MgCl2 1 .25 1 .25 1 .25
gelatin 0.5mg/ml 1 .2 1.21 1.19
T^ ligase 2.0 2.0 2.0
h 20 23.65 26.64 26.96
ATP = adenosine triphosphate, DDT = dithiothreitol 
M g C ^  = magnesium chloride
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Transformation mixes
A = ligation mix 1 + 200ai1 competent cells (E.coli ED8654)
B = ligation mix 2 + 200nl competent cells
C = ligation mix 3 + 200nl competent cells
D = Control : 50nl TEN buffer + 200a i1 competent cells
Each transformation mix was divided into three aliquots 
and plated out onto well dried L agar plates containing 
1Oug/ml of Ampicillin and tetracycline. The plates were 
incubated at 37°C for 48 hours.
Table 9 Colony counts from transformation mixes
Replicate Trans 
mix A
Trans 
mix B
Trans 
mix C
Trans 
mix D
1 0 2 0 0
2 0 0. 0 0
3 0 1 o 0
Trans = Transformation
Table 9 lists the colony counts obtained after plating out 
transformation mixes A ^ D. The results indicate that only 
transformation mix B was successful but even here, the 
level of clones obtained was very low. This limited success 
may reflect a poor transformation of the ligated DNA or, 
more likely, a limited cloning success. The cloning 
experiment utilised a shotgun technique in which there was 
no amplification of the required DNA segment containing 
the bla gene. A low level of the required clones would, 
therefore, be expected. The three clones were picked off 
from the transformation plates and repurified onto fresh
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L agar plates containing 10jug/ml Tc and Ap. ' Each clone was 
then tested for colicin (col) E1 immunity.
ColEl immunity test
A single colony from each clone was inoculated into 
10ml of L broth containing 10jug/ml of ampicillin which was 
incubated at 37°C for approximately 4 hours. A 0.1 ml 
aliquot from each culture was spread onto the surface of a 
well dried L agar plate. Whatman number 3 filter, paper 
strips (0.5cm wide, 8cm long) were soaked in a culture 
filtrate from a colEl producing strain and placed along 
the central axis of the pre-innoculated agar plates. A 
sensitive control strain was set up to act as a comparison.
The plates were incubated overnight at 37°C. Growth right 
upto the filter paper strip was indicative of colEl immunity.
Each of the three strains was colEl immune. The phenotype
R R Xof the cloned strains which was Ap , Tc , Iel , suggested 
that the bla OXA-2 gene had been successfully cloned into 
the pMB9 vector plasmid. Single colony lysis (Twigg and 
Sherratt,1980) was therefore performed on each of the clones 
in order to estimate the size of the pkM101 insert.
Plate 1 illustrates the results from two of the clones 
following single colony lysis and gel electrophoresis.
The three clones were apparently identical as judged by single 
colony lysis therefore all further work was based on one of 
the clones which was designated clone A and which was assigned 
the strain number 6. A sample of pkM101 DNA and an EcoR1 
digest of bacteriophage lambda were included on the 
electrophoresis gel containing the single cell lysates.
The R1 digest of' lambda was only partial and it was therefore 
difficult to measure the size of the cloned DNA accurately.
By referring, however, to previously calculated mobility 
values for pMB9 DNA, the size of the recombinant plasmid 
was estimated to be approximately 6 6.5 kilobases. The
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CLONING EXPERIMENT  
-  CLONING R1* FRAGMENTS OF PKM101 INTO PMB9
PLATE I
3 4
KEY
Track 1 = EcoRl digest of lambda (partial)
Track 2 = pkM101
Tracks 3 and 4 = Single cell lysates of two of the clones
obtained by ligating R1* fragments of 
pkM101 into pMB9.
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size of the pkM101 insert into pMB9 (5.4kb) was therefore 
somewhere in the region of 0.5 1kb. Prior to a more 
detailed size characterisation, it was decided to test 
the host strain 6 carrying the recombinant plasmid for 
enzyme production in comparison with a control R46 strain
i.e. strain number 3. Two other cloned strains were 
included in this study. These clones, designated B and C, 
were produced by Dr. D. Godwin. Both B and C were 
produced in a cloning experiment in which Bam HI and 
Sail double digests of pkM101 were cloned into the vector 
plasmid pACYC184. The resulting chimaeric plasmids 
(clones B and C) were then transformed into E.coli ED8654 
to produce strains 7 and 8.
10.2 Testing the cloned strains 6, 7 and 8 for beta-lactamase 
production relative to a control R46strain
Crude cell extracts*-were prepared from strains 6, 7, 8 
and 3 according to the method described in section 9.3 
except that the cultures were grown for 8 hours rather than 
incubated overnight. The cell extracts were assayed for 
enzyme activity using the spectrophotometric technique.
Protein concentrations were measured using the Waddell 
assay. The results of these tests are listed in table 10.
Each value is the mean of three separate determinations.
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Table 1Q A comparison of the levels of beta-lactamase 
production by cloned strains 6,7 and 8 with a
control R46 strain
Strain
number
‘ Enzyme 
activity 
U/ml
Protein
concentration
mg/ml
Specific t 
activity 
U/mg
6 (clone A) 0.023 0.597 0.038
■ s d  0.005 s d  0.086
7 (clone B) 0.039 0.707 0.055
sd 0.008 , sd 0.065
8 (clone C) 0.041 0.561 0.073
sd 0.011 sd 0.071
3 (R46) 0.14 0.801 0.177
0.02 sd 0.093
Specific activity = Enzyme units/mg of protein.
U = Units of enzyme activity, sd = standard deviation
The results listed in table 10 indicate that, although 
all three of the cloned strains produced a beta-lactamase, 
the level of enzyme production was significantly lower than 
the control R4 6 strain. This low level of expression may 
reflect inefficient transcription or translation of the cloned 
beta-lactamase DNA. Poor transcription may, in turn, reflect 
the absence of an efficient promotor region. The expression 
of a cloned structural gene is dependent upon that gene being 
placed under the control of a promotor. The promotor may be 
derived from either the donor or the vector plasmid. In
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the case Of clone A (strain 6) it seems unlikely that the 
bla gene would come under the control of a pMB9 promotor 
when inserted into the EcoR1 site of pMB9. Presumably, 
the expression of a cloned beta-lactamase gene in this 
instance is dependent on cloning the bla gene promotor with 
the structural gene. The inefficient expression of the bla* 
gene in strain 6 may, therefore, derive from the failure 
to clone the bla promotor intact. In the case of clones 
B and C (strains 7 and 8) the promotor is probably cloned 
with the bla structural gene since the BamHI and Sail 
restriction sites in the donor pkM101 plasmid are distant from 
the bla gene. Consequently, the lack of an efficient 
promotor in clones B and C may not account for the low 
level of beta-lactamase expression in these cases. None 
of the strains in question was considered suitable for 
the purpose of increasing the yield of the OXA-2 enzyme.
The three strains were, therefore, discarded.
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10.3 CICning R1* fragments of the plasmid R46 into an R1 
digest of the vector plasmid pMB9
A cloning experiment was carried out by Dr. J.W. Dale in 
which R1* fragments of R46 were cloned into pMB9. A series 
of cloned strains were generated which were designated 
10/8 — 1 to 11. These strains were tested for beta- 
lactamase production in comparison with a control R46 strain. 
Crude cell extracts of each strain were prepared in accordance 
with the method described in section 9.3 except that the 
cultures were incubated for 8 hours rather than overnight.
Three culture replicates of each strain were carried out.
Each extract was then assayed for enzyme activity using 
the spectrophotometric technique. Protein concentrations 
were measured using the Waddell assay and the results 
listed in figure 11 represent the mean of the three replicates.
Figure 11: The level of beta-lactamase production by strains
10/8-1 ■» 11 as compared with the control R46 strain
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Figure 11 indicates the level of enzyme production as 
a function of cellular protein by strains 10/8-1 to 11.
The results indicate that three of the 10/8 series, namely 
10/8-1, 2 and 3, produce significantly higher levels of 
the OXA-2 beta-lactamase than the control R46 strain.
One of these strains, 10/8-2 which produces the highest 
beta-lactamase level in this study, was selected for further 
analysis. This 10/8-2 strain was assigned the strain number 
9 and the chimaeric plasmid carried by this strain was 
designated pSu3.
10.4 Analysis of the level of beta-lactamase production by 
strain 9 as compared with the control R46 strain
A more detailed analysis of the level of enzyme production 
by strain 9 (pSu3) in comparison with the control strain 3 
(R46) was carried out. Crude cell extracts were prepared 
from strains 9 and 3 in* accordance with the method described 
in section 9.3 except that 150ml culture volumes in 500ml 
conical flasks were utilised. A 50ml aliquot of the culture 
was used for enzyme extraction and 75ml was used for dry 
weight estimation. The remainder was utilised for viable 
counts and measurement of protein concentration. Viable 
counts were performed on both ampicillin and non-ampicillin 
containing agar plates in order to estimate the level of 
plasmid loss. Five culture replicates for each strain 
were carried out.
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Table 11:.Comparison of the levels of beta-lactamase 
production by strains 3 and 9 .
- Strain 3(R46) Strain 9(pSu3)
Enzyme activity 
U/ml
0.392 
sd0.011
0.864
sd0.08
Protein
concentration
mg/ml
0.910
sd0.025
0.805
sd0.041
Dry weight 
mg/ml
1 .590 
sd 0.032
1 .282 
sd 0.068
Viable count 
x10 R+ cells
5.3 
sd 0.774
6.380 
sd 0.838
% Plasmid loss 0 0
Specific activity 
U/mg protein
0.431 1.073
Enzyme activity 
per mg dry weight
0.247 0.674
Enzyme activity 
per 109 R+ cells
-
0.074 0.135
The results listed in table 11 indicate that the specific 
activity of the beta-lactamase produced by strain 9 was 
approximately 2.5-fold greater than that produced by the 
control R46 strain. Strain 9 therefore seemed promising 
for large scale enzyme production.
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10.5 Characterisation of the beta-lactamase substrate
profile specified by the pSu3 plasmid
In order to check the physico-chemical properties of 
the enzyme had not been altered during the cloning procedure,
.for example by deletion of any region within the bla 
structural gene, a substrate profile of the enzyme 
produced by the pSu3 chimaeric plasmid was determined.
A beta-lactamase preparation was extracted and purified 
from a 12 litre batch culture of strain 9 (pSu3). The 
purification protocol utilised was as described in 
section 11. The specific activity of the preparation used 
for the profile determination was approximately 140 U/mg.
The substrate profile of the pSu3 enzyme was determined 
using the spectrophotometric and HPLC assay methods 
described in section 9.2. The substrate concentration for 
both assay methods was 500 /ig/ml and the assay temperature 
was 30°C.
The substrate profile of the pSu3 enzyme is represented 
as a histogram in figure 12. Table 12 lists the profile 
in comparison with previously published data. Substrate 
profiles of the OXA-2 enzyme as specified by the R46 plasmid 
produced prior to this study utilised other assay techniques 
principally the hydroxylamine assay. The profile of the 
pSu3 enzyme is in reasonable agreement with that of R46.
The values for the pSu3 plasmid tend however, to be slightly 
lower than those for the R46 enzyme. This discrepancy 
probably reflects the different assay techniques used in 
each case. The substrate profile of the pSu3 enzyme is 
therefore characteristic of the OXA-2 beta-lactamase. The 
profile determined in this study is more extensive than 
previously published data. It illustrates a discrepancy 
between the cefazolin and cephalothin values determined here 
and those published by I.N. Simpson (Simpson et al.,1980).
On examining the text of I.N. Simpson's paper, the values 
for cefazolin and cephalothin probably relate to the OXA-3 
beta-lactamase and not to an OXA-2 enzyme.
BRL 17421, or disodium 6 beta-(2-carboxv-2~thien 3-y^acetamido) 
is a semi-synthetic beta-lactam.(SLOCOMBE et al,1982).
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F igure  12: Substrate  Profi le  of the Beta- lactamase
produced by pSu3
100-.
5 0 -
Ti Met Cab Cef  Cet Ce l
KEY : Ti = T ic a r c  i l l in , M e t=  Meth ic i l l in  , Carben ic i l l in  , Cef = Cefazol in  
Cet = Cephalothin,  Ce l=Cephalor id ine ,C IX"=Cloxac i l l  in 
Ben= Benzyl  penic i l l in ,  Amx=Amoxic i l l in ,  A m p=A m pic i l l in ,
Oxa = Oxaci  11 in. All values are relative rates of hydrolysis 
with that of benzylpenici l l in taken  as 100 .
600-,  -----------------
3 0 0 -
OJ-----------------L--------------------------------- --------- -------- ----------
C lx  Ben Amx Amp Oxa
92
Ta
bl
e 
12
: 
Co
mp
ar
is
on
 
of
 
th
e 
su
bs
tr
at
e 
pr
of
il
es
 
of
 
th
e 
b
e
t
a
-
l
a
c
t
a
m
a
s
e
s
 
sp
ec
if
ie
d 
by
 
th
e 
ch
im
ae
ri
c 
p
l
a
s
m
i
d
 
 
 
 
- 
 
PS
u3
 
an
d 
th
e 
R 
fa
ct
or
 
R4
6_
a) to
Ul 0to fp
o
o C\J
m
VO
■'=?K
r-vo<T>r~ U0ou ro
01—1 >irH to N
•H m P
¥ in0 0P 00 >< "P+> O PrH UuMto ffi
o
o
vo
in
vo
CM
r- U 
o \ o  
o  
'— ro
to to
■p _ 0 to
o
o <T>r-~
vo
vo
ro
vo
vo
>1 0
O
o
vo
o
CM
in vo
o
ro
Pcocu
to o
o
o
U)•H
in
£
o
&
§
to o
&
o
o
o vo
LD
r-
o
o
CM
ID
O
CO
CM
O
CM
COcr>
r -
r"
r-
CTi
in
0
id
8
8
5
0
.g
rH i—I
•H
.3
1
CM
PQ
•3
•H
.3
&
rH•H
•3
p
JSu
.g
rH
oN0M-l
0
0.g
a
3
I
0
.g
5
*&
■3
I-1
•H
•3
5
rH
•H
3
.g
rH
rH
•H
i
.3
Al
l 
va
lu
es
 
are
 
re
la
ti
ve
 
ra
te
s 
of
 
hy
dr
ol
ys
is
, 
wi
th
 
th
at
 
of 
be
nz
yl
pe
ni
ci
 11
 in
 
ta
ke
n 
as 
10
0'
- 
H
yd
ro
x=
H
yd
ro
xy
 l
am
in
e 
as
sa
y 
(D
al
e&
S
m
it
h,
 1
9'
 
S
pe
c”
* = 
Sp
ec
t 
ro
ph
ot
om
et
r 
ic 
as
sa
y 
(S
am
u
n
i, 
19
75
 
): 
Sp
ec
 ^
= 
S
pe
ct
ro
ph
ot
om
et
ri
c 
as
sa
y 
(O
’C
a 
II 
ag
ha
n 
et
 
a
l.
,1
9
6
9
)
10.6 Construction of a restriction map of pSu3
A detailed restriction map of pSu3 was prepared in 
order to characterise the segment of R46 which had been 
cloned into pMB9. pSu3 DNA was isolated from strain 9 in 
accordance withthe protocol described in section 9.5.
Attempts were made to amplify the DNA of pSu3 using 
chloramphenicol treatment. On a purely visual comparison of 
the DNA extracted from chloramphenical treated and untreated 
cells, pSu3 was apparently not susceptible to amplification 
in this manner. The restriction map was constructed from 
the information obtained by a series of single and double 
digests, all digests being run on 0.8% agarose gels.
The size of the DNA fragments produced by restriction 
analysis were determined from a semilog plot of molecular 
size against mobility (mm), with reference to a series of 
standard size markers. The standards were usually EcoRl 
and Hind III double digests of bacteriophage lambda DNA.
Table 13 indicates the nature of the digests which were 
performed and the number and size of the fragments which 
were produced following restriction analysis. A series of 
preliminary single digests were performed including those 
which had a known single restriction site in the vector 
plasmid pMB9. A preliminary restriction map was constructed 
using the information obtained from these single digests. 
Further single and double digests were then selected with 
reference to preliminary map in order to elucidate the 
complete restriction map. For example, a PstI digest indicated 
a single restriction site within pSu3. By selecting a 
double EcoR1/PstI digest, the position of the Pst site was 
located within the smallest of the three EcoRl fragments.
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Table 13; Restriction Analysis of pSu3
Restriction
digest
Number
of
fragments
Length 
in kb
Restriction
digest
Number
of
fragments
Length 
in kb
Hind III 1 14.7 Bgl II 1
2
3
5.9
4.6
3.8
(0.4)
Sal 1 1 14.7
1 14.7
4
Pst 1 R1/Hind 1 7.5
Bam H1 1
2
7.8
6.9
2
3
4
5.05
1.8
(0.35)
Pst/Hind 1
2
8.9
5.8
R1 /Sal 1
2
7.5
4.4
EcoRl 1 7.5
3
4
1.8 
1.0
2
3
5.4
1.8 R1/Pst 12
7.5
5.4
Hpa 1 1
2
5.2
5.0
4.5
3
4
1.05
0.75
3 Pst/Hpa 1 5.2
Pst/Bam 1
2
6.9
5.4
2
3
4
5.0
3.35
1.15
3 2.4 R1/Bam 1 6.15
Pst/Bgl 1
2
3
4
5.9
4.55
2.95
0.9
2
3
4
5
4.65
1.8
1.35
(0.75)
5 (0.4) R1/Hpa 1 5.2
Hpa/Bam 1
2
3
4
4.65
4.1 
2.7
2.1 
1.15
2
3
4
5
6
2.8
2.7 
2.05
1.8 
(0.15)
5 R1/Bgl 1 5.3
kb == kilobases
2
3
4
5
6
‘ 7
4.55
1.9
1.8
0.6
(0.45)
(0.1)
The fragment sizes in parentheses were too small to be 
identified by restriction analysis on agarose gels. These 
val]ues have been calculated according to the total sum of the 
fragment sizes subtracted from the 14.7 kb value for the 
composite pSu3 plasmid.
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Single restriction digests: A 2jal aliquot of pSu3 DNA at a 
concentration of approximately 2ug/nl, was mixed with 8ul of 
J^O, ICUil of twice the normal concentration of the 
appropriate restriction buffer and 2/al of the restriction 
enzyme in question. Each enzyme has a particular buffer 
composition which optimises the restriction digest. All the 
digest buffers were prepared according to the manufacturers 
instructions. The digests were incubated at 37°C for 1 hour.
Double restriction digests: The EcoRl digest buffer was
used as a universal buffer for all the double digests.
Single digests were prepared as described above. Following 
incubation at 37°C the digests were heated at 60°C for 
15 minutes in order to denature the restriction enzyme.
A 2*il aliquot of the second enzyme was then added and the 
digest was incubated for a further hour at 37°C.
Photographs of two of the agarose gels featuring various 
restriction digests of pSu3 are shown in Plates 2 and 3. 
Figure 13 illustrates the completed restriction map of 
pSu3. Figure 14 indicates the construction of pSu3 from 
the donor and vector plasmids R46 and pMB9. pSu3 consists 
of a 9.3kb fragment of R46 cloned into the single EcoRl 
site of pMB9. The orientation of the insert is illustrated 
in figure 13. The DNA fragment from R46 encompasses the 
OXA-2 bla gene and the origin of replication. The fragment 
terminates in the region of the uv protection gene. Since 
the exact boundaries of this gene are imprecise, the pSu3 
plasmid may provide information governing these gene 
boundaries.
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List of tfre DNA samples run on the Agarose gels illustrated
in plates 2 and 3
Plate 2
Track Number
1 = pMB9
2 = EcoRl digest of R46
3 = R4 6
4 = pSu3
5 = EcoRl digest of pSu3.
Plate 3
Track Number
1, 7, 11 & 17 = EcoR1/Hind III digest of lambda 
2 & 16 = Hind III digest of lambda
3 = EcoR1/Bg1II digest of pSu3
4 = Pst1/Bg1II digest of pSu3
5 = Bam H1 digest of pSu3
6 = EcoRl /Pst1 digest of pSu3
8 = Hind III/Hpa1 digest of pSu3
9 = Bam H1/Hpa1 digest of pSu3 
10 = Pst1/Hpa1 digest of pSu3
12 = Pst 1 digest of pSu3
13 = EcoRl digest of pSu3
14 = Bg1 II digest of pSu3
15 = EcoR1/Hpa digest of pSu3
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R e s t r i c t i o n  m a p p in g  of PSu 3
P la te  2
1 2 .3 4 5
Plate 3
1 5
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10 15
Figure 13: Restriction Map of pSu 3
cc -
pSu 3
Size=14-7 kb(9-5m d)
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10.7 Transformation of the pSu3 plasmid into a high
cell yielding strain
The large scale production and purification of the 
OXA-2 beta-lactamase was one of the principle aims of this 
project. A 400'-'litre batch fermentation of the appropriate, 
beta-lactamase producing strain was to be utilised for this 
purpose. The pSu3 plasmid, which produces increased levels 
of the OXA-2 enzyme, was adopted for the large scale 
fermentation. It was hoped, however, to achieve further 
increases in enzyme production by transferring the pSu3 
plasmid into a high cell yielding strain. Three high cell 
yielding strains were provided by CAMR Microbial Products 
development and production laboratory, Porton. As 
specialists in the field of microbial fermentation products, 
they have characterised the growth conditions which optimise 
the cell yield from these strains. Since CAMR were to 
produce the 4 00 litre batch culture, the use of one of their 
strains as a host for the pSu3 plasmid had certain other 
advantages. Primarily, the cost of the fermentation was 
kept within the financial constraints of this project in that 
it dispensed with the need for a detailed investigation 
into the fermentation conditions favourable to the growth 
of a novel host strain.
Transformation of the pSu3 plasmid into the three
Porton strains
Porton strains
Strain no. 10 = E.coli CA244
no. 11 = E.coli CA265
no. 12 = E.coli MRE600
pSu3 DNA was prepared in accordance with the method 
described in section 9.5. Competent cell samples were 
prepared from strains 10, 11 and 12 as described in section 
9.8. The pSu3 DNA was then used to transform each of the 
cell preparations from the three strains in question.
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The transformation mixes were plated out onto L agar plates 
containing 10jug/ml of ampicillin. The plates were incubated 
at 37°C for 48 hours.
The transformation of pSu3 into strains 10 and 11 was 
.successful but that into strain 12 was not (results not 
shown). The failure to transform strain 12 probably stems 
from a low inherent transformation frequency. The two 
Porton strains which were successfully transformed with 
pSu3 were assigned the strain numbers 13 and 14.
10.8 Comparison of the level of enzyme production by 
strains 13 and 14 with a control R46 strain
Strains
No. 13 = E.coli CA244 (pSu3)
No. 14 = E.coli CA265 (pSu3)
No. 15 = E.coli ‘ CA265 (R46)
The R46 control plasmid was transformed into E.coli 
CA265 as previously described. This strain was assigned the 
strain number 15 (Table 4). Crude cell extracts of strains 
13, 14 and 15 were prepared as described in section 9.3 
except that 150ml culture volumes in 500ml conical flasks 
were utilised. A 75 ml aliquot of the culture was used for 
dry weight estimations and 50ml was utilised for measuring 
enzyme activity using the spectrophotometric assay. The 
remainder of the culture was used for protein estimations 
using the Waddell assay and for viable counts. Viable counts 
were performed on selective and non-selective L agar in 
order to estimate plasmid loss. Five individual culture 
replicates of each strain were carried out.
Table 14 lists a comparison of the levels of beta-lactamase 
production between strains 13, 14 and 15. The results 
indicate that strain 14 (E.coli CA265), containing the pSu3 
plasmid, produces the OXA-2 enzyme at a specific activity
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Table 14: The level of beta-lactamase production by strains
13 and 14 compared with a control R46 strain
Strain 13 Strain 14 Strain 15
pSu3 pSu3 R46
Enzyme activity 
U/ml
0.320 
sd 0.02
1.15 
sd 0.13
0.29 
sd 0.02
Protein conc 
mg/ml
0.797 
sd 0.07
0.89 
sd 0.13
0.821 
Sd 0.09
Dry weight 
mg/ml
1 .14 
sd 0.12
1 .28 
sd 0.15
Viable count 
x10 R cells
3.35 
sd 0.7
3.81 
sd 0.78
3.51 
sd 0.91
% Plasmid loss 57 3 0
Specific activity
U/mg protein
0.401 1 .292 0.353
Enzyme activity 
per mg dry weight
0.281 0.898
Enzyme activity 
per 10^ R cells
0.096 0.302 0.083
Where blanks are left the value was not determined, 
ccon = concentration, U = units, sd = standard deviation.
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of approximately 3.5 *>4 times greater than that produced 
by a control R46 strain. The level of enzyme production 
by strain 13 (E.coli CA244) was, however, only slightly 
greater than that produced by the R46 strain. Strain 13 
exhibits a higher level of plasmid loss than either of the 
two other strains. The reasons for the low level of beta- 
lactamase production by strain 13 were not rigourously 
pursued but it probably reflects the high degree of plasmid 
instability within the host strain. Due to the increased 
levels of enzyme production, strain 14 seemed a promising 
candidate for large scale enzyme isolation. The preceding 
experiment was performed under small scale batch conditions, 
therefore, the effects of the high cell yielding Porton 
strain on the level of enzyme production were not fully 
realised. It is extremely difficult to correlate the 
performance of different strains under small scale conditions 
with those corresponding to large scale production. 
Consequently, it was decided to scale up the fermentation 
to a 1 litre batch culture in order to examine the 
behaviour of strain 14 under such conditions.
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10.9 One litre batch fermentation of strains 9 , 14 and 15 
Strains
no.15 = E.coli CA265 (R46)
no. 9 = g.coli ED8654 (pSu3)
no.14 = E.coli CA26 5 (pSu3)
Procedure
The fermentations were carried out in a 4 x 1 litre 
multistation batch fermenter (L.H. Engineering Co.Ltd).
The unit consists of a console on which are mounted four 
culture vessels each of 1 litre capacity. Each vessel is 
agitated by its own independent magnetic stirrer. A built 
in air pump provides oil-free air via separate control 
valves and flow meters. Each vessel has its own sterile air 
input via resin bonded microfibre filters. The temperature 
is regulated by a circulating thermostat unit. A sampling 
port is provided in each vessel which permits sterile 
sampling. Three of the four batch fermenters were filled 
with 1 litre of L broth and autoclaved. Following autoclaving 
the vessels were linked to the console and the broth was 
equilibrated at 37°C. A single colony of each strain was 
inoculated into 10ml of prewarmed L broth and incubated 
at 37°C for 4 hours. The starter broths were subcultered 
into 50ml of L broth in 250 ml conical flasks and incubated 
at 37°C overnight. A 25ml aliquot of each starter broth was 
then used to inoculate each of the 1 litre batch fermenters. 
The cultures were grown at 37°C with airation and agitation.
At regular time intervals, 25ml samples were removed for 
assay of enzyme activity and protein concentration. Viable 
counts were performed on selective and non-selective media 
in order to estimate plasmid loss.
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Figure 15 ? Relationship between the formation of the OXA-2 
beta-lactamase and growth of strains 9,14 and 15 in 1 litre 
batch cultures
10
E 0-75
0-5
0 62 4 8 10 1412
T IM E  OF INCUBATION (HOURS)
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Figure 15 illustrates the variation in the production of 
the OXA-2 beta-lactamase during the growth cycle of strains 
9 f 14 and 15. Strain 14 produces a very low level of enzyme 
throughout the fermentation. The viable counts on selective 
and non-selective media indicated that the original inoculum 
of this strain contained a significant number of plasmid- 
free L R ] segregants which increased progressively 
throughout the fermentation. The rate of plasmid loss 
exhibited by strain 14 is indicated in figure 16.
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Figure 16: The rate of plasmid loss by strain 14 in a 1 litre
batch fermentation
100
75
O 25 —
4 6 10 12 142 80
T IM E  OF INCUBATION ( H O U R S ) -------------- *
In a non-selective environment (i.e. the 1 litre batch 
cultures contained no selective pressure) no plasmid encoded 
function is necessary or advantageous for growth, an R 
segregant can therefore achieve a higher specific growth rate 
(a i max) than its R counterpart since the energy originally 
used for plasmid replication is redirected into biomass and 
high population growth rate (Godwin and Slater,1979). The 
R cells will therefore outcompete the plasmid containing 
cells and become established in a mixed population fermentation. 
The chimaeric plasmid pSu3 was apparently prone to instability 
when hosted by the two Porton strains CA244 and CA265. In 
the case of strain 14, E.coli CA265 (pSu3) the occurrence of
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R cells in the original inoculum leads to R segregation 
in the 1 litre batch culture and results in a low level of 
beta-lactamase production. Strain 13, E.coli CA244 (pSu3) 
apparently suffers the same fate. In a comparison of the 
level of enzyme production by strains 13 and 14 in a 150ml 
shake flask culture as described in section 10.8, strain 13- 
produced a low level of the OXA-2 enzyme due to the high 
percentage of R segregants in the culture. The presence of 
R cells in the starter inoculum obviously leads to R 
segregation. Presumably, however, if the original 'inoculum 
is 100% R+ , then R segregation does not occur and the strains 
in question retain their full potential for beta-lactamase 
production. This is illustrated in table 14. Strain 14 in 
the absence of R segregation produced a high level of the 
OXA-2 enzyme at a specific activity of approximately 3.5-fold 
greater than that produced by the R4 6 control strain.
Strain 13 experienced R segregation in the 150ml shake flask 
experiment described in section 10.3 whereas strain 14 did 
not. The reason for this discrepancy is unknown, but it 
probably stems from the fact that either the single colony 
of strain 13 used for the starter inoculum contained a 
proportion of R cells whereas that used for strain 14 did 
not, or that strain 13 experiences a higher rate of R 
segregation than its strain 14 counterpart, or both. In view 
of the increased levels of OXA-2 beta-lactamase production 
by strain 14, it was decided to utilise this strain for 
the 400 litre batch culture. Strain 14 obviously suffers from 
plasmid instability. To protect against R segregation in 
the large scale fermentation it was decided to use a 
selection pressure of 20 vug/ml of ampicillin in the scale 
up of the starter inoculum. As a further fail-safe 
precaution it was decided to use the same selection pressure 
in the actual 4 00 litre fermentation.
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The pattern of enzyme production by strain 9 exhibited 
a sharp decrease in specific activity at the beginning of 
the stationary phase of the growth cycle. This drop was 
mimicked by strain 14 when no R segregants were present 
in the cell population (section 10.10* figure 17).
Certain plasmids experience a drop in plasmid copy number 
under conditions of nutrient limitation such as occurs during 
the stationary growth phase (Jones et al.,1980). The fall 
in copy number is thought to be due to a limitation in 
plasmid replication by the lack of availability of free cell 
constituents such as nucleoside triphosphates. The 
expression of the bla gene carried by the plasmid Rldrda is 
directly related to plasmid copy number (Uhlin and Nordstrom, 
1977). Presumably, if this relationship holds true for the 
pSu3 plasmid, then the decrease in specific activity 
exhibited by strain 9 may be due to a fall in copy number. 
When batch fermentations were studied well into the 
stationary growth phase R segregants of strains 9 and 14 
began to appear albeit at a low frequency of ^  10%
(results not shown). The pSu3 plasmid carried by both 
strains 9 and 14 contains the vector plasmid pMB9 which lacks 
a functional partition (par) locus. The par locus functions 
to ensure the segregation of plasmid copies into daughter 
cells. At a high copy number the function of th6 par locus 
is redundant since stoichastic distribution would ensure 
that all the daughter cells contain a plasmid copy. At 
low copy numbers, however, the function of the par locus 
becomes necessary to ensure efficient segregation. The R 
segregants of strains 9 and 14 which arise during the 
stationary growth phase may therefore be due to a dual 
combination effect of low copy number and ineffective 
partitioning.
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The pattern of enzyme production displayed by strain 15 
is common to many plasmid-mediated beta-lactamases. The 
specific activity of the enzyme increases linearly 
throughout the logarithmic growth phase, tails off in the 
decline phase and reaches a plateau during the stationary 
phase. This pattern is in sharp contrast to that displayed- 
by strain 9.
10.1Q ; Characterisation of the growth conditions favourable 
to OXA-2 beta-lactamase production by strain 14
It was necessary to determine the phase of the growth 
cycle at which enzyme production was at a maximum in order 
that the optimal time of harvest for the large scale batch 
fermentation could be calculated. Since the presence of 
R segregants of strain 14 within the original inoculum 
leads to an extensive production of R cells within the 
fermentation population* it was necessary to ensure that the 
original innoculum was 100% R+ . Consequently, a selection 
pressure of 20 ng/ml of freshly prepared ampicillin solution 
was used in the starter innoculum.
Procedure
A single colony of strain 14 was picked from an L agar 
plate containing 20 jug/ml ampicillin and inoculated into 
10 ml of prewarmed L broth + selective agent. The broth 
culture was incubated for four hours at 37°C and then 
sub-cultured into a further 10ml of L broth + selective 
agent. The culture was grown overnight at 37°C, the optimal 
density at 550nm of the culture adjusted to 0.5 absorbance 
units and a 3.5ml aliquot used to innoculate 350ml of L broth. 
The 350ml batch culture was grown in a 1 litre flask fitted 
with a side arm. The culture was aerated using an air pump 
and filter system and agitated with a sterilised magnetic 
stirrer. At regular time intervals, samples were removed 
aseptically using a pump system fitted to the side arm.
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The samples were assayed for enzyme activity and protein 
concentration. Viable counts were performed on selective 
and non-selective media in order to measure plasmid loss.
Figure 17 : Relationship between the production of the OXA-2 
beta-lactamase and the growth of strain 14
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Figure 17 represents the production of the OXA-2 
beta-lactamase by strain 14 (E.coli CA265-pSu3) as a function 
of cell growth. The results indicate that strain 14 should 
be harvested at the beginning of the stationary growth phase 
in order to ensure maximum enzyme production. Strain 14 
exhibits a sharp drop in specific enzyme activity during the 
stationary growth phase. This pattern is analagous to that 
exhibited by strain 9 and has been discussed previously in 
section 10.9•
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Relationship between OXA-2 beta-lactamase production by
Strain 14 and growth temperature
The optimum growth temperature for enzyme production by 
strain 14 was investigated.
Procedure
Strain 14 was grown at 4 different growth temperatures 
i.e. 25°C, 30°C, 37°C and 45°C, in 50ml aliquots of L broth
in 250ml conical flasks. A single colony of strain 14 was 
picked from an L agar plate containing 20 jug/ml ampicillin 
and inoculated into 10ml of L broth also containing the 
same selection pressure. The starter broth was incubated at 
37°C for 4 hours and a 1 ml aliquot was then sub-cultured 
into 50ml aliquot of prewarmed L broth in the 250ml conical 
flasks. The cultures were then incubated at the 4 different 
growth temperatures overnight. The cells were harvested 
and crude cell extracts of each culture were prepared 
according to the procedure described in section 9.3. The 
enzyme activity of each extract was measured using the 
spectrophotometric assay and the protein concentration was 
calculated using the Waddell assay.
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Figure 18,: Relationship between beta-lactamase production
and growth temperature
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Figure 18 indicates the relationship between the growth 
temperature of strain 14 and beta-lactamase production.
The results indicate that the optimum growth temperature 
for enzyme production is 37°C.
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10.1.1 400 litre batch fermentation of strain 14
The 4 00 litre batch fermentation of strain 14 was 
carried out by the Microbial products development and 
production laboratory at the PHLS centre for applied 
microbiology and research, Porton. The strain was sent to the 
laboratory together with a set of specifications for the 
fermentation protocol which were designed to optimise OXA-2 
enzyme production by strain 14. The relevant specifications 
were as follows
a) A growth temperature of 37°C
b) The use of a selection pressure of 20 Aig/val ampicillin 
in both the scale up of the starter innoculum and
in the actual 400 litre batch fermentation.
c) The culture was to be harvested in the early 
stationary phase.
The process used to grow strain 14 was a standard batch 
culture technique which was based on modification of the 
method described by Elsworth et al.,(1968). The strain was 
grown in the complex medium described below.
Culture medium used for 4 00 litre batch fermentation
The recipe for the medium is for a 1 litre volume
Solids Solutions (distilled water)
Tryptone 20g
Yeast extract 1g
NaCl 2.9g
MgSO^.7H2O 1g
Na2HPO^(anhydrous) 5.76g
NaH2P04 .2H 20 1.48g
2M K 2 HP04 5.0ml 
1OOmM Ferric citrate 10ml 
1M CaCl2 4ml
25mM MnCl2 «4H20 1ml
The pH of the medium is adjusted to 7.4
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The batch fermentation of strain 14 was carried out as 
a commercial enterprise and as such the actual details of 
the fermentation were not disclosed presumably in order to 
protect the commercial rights of the establishment.
Following the fermentation, the cell paste was recovered by 
centrifugation Of the cooled mature culture in an industrial 
centrifuge. The total yield of the cell paste from the 
400 litre batch culture was approximately 13.3 kg. The cell 
paste was resuspended in 45 litres* of 10mM sodium phosphate tuffer 
pH7.4 and passed through a Manton-Gauiln high pressure 
homogeniser (APV-Ltd.) at 6,000 psi to break open the cells. 
The cell debris was removed by centrifugation and the crude 
cell extract was frozen rapidly in solid carbon dioxide in 
20 litre plastic containers. The final volume of the cell 
extract was approximately 40 litres. A 1 litre aliquot of 
the extract was defrosted and used to calculate the yield 
of the OXA-2 beta-lactamase from the 4 00 litre batch culture 
in terms of total enzyme activity, total protein concentration 
and specific activity of the enzyme sample. This data is 
expressed in table 15, as per litre and per 400 litres of 
the original batch culture and is compared with the yield 
of the OXA-2 enzyme from the E.coli J6-2 (R46) strain.
The data for the R46 strain was derived from the results 
reported by Dale and Smith (1971).
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Table 15:' The yield of the OXA-2 beta-lactamase derived from 
the 400 litre batch fermentation compared with that 
from a control R46 strain E.coli J6-2 (R46)
Volume Wet Total Total Specific
weight Enzyme protein activity
(litres) of cells Activity
(Units) (mg)
(U/mg)
Strain 14 400 13.3kg 23.8 x 105 20 x 105 1.19
E.coli
CA265//pSU3 1 33g 5946 4997 1.19
E.coli
J6-2/R46
1 1.1g 76.4 166 0.46
Ratio of 
strain 14 
to R46 
strain
1 30 77.8 30 2.6
The effect on the level of OXA-2 beta-lactamase 
production of using a high cell yielding strain (E.coli CA265) 
in conjunction with the chimaeric plasmid pSu3 is indicated 
in table 15. Strain 14 produces approximately 30 times the 
cell mass of the J6-2 strain with a concomitent increase in 
total enzyme yield of 78-fold. The specific activity of the 
enzyme produced by strain 14 is approximately 2.6 times 
greater than that produced by the J6-2 strain, which reflects 
the increased level of enzyme production by the chimaeric 
plasmid pSu3 compared to that produced by the R factor R46.
The use of strain 14 to produce the OXA-2 enzyme has therefore 
provided a crude cell extract with an increased total enzyme 
.yield of approximately 78-fold.
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Section 11 Purification of the OXA-2 Beta-lactamase
As a result of increasing the yield of the OXA-2 beta- 
lactamase by a factor of between 7CW80 fold, the 4 00 litre 
batch fermentation of strain 14 produced 13.3 kg of crude 
cell paste with*a corresponding enzyme yield of 180 Units/g. 
The original purification protocol devised by Dale and 
Smith (1971) was. applicable to a relatively small scale 
enzyme isolation process. This procedure was capable of 
processing approximately 13.5gof crude cell extract with a 
corresponding yield of 4mg of purified enzyme. Biochemical 
characterisation of the enzyme, in particular amino acid 
sequencing studies, requires large quantities of purified 
beta-lactamase. It was intended that sufficient purified 
enzyme would be available, not only to fulfill the 
requirements of this project but also for future research.
The techniques used for small scale purification are;- not 
always applicable to the large scale situation. It was 
therefore necessary to adapt the original protocol to cope 
with large scale purification. In addition, the original 
procedure was relatively laborious in that it required 
2*»3 weeks for completion.. The large scale purification 
protocol was subsequently developed in the interests of 
expedience.
Investigation into techniques designed to optimise 
enzyme purification on a large scale
Various novel purification techniques were investigated 
in order to optimise enzyme purification. In addition, 
attempts were made to adapt the original purification protocol 
for large scale purposes. The large scale purification 
protocol was based on the results of these experiments«
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11.1 The•application of novel techniques to the purification 
of the OXA-2 beta-lactamase
Since the original purification protocol was devised 
by Dale and Smith (1971), several novel and innovative 
purification techniques have been developed. Attempts 
were made to adapt certain of these techniques to the 
purification of the OXA-2 enzyme.
Crude beta-lactamase extract
At the time at which these experi ments were performed 
the large scale fermentation had not been completed. 
Consequently, the crude enzyme preparation used for the 
following series of experiments was extracted from a 12 
litre batch fermentation of strain 9 (E.coli ED8654) carrying 
the chimaeric plasmid pSu3. The specific activity of the 
crude cell extract was 0.826.
/ i.
11.1.1 Isoelectric chromatography
Isoelectric chromatography (Petrilli et al.1977) 
involves performing consecutive ion exchange chromatography 
on anion and cation exchange matrices at the isoelectric 
point (pi) of the protein to be purified. The protein in 
question has a neutral charge at its pi and consequently 
passes through both ion exchangers whilst contaminating 
proteins are absorbed. A small pilot experiment was 
carried out in order to examine the feasibility of this 
technique.
Procedure
A pi value of 8.0 (Sykes and Smith, 1979) for the OXA-2
beta-lactamase was utilised. DE-52 and CM-52 ion exchangers
were equilibrated in 1OmM sodium phosphate buffer at pH8.0,
according to manufacturer's instructions. The fines were
removed and the slurries were poured into two seperate
2
Wright chromatography columns (60x4cm ). The output from
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the anion'exchange column was linked to the input valve of 
the cationic column and a 200ml aliquot of the 
chromatography buffer was pumped through the two columns 
at a speed of 1Oml/minute to allow for equilibration.
38ml of crude enzyme in 1OmM sodium phosphate buffer pH7.4 
was applied to t?he top of anion exchange column. The enzyme 
was eluted with the same buffer. 8ml fractions of the 
eluent were collected and tested for enzyme activity using 
the microiodometric assay. The enzyme continuing fractions 
were pooled and the pooled fractions were measured for 
enzyme activity using the spectrophotometrie assay and 
protein concentration using the Waddell assay. The recovery 
of enzyme activity and the purification achieved were 
calculated and the results are listed in table 16.
Table 16: Isoelectric chromatography of the QXA-2
beta-lactamase
Total
Enzyme
activity
(Units)
Total
Protein
(mg)
Specific
activity
(U/rrg)
Purification Recovery
(%)
Enzyme 
applied onto 
column
300.3 363.6 0.826
Pooled
fractions
following
chromato­
graphy
42.41 3.00 14.12 17.1 14.12
conc = concentration
Specific activity = Enzyme Units/mg of protein 
% Recovery = % Recovery of enzyme activity
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The results listed in table 16 indicate that the purification 
achieved by isoelectric chromatography was significant but 
the recovery of enzyme activity was, however, very low.
The results of isoelectric chromatography of the OXA-2 
beta-lactamase are compared with the figures obtained 
from other purification techniques and are listed in table • 
17. The figures from the various purification techniques 
were taken from the results of experiments listed in 
section 11.2.
Table 17: A comparison of various techniques used for the
purification of the OXA-2 beta-lactamase
Technique
Recovery of enzyme 
activity (%) Purification
Isoelectric
chromatography 14 17.1
Batch DEAE + 
cellulose treatment
72.23 
sdO.07
2.9 
sdO. 3
Ion exchange * 
chromatography pH8.9
59.2 
sd9 .8
5.0 
sd 0.7
Sephadex G-100 + 
gel filtration
49.9 
sd5.47
2.9 
sdO.08
* Each of the values listed represents the mean of 
three separate determinations.
+ Each of the values listed represents the mean of two 
separate determinations.
1 2 0
On examination of the data listed in table 17, it can 
be seen that the purification achieved by isoelectric 
chromatography was considerably greater than that produced 
by the other techniques. The recovery of enzyme activity 
was, however, so low as to counterbalance the effect of the 
high level'of pu'rification therefore rendering the 
technique impracticable for large scale enzyme purification.
11.1.2 Affinity chromatography
Affinity chromatography is a powerful technique for the 
purification of almost any biomolecule based on its 
biological function or individual chemical structure. The 
technique is a form of absorption chromatography in which 
the substance to be purified is specifically and reversibly 
absorbed by a complementary binding substance or ligand 
immobilized on an insoluble support. Dale (1971) reported 
that the OXA-2 enzyme apparently binds to Dextran blue.
Attempts were therefore made to purify the OXA-2 enzyme by 
affinity chromatography on Blue-Sepharose CL-6B, which is 
composed of the dye Cibacron blue F3G-A (Blue dextran is a derivitive 
of Cibacron blue)covalently linked to a Sepharose CL-6B matrix. 
Various conditions for the attachment and subsequent elution 
of the enzyme to the affinity gel were investigated.
Adsorbtion of the enzyme to the gel was achieved using a 
sodium phosphate buffer system. Cibacron blue interacts 
with most nucleotide requiring enzymes at a supersecondary 
structure within the enzyme molecule known as the 
dinucleotide fold (Thompson and Stellwagen,1976). Enzymes 
bound to the dye in this manner can be eluted with low 
concentrations of nucleotide cofactors. Although the OXA-2 
enzyme does not require a nucleotide cofactor, attempts 
were made to elute the enzyme from the affinity gel using 
a series of cofactors in order to determine whether the 
nature of the interaction was similar to that occuring with 
other nucleotide-binding enzymes.
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Procedure'
3.5g of Blue Sepharose CL-6B was swollen in 25ml of
deionised water and washed with 700ml of deionised water in
several aliquots on a sintered glass filter. The swollen
gel was packed into a Wright chromatography column 
2(25 x 0.9cm ) to a bed height of 14cm and a bed volume of
3
12cm . The column was equilibrated with 90ml of 1OmM 
sodium phosphate buffer pH7.4. The packing, equilibration 
and running of the column was carried out at 4°C. A 5ml 
aliquot of the crude beta-lactamase extract was applied to 
the drained upper surface of the column bed and allowed to 
absorb onto the gel. The column was washed with 200ml 
of phosphate buffer at a pump speed of 30ml/hour. Various 
conditions for the elution of the enzyme were tested. A 
linear salt gradient was applied to the column, the enzyme 
not being eluted below the molarity of the salt at which 
enzyme inhibition was significant. Elution was attempted 
using the nucleotide cofactors, ATP (5m'M) , NADH (10mM), or 
FMN (10mM), but was unsuccessful. Elution was achieved 
using 1Omg/ml of benzylpenicillin (26.5mM). Enzyme elution 
was measured using the microtitre nitrocefin assay.
Following elution with benzylpenicillin, the enzyme 
containing fractions were pooled and precipitated with 
ammonium sulphate at 60% saturation. This process removed 
the antibiotic so that it did not interfere with measurements 
of the recovery of enzyme and the degree of purity achieved 
by affinity chromatography. Three separate columns were 
utilised for each of the elution conditions ie. salt elution, 
cofactor elution and substrate elution.
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Table 18: The purification of the OXA-2 beta-lactamase
by affinity chromatography
Volume
(ml)
Protein
(mg)
Enzyme 
activity 
(Units)
Specific
activity
(Units/mg)
Sample
applied
5 70 106 1 .5
Material
eluted
1 0.11 15.6 142
N.B. The crude enzyme solution applied to the column was 
previously precipitated with ammonium sulphate at 55% 
saturation, resuspended in phosphate buffer and dialysed 
against 2 x 500ml phosphate buffer at 4°C. The enzyme was 
eluted from the column with 10 mg/ml benzylpenicillin.
Table 18 indicates the purification of the OXA-2 enzyme 
achieved by affinity chromatography on Blue Sepharose 
CL-6B. Affinity chromatography is preceded and followed 
by two ammonium sulphate precipitation steps. The results 
indicate that the OXA-2 enzyme can be purified by a 
simple affinity chromatography and precipitation protocol 
which yields enzyme of a specific activity equal to that 
achieved by the more complex procedure described by Dale 
and Smith (1971). The recovery of enzyme activity by the 
affinity technique was approximately 14.7%, which compares 
favourably to the 9.3% recovery obtained using the Dale 
and Smith protocol. The affinity technique can, however, 
only be utilised on a small scale due to the low binding
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capacity of the dye and the high cost of the affinity gel. 
Therefore, although affinity chromatography provides an 
efficient and extremely powerful technique for the 
purification of the OXA-2 enzyme, its various limitations 
do not permit its adaption to large scale purification.
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11.2 The>adaption of the small scale purification protocol
devised by Dale and Smith (1971) for large scale purposes
A summary of the purification protocol devised by Dale 
and Smith is listed in table 19.
Table 19: The purification protocol for the OXA-2 beta-
lactamase devised by Dale and Smith (1971)
Step Process
1 2% protamine sulphate precipitation
2 Ammonium suI phate precipitation (50% 
saturation)
3 Dialysis against 5 litres of 1OmM sodium 
phosphate buffer pH8.0
4 DEAE - cellulose column at pH8.0
5 Dialysis against 1OmM Tris-HCl buffer 
at pH8.9
6 Tris-HCl DEAE cellulose column at pH8.9
7 Ammonium sulphate precipitation 
(60% saturation)
8 Sephadex G-100 gel filtration
9 Ammonium sulphate precipitation 
(60% saturation)
The purification protocol devised by Dale and Smith 
was simplified and adapted for large scale enzyme purification. 
The protocol contained two ion exchange chromatography 
columns, the first at pH8.0 and the second at pH8.9. Ion 
exchange provides a method for the separation of closely 
similar biological molecules from highly complex mixtures.
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Separation is achieved on the basis of reversible adsorption 
of solute molecules which vary in their affinity for the ion 
exchanger due to the differences in the charges which they 
carry. The affinities for the exchanger can be controlled 
by varying the adsorption conditions such as ionic strength 
and pH. Ion exchange can involve either the binding of. 
the substance of interest or the adsorption of contaminating 
proteins and can be carried out in a column or by a batch 
procedure. The adsorption conditions for the 1st ion exchange 
DEAE cellulose column (pH8.0) at step 4 in table 19 were 
chosen such that contaminating proteins' were bound to the 
ion exchanger. The pouring, equilibration and running of 
such a column is complex and time consuming. Attempts, 
therefore, were made to convert the column step to a batch 
process. The batch process involved mixing the crude cell 
extract directly with the ion exchanger to form a slurry.
The slurry was stirred slowly to allow for the adsorption 
of contaminants and the' ion exchanger together with the 
adsorbed proteins was separated from the enzyme preparation 
by filtration. The optimal conditions for the adsorbtion 
of the contaminating proteins were investigated.
Crude beta-lactamaseextract
The beta-lactamase preparation used for the following 
series of experiments was obtained from the 400 litre batch 
fermentation of strain 14 (E.coli CA26 5) containing the 
chimaeric pSu3 plasmid. The crude enzyme extract from the 
400 litre fermentation was supplied as a 40 litre broken 
cell suspension in sodium phosphate buffer at pH 5.8. The 
preparation was divided into 2.25 litre aliquots and stored 
at -20°C. Prior to use, a sample was removed and allowed 
to defrost at 4°C. The extract contained a small but 
significant amount of cellular debris which was removed by 
centrifugation at 16,000g for 30 minutes. The supernatant 
was maintained at 4°C and the pellet discarded. The specific 
activity of the final crude enzyme extract was approximately 
1 .,19 Units/mg.
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11 .2.1 Batch DEAE cellulose treatment at pH 7.4
The pH of the crude enzyme extract used for the batch 
treatment was approximately 5.8. The conditions for the batch 
treatment were set a pH 7.4 in 0.025M sodium phosphate buffer.
A batch treatment at pH7.4 was chosen as the optimum pH 
value at which to maximise the adsorption of contaminating 
proteins whilst at the same time minimising the extent to 
which the pH of the crude extract necessitated altering to that 
of the starting pH of the batch treatment. A batch treatment 
at a pH of less than 7.4 was impracticable, since as the pH 
value of the treatment is lowered, the concentration of 
contaminating proteins adsorbed by the DEAE is greatly reduced.
Procedure
The pH of enzyme extract was raised from pH 5.8 to pH
7.4 with 1M Tris. DE52 (DEAE-cellulose) was equilibrated 
in 25mM sodium phosphate buffer pH 7.4 and the fines were 
removed in accordance with the manufacturer's instructions.
The capacity and equilibration times of the ion exchanger 
were measured at various concentrations of crude cellular 
protein mixed with known wet weights DEAE cellulose. 500ml 
volumes of crude enzyme solution were mixed with various 
quantities of ion exchanger to form a slurry at 4°C and this 
was stirred slowly using a glass stirrer and motor 
attachment. At regular time intervals, 30ml samples were 
removed from the slurry, filtered to remove the ion exchanger 
and then assayed for enzyme activity and protein concentration. 
The results of this series of batch experiments are 
illustrated in figures 19, 20 and 21.
Figure 19 illustrates the time course for the adsorption 
of protein from the crude cell extract by DEAE cellulose 
at different ratios of cellular potein to wet weight DEAE. 
Equilibration is a rapid process with the maximum amount of 
protein per wet weight DEAE adsorbed within the first 10 
minutes of the reaction. The amount of contaminating protein 
that is adsorbed is dependent upon the quantity of the ion
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at different ratios of cellular protein per 1g of (wet 
weight DEAE)
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Figure 20: Batch DEAE treatment. Relationship between the
percentage cellular protein adsorbed by DEAE cellulose and
the ratio of the amount of cellular protein (mgs) per 19
of DEAE (wet weight)
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exchanger * present. The relationship beween these two 
parameters is, however, not linear. A preliminary plot of 
the percentage of protein adsorbed versus the concentration 
of DEAE, as shown in figure 20, indicates that, as the 
concentration of crude cellular protein per g of ion exchanger 
increases, the percentage of adsorbed protein does not 
decrease linearly.
Figure 21: The percentage loss of protein and enzyme activity
from a crude beta-lactamase extract following a batch DEAE 
cellulose treatment at a concentration of 100mg cellular 
protein/1g of wet weight DEAE.
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Figure 21 illustrates the percentage loss of protein 
and enzyme activity from a crude enzyme extract treated by 
a batch DEAE process at a concentration of 100mg of crude 
cellular protein to 1g of wet weight DEAE. The results 
indicate that approximately 70% of the contaminating proteins 
are removed froifi the extract by the batch treatment with 
a concomitant loss in enzyme activity of approximately 27%.
The loss in enzyme activity probably results from a 
combination of denaturation and non-specific adsorption 
to the exchange matrix.
On the basis of the results listed in figures 19-»21, 
the batch DEAE cellulose treatment provides an efficient, 
simple and extremely rapid process for the purification of 
the OXA-2 enzyme, which can be easily adapted for large 
scale purification. The batch technique dispenses with the 
necessity of pouring and equilibrating a column and is 
therefore considerably less time consuming. It was envisaged 
that 2.25 litres of the crude cell extract would be 
processed by the large scale protocol. Two successive 
batch DEAE treatments were devised for the large scale 
purification. The first treatment at a concentration of 
200mg of crude cellular protein per 1g of wet weight DEAE, 
would remove approximately 50% of the contaminants, whilst 
the second treatment at a concentration of 100mg/g wet 
weight DEAE, would provide further purification.
11.2.2 Ammonium sulphate precipitation
Following the batch DEAE treatments it was necessary 
to concentrate the 2.15 litres of partially purified enzyme 
extract by a 10-fold factor prior to its application to the 
2nd Tris-HCl DEAE cellulose column (step 6 in table 18). 
Concentration was achieved by ammonium sulphate precipitation. 
Since the concentration step was additionally designed 
as a purification step, the optimal percentage saturation 
of ammonium sulphate satisfying both criteria was investigated.
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Procedure'
100ml aliquots of partially purified beta-lactamase 
following batch DEAE treatment, were brought to a range of 
percentage saturation levels with solid ammonium sulphate.
The saturation values chosen ranged from 20-^80% in 10% 
increments. The relative quantities of salt to be added 
to each enzyme preparation were obtained from the standard 
table listed in "Data for Biochemical Research", 2nd Ed, 
(Dawson et al.,1969). The salt was added slowly and in 
portions to each enzyme suspension which were maintained at 
4°C. The salt/enzyme solutions were stirred gently until 
all the salt had dissolved and left at 4°C overnight.
Following storage at 4°C, the suspensions were centrifuged 
at 16,000g for 30 minutes with the exception of the 80% 
saturation extract which was centrifuged for 1 hour.
The supernatants were decanted and tested for enzyme activity 
and protein concentration. The percentage protein and 
enzyme activities remaining in the supernatants following 
precipitation were calculated and are shown in figure 22.
Figure 22: Ammonium sulphate fractionation of a partially 
purified OXA-2 beta-lactamase solution. The percentage 
cellular protein and enzyme activity remaining in the 
supernatant following precipitation and centrifugation 
plotted as a function of percentage salt saturation levels
100 r
#-• = % Beta-lactamase 
activity
0 20 40  60 80
Percentage Ammonium sulphate Saturation--------------->
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Figure 22 represents the results of the salt fractionation 
of a partially purified OXA-2 enzyme preparation. The 
percentage of protein and enzyme activity remaining in the 
supernatant following precipitation is plotted as a function 
of the percentage salt saturation level. The optimum salt 
saturation level for concentration and purification is 
given at the point in figure 22 at which the minimum amount 
of protein and the maximum amount of enzyme activity are 
precipitated. This value, read from figure 22, was 
approximately 55% and consequently, a 55% ammonium sulphate 
saturation level was utilised for the precipitation of OXA-2 
enzyme preparation following batch DEAE treatment.
Subsequent precipitation steps were carried out at a 60% 
saturation level. At these later stages in the purification 
protocol the concentration and recovery of the enzyme 
becomes more important than purification. At the 60% 
saturation level, approximately 98.5% of all the enzyme 
activity is precipitated which provides excellent enzyme 
recovery and concentration.
11.2.3 Ion exchange chromatography at pH 8.9
The original purification protocol listed in table 19
included an ion exchange column equilibrated in tris-HCl
buffer at pH8.9. The adsorption conditions were chosen such
that the OXA-2 enzyme was bound to the ion exchange matrix
whereas contaminating proteins were not. The enzyme could
subsequently be eluted via a salt gradient. This tris-HCl
column was adapted for large scale purification on the basis
of thie following criteria ; efficiency, recovery of enzyme
activity and speed. Modifications to the column technique
included increasing the dimensions of the column to 150 x 
2
5 cm , washing the column following adsorption of the enzyme 
with 500ml of tris-HCl buffer and elution via a single 
step salt treatment.
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Procedure.
2 litres of fines free equilibrated DE52 were prepared 
in 1OmM tris-HCl buffer pH8.9. The slurry was then poured
2
into a Wright chromatography column of dimensions 150 x 5 cm . 
The equilibration of the DE52 and the preparation and running 
conditions of the chromatography column were carried out 
at 4°C in accordance with the instructions listed in the 
Whatman technical bulletin IE2. The column was equilibrated 
with 500ml of tris-HCl buffer at a pump speed of 90ml/hour.
The 200ml enzyme sample following batch treatment and 
precipitation was dialysed against 2 x 2.5 litres of 1OmM 
tris-HCl buffer pH8.9 at 4°C. The enzyme sample following 
dialysis was applied to the drained upper surface of the 
column bed and allowed to adsorb into the ion exchange 
column. The column was washed with 500ml of 10mM tris-HCl 
pH8.9 to remove the contaminating proteins. The enzyme 
was eluted via a single step elution with 225mM sodium 
chloride prepared in the same buffer. The eluent was 
collected in 15ml fractions and the position of the enzyme 
was determined qualitatively by the microtitre nitrocefin 
assay and quantitatively by the microiodometric assay.
The fractions containing the enzyme were pooled and dialysed 
against 3 x 2.5 litres of 25mM sodium phosphate buffer pH
7.4 to remove the sodium chloride. The pooled dialysate 
was tested for enzyme activity by the spectrophotometric 
assay and for protein concentration using the Lowry assay. 
Three separate columns were run in order to estimate the 
level of purification achieved and the efficiency of the 
single step salt elution. A separate column was prepared 
and eluted with a linear salt gradient to act as a comparison. 
The results of the various methods of elution from the 
chromatography columns are listed in table 20 as a 
comparison of the levels of purification achieved and the 
recovery of enzyme activity. The data from the original 
small scale purification protocol (Dale and Smith 1971) 
have also been included.
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Table 20: The purification of the OXA-2 beta-lactamase by
ion exchange chromatography on DE52 cellulose at 
pH8.9 : A comparison of the purification achieved
and the recovery of enzyme activity using different 
methods of enzyme elution
Method of 
elution
Recovery of 
enzyme activity 
(%)
Purification 
(Increase in 
specific activity)
Gradient elution
46.1(Dale and Smith,1971) 1 .69
Gradient elution 43.12 3.73
(this work)
Single step elution* 59.2 5.0
(this work) sd 9.8 sd 0.7
*Each figure represents the mean value of three separate
determinations.
The results listed in table 20 indicate that the 
purification achieved by a single step salt elution was 
greater than that achieved by gradient elution. The improved 
level of purification achieved in this study by both single 
step and gradient elution over that obtained by Dale & Smith 
(1971) probably reflects the increased volume of buffer 
which was used to wash the column free from contaminating 
proteins. The purpose of using single step elution was to 
limit the time to which the OXA-2 enzyme was exposed to the 
sodium chloride which has been shown to inhibit the OXA-2 
enzyme (Dale, 1971).
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11.2.4 Sephadex G-100 gel filtration
The original purification protocol listed in table 19
included a penultimate sephadex gel filtration step following
ion exchange chromatography at pH8.9. Only minor
modifications of this process were necessary for large scale
purification. The sephadex gel filtration column was set
up as described by Dale and Smith (1971) except that the
2column dimensions were increased to 100 x 4cm and the 
column was developed with 25mM sodium phosphate buffer pH7.4 
by downward flow.
Procedure
The running conditions of the column were those 
described by Dale and Smith (1971) with the exceptions 
listed above. The preparation of the column at 4°C was 
carried out according to the instructions listed in the 
Pharmacia Fine Chemicals AB technical bulletin on Gel 
Filtration, theory and practice. The OXA-2 enzyme sample 
following ion exchange chromatography at pH8.9 was 
precipitated with ammonium sulphate at 60% saturation.
The precipitate was collected by centrifugation, redissolved 
in 5ml of 25mM sodium phosphate buffer pH7.4 and applied to 
the upper drained bed surface of the sephadex column.
The enzyme was eluted in the same buffer at a pump speed of 
20ml/hour. The eluent was collected in 3ml fractions and 
the elution position of the enzyme was determined using the 
microtitre nitrocefin assay. The enzyme containing fractions 
were pooled and tested for enzyme activity using the 
spectrophotometric assay and for protein concentration using the 
Lowry assay. Three separate columns were run and the level 
of purification achieved by each and the recovery of enzyme 
activity was calculated. These figures were utilised for 
a comparison of purification technique with isoelectric 
chromatography described in section 11.1.1.
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Section 11.3 The large scale purification protocol
The large scale purification protocol was designed in 
terms of cost, efficiency and speed and was based, on the 
results listed in section 11.2. The protocol is described 
below in a series of steps.
Step 1 : Removal of cellular debris
2.25 litre of crude cell extract was defrosted at 4°C. The 
cellular debris was removed by centrifugation at 1 2 0 0 0 ^  for 
30 minutes. The pellet was discarded and the supernatant 
was maintained at 4°C.
Step 2 : pH modification
The pH of the enzyme extract was raised from pH 5.8 to 
pH 7.4 with 1M Tris.
Step 3 : Batch DEAE cellulose treatment
The enzyme extract was treated with two consecutive batch 
DEAE cellulose treatments, the first at concentration of 
200mg crude cellular protein/g wet weight DEAE and the 
second at a concentration of 100mg/g wet weight DEAE. The 
enzyme sample was mixed with the appropriate amount of DE52 
to form a slurry and stirred for 10 minutes at 4°C.
The DE52 was removed by filtration and the process repeated 
The enzyme was precipitated with ammonium sulphate at 55% 
saturation overnight at 4°C and the precipitate collected 
by centrifugation and redissolved in 200ml of 10mM tris-HCl 
pH 8.9 and dialysed against 2 x 2.5 litre of the same 
buffer at 4°C.
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Step 4 : Ion exchange chromatography at pH 8.9
The contents of the dialysis tube were applied to a column 
2
(150 x 5 cm ) of DE-52 cellulose equilibrated with 10mM 
tris-HCl buffer pH 8.9. The column was washed with 500ml 
of the same buffer. The enzyme was eluted with 225mM 
sodium chloride prepared in the same buffer.
Step 5 : Sephadex G-100 gel filtration
The fractions containing the enzyme were pooled and
precipitated with ammonium sulphate at a 60% saturation.
The precipitate was collected by centrifugation and
redissolved in 5ml of 25mM sodium phosphate buffer pH 7.4.
The redissolved precipitate was applied to a column 
2
(100 x 4 cm ) of sephadex G-100 which was developed with 
phosphate buffer by downwards flow. The fractions containing 
the enzyme were pooled and precipitated with ammonium 
sulphate at 60% saturation.
Step 6 : The purified enzyme was stored as a salt solution 
at 4°C. For long term storage the enzyme was desalted on 
a sephadex G-50 column and freeze dried. The purity of 
the enzyme was checked by SDS - PAGE.
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11,4 A comparison of the large and small scale purification
of the OXA-2 beta-lactamase
Table 21 indicates the purification of the OXA-2 beta- 
lactamase achieved using the large scale protocol. The level 
of enzyme purification achieved using the original small 
scale protocol (Dale and Smith 1971) is listed in table 22 
for comparison. The purification of the OXA-2 enzyme using large 
scale methodology was successful. The yield of purified 
enzyme was approximately 90mg from 2.25 litres of crude 
enzyme extract. The recovery of enzyme activity was 
approximately 15 % which compares favourably with the 9% 
achieved by the small scale technique. The specific 
activity of the purified enzyme was 229.5 Units/mg 
proteiny this value being approximately 1.6-fold greater 
than the specific activity achieved by Dale and Smith (1971).
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Table 21: Purification of the OXA-2 beta-lactamase
on a large scale
Step '•Volume
Total
enzyme
activity
(Units)
Total
protein
(mg)
Specific
activity
(Units/mg)
Purifn
Crude enzyme 2.25 1 134460 115741 1.16 1
Batch DEAE
cellulose
treatment
2.15 1 83910 16696 5.03 4.34
Ammonium p 
sulphate prec 
(55% saturation)
200 ml 73488 10018 7.34 6.32
DEAE cellulose 
column pH8.9
120 ml 42996 1102 39 33.62
Ammonium 
sulphate prec 
60% saturation
5 42351 * 771 55 46.22
Sephadex
G-100
25 21082 123 171 143.7
Ammonium 
sulphate prec 
60% saturation
8 20314 88.6 229.5 192.86
p
prec = precipitation 
pur if11 = purification
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Table 22 : The purification of the OXA-2 beta-lactamase 
by the original protocol devised by Dale &
Smith (1971)
Step Volume
(ml)
Total
enzyme
activity
(Units)
Total
protein
(mg)
Specific
activity
(Units/mg)
Purif11
Crude enzyme 360 6190 13460 0.46 1
Ammonium p 
sulphate prec 
50% saturation
46 4070 2320 1.76 4
First DEAE 
cellulose column
80 1649 72.5 22.7 49
Second DEAE 
cellulose column
50 760 19.9 38.2 83
Sephadex
G-100
28 410 6.0 68.3 148
Ammonium _ 
sulphate prec 
60% saturation
3.5 577 4.0 143.2 312
P . . .prec = precipitation
This data was derived from results listed by Dale & Smith (1971).
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Section 12 Characterisation of the OXA-2 Beta-lactamase
12.1 Molecular weight determination
The molecular weight of the purified enzyme was 
determined by sodium dodecyl sulphate polyacrylamide gel 
electrophoresis (SDS-PAGE) using the method of Laemmli and 
Favre (1973). The molecular weight was determined from a 
plot of Rf values against corresponding log values of 
molecular weights using a series of standard molecular weight 
markers, as shown in Figure 23. The purified OXA-2 enzyme 
focuses as a single band following SDS-PAGE. The molecular 
weight of the OXA-2 enzyme was determined from figure 23 as 
32,170. This value is the mean of three separate 
determinations.
Figure 23; Determination of the molecular weight of the 
OXA-2 enzyme by SDS-PAGE
0-8
0-6
if )m“5 0-4-j
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in d ica ted  by • .  The s tandard  proteins a re  ind icated  by o 
The standard prote ins were , Bovine a lbum in Mw = 6 6 , 0 0 0  ; 
Ovalbum in Mw = 4 5 , 5 0 0  ; T ryps inogen  Mw = . 2 4 , 0 0 0 ;  Beta-lactoglobin  
Subunit Mw = 1 8 , 0 0 0 ;  Lysozyme Mw = 1 4 ,0 0 0  . M w =M olecu la r  weight
The 32,170 value for the molecular weight of the OXA-2 
enzyme is larger than the 28,400 figure determined by SDS-PAGE 
using the method of Weber and Osborne (1969) as calculated 
by Dale and Smith (1976). This discrepancy probably results 
from differences in the two electrophoresis methods. The 
molecular weight of 32,170 represents approximately 72% of 
the 44,600 value determined by gel filtration (Dale,1971). 
Comparison of the lower SDS-PAGE molecular weight values 
of the OXA-2 and OXA-3 enzymes with the gel filtration 
figures, prompted the suggestion by Dale and Smith (1976) 
that the two enzymes may be dimers in their native states. 
Further evidence of a subunit structure was obtained from 
the demonstration of 'in vivo' hybridisation between the 
subunits of the OXA-2 and OXA-3 beta-lactamases. The OXA-2 
and OXA-3 enzymes are the only beta-lactamases for which a 
subunit structure has been implied. It was therefore decided 
to investigate the dimeric nature of the OXA-2 enzyme in 
more detail.
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12.2 Cross-linkage of the OXA-2 beta-lactamase
Purified OXA-2 beta-lactamase produces a single band 
on SDS-Polyacrylamide gels. The enzyme is therefore a 
monomeric protein of molecular weight 32,170 or a dimeric 
protein consisting of two subunits of equal molecular weight. 
The composite molecular weight of the dimer would 
correspond to approximately 64000. Diimidoesters such as 
dimethyl suberimidate are highly specific reagents for 
amino groups in proteins and can be utilised to produce 
amidine cross-links between the protomers of oligomeric 
proteins (Davies and Stark,19 70). The series of molecular 
species generated by intra molecular cross-linkage which 
have molecular weights equal to integral multiplies of the 
protomer molecular weight, can then be analysed by SDS-PAGE, 
Cross-linkage of the dimeric OXA-2 enzyme would be expected 
to produce two species, one of molecular weight 32,000 and 
one of 64/000,provided that the conditions of the reaction 
were chosen such that cross-linkage does not reach 
completion.
Procedure
Cross-linking reagent : dimethyl suberimidate (DMS)
Buffers : Tris-HCl, 0.2M, pH8.5
Sodium borate, 0.25M,pH9
Concentration of reagents in cross-linkage reaction
2mg/ml protein : 2mg/ml DMS
1mg/ml protein : 2mg/ml DMS
5mg/ml protein : 2mg/ml DMS
Beta-lactoglobin was used as a control to test the 
efficiency of the cross-linking reaction. This enzyme is 
composed of two identical subunits of molecular weight 18,000.
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Two separate buffers were utilised to optimise cross-linkage.
In addition the concentrations of the proteins to be cross- 
linked and the cross-linking reagent were varied relative 
to each other, in order to maximise the cross-linking reaction. 
The OXA-2 and beta-lactoglobin preparations were dialysed 
separately in the appropriate buffer. Immediately prior 
to the cross-linking reaction, DMS was dissolved in the 
appropriate buffer at a 2mg/ml concentration. The pH of 
the DMS solutions were checked in order to ascertain that 
the pH of the buffer had not been altered by the addition 
of the DMS. The protein and DMS solutions were mixed at 
the concentrations listed above and the reaction was allowed 
to proceed at room temperature for 3 M  hours. The cross- 
linked samples were then analysed by SDS-PAGE according to 
the method of Laemmli and Favre (1973). The running gel 
was 12.5% acrylamide with 2.16% cross-linkage; the stacking 
gel was 3.75% acrylamide with 1.33% cross-linkage. The 
molecular weight markers were the same as listed in figure 
23. 1 Oug of the purified OXA-2 enzyme and the molecular
weight markers and 20 >ug of the cross-linked samples were
loaded onto the gel. The protein bands were stained with
PAGE-Blue 83 which is a more sensitive replacement for 
Coomassie brilliant blue R-250.
Plate 4 represents two SDS-PAGE gels designated A and 
B on which cross-linked samples of the OXA-2 enzyme and 
beta-lactoglobin were analysed.
Gel A
Tracks 1, 3, 4 and 8 = Molecular weight markers
Tracks 2 and 5 = Pure OXA-2 samples
Tracks 6 and 7 = Pure OXA-2 samples treated by the
cross-linkage reaction in tris-HCl buffer at 0.5 : 1 (track 6)
and 1:1 (track 7) reaction concentrations.
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PLATE 4 : PAGE-SDSGELS
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.
GEL B
t
Gel B
Tracks 1 and 6 = Molecular weight markers
Tracks 2 and 3 = Beta-lactoglobin cross-linked in sodium
borate buffer at 0.5 : 1 (track 2) and 1:1 (track 3)
reaction concentrations.
\'
Tracks 4 and 5 = Pure OXA-2 samples treated by the
cross-linkage reaction in sodium borate at 0.5:1 (track 4) 
and 1:1 (track 5) reaction concentrations.
The results illustrated in plate 4, indicate that the 
reaction conditions were appropriate for cross-linkage. 
Beta-lactoglobin (tracks 2 and 3 in gel B) was successfully 
cross-linked in both buffer systems and at different 
reaction concentrations. The reaction conditions were 
designed so that cross-linkage did not reach completion 
and that with beta-lactoglobin two reaction species were 
produced, the 18,000 molecular weight subunit and the 36,000 
dimer.
Tracks 6 and 7 in gel A and tracks 4 and 5 in gel B 
represent the cross-linkage of the OXA-2 enzyme in tris-HCl 
and sodium borate buffer systems. Cross-linkage was 
unsuccessful since no protein species was produced with a 
dimer molecular weight of 64,000. The OXA-2 samples treated 
by the cross-linkage reaction in tris-HCl buffer, produced 
a single protein band of molecular weight 32,000. The 
samples cross-linked in sodium borate buffer, however, 
produced two bands of closely similar molecular weight 
corresponding to approximately 31,000 and 32,000 respectively. 
The lower molecular weight band in this case may correspond 
to a smaller molecular form of the OXA-2 enzyme produced 
by intrachain cross-linkage of the monomeric protein. The 
failure to cross-link the postulated subunits of the OXA-2 
enzyme may indicate that the OXA-2 enzyme is not dimeric. 
Consequently, it was decided to re-examine the strain 
constructed by Dale and Smith (1976) containing the hybrid 
OXA-2/OXA-3 enzyme by isoelectric focusing.
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12.3 Isoelectric focusing (ief) studies
The reasons for carrying out isoelectric focusing studies 
on the OXA-2 beta-lactamase were two-fold. Initially, it 
was necessary to determine an accurate pi value for the 
OXA-2 enzyme. '.'Previously recorded pi values have varied 
from 7.3 (Matthew and Hedges, 1976) to 8.1 (Matthew et al 
1975) and in certain cases the OXA-2 enzyme has been 
reported to focus as a doublet with a dual pi of, for 
example, 7.45 and 7.7 (Hedges et al.,1974). Secondly, it 
was decided to investigate the subunit structure of the 
OXA-2 enzyme using ief. Dale and Smith (1976) constructed 
an E.coli J5-3 strain carrying the R factors R46 and R55 
which encode for the production of the OXA-2 and OXA-3 
beta-lactamases respectively. On examination of a crude 
cell extract from this strain (designated number 27 in this 
study) by starch gel electrophoresis, they observed a band 
with beta-lactamase activity which did not correspond to 
either the OXA-2 or OXA-3 enzymes. They attributed this 
band to the formation of a hybrid enzyme formed by the 
association of the subunits from the OXA-2 and OXA-3 
enzymes. Isoelectric chromatography, which was not 
available at the time of the original study, has a much 
higher resolving capacity than starch gel electrophoresis.
In conjunction with the highly sensitive nitrocefin assay, 
isoelectric chromatography can be used to detect hybrid 
enzyme forms with a greater level of accuracy.
The following enzyme samples were examined by isoelectric 
chromatography:-
1. Pure OXA-2 enzyme extracted from strain 14 (E.coli CA265) 
carrying the chimaeric plasmid pSu3.
2. Crude OXA-2 beta-lactamase extracted from strain 1 
(E.coli J6-2) carrying the R factor R46.
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3. Crude OXA-3 beta-lactamase extracted from strain 26
(E.coli J6-2) carrying the R factor R55.
4. Crude cell extract from strain 27 (E.coli J5-3)
carrying both the R factors R46 and R55.
The crude beta-lactamase extracts were prepared as 
described in section 9.3 except that the culture volumes 
were increased to 100ml. Following extraction, the samples 
were precipitated with ammonium sulphate at 55% saturation 
and resuspended in 10ml of 25mM sodium phosphate buffer 
pH 7.4.
Isoelectric chromatography: procedure
Isoelectric chromatography was performed on LkB 
pre-prepared Ampholine PAG plates pH 3.5 i 9.5, mounted on 
an LkB multiphor fitted with a cooling system. The 
apparatus and PAG plates were constructed according to the 
manufacturer's instructions. The sample applicators were 
applied at the centre of the gel and the chromatograms 
were run for 1 hour 40 minutes at 1.5 kilovolts, 30 watts. 
The sample applicators were removed after 30 minutes to 
avoid tailing of the samples. The pH gradient was 
determined using a precalibrated flat head electrode 
connected to a Kent EIL 7055 pH meter. The samples were 
refocused for 10 minutes following the measurement of the 
pH gradient. The samples were developed for enzyme 
activity using nitrocefin. A piece of Whatman number 3 
filter paper was cut to the size of the gel and soaked in 
a nitrocefin solution (500 jug/ml nitrocefin dissolved in 
25mM sodium phosphate buffer pH 7.0). The plates were 
developed by laying the filter paper over the gel. The 
development time for each gel was dependent on the enzyme 
activity of each sample. Prior to development, the gels 
were mounted for photography. The pi of each sample was 
determined by reference to the standard pH gradient of each 
gel.
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Figure 24: pH gradient from an isoelectric focusing gel used 
to determine the pi of the OXA-2 and OXA-3 enzymes
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A standard pH gradient from one particular 
chromatogram is illustrated in figure 24. The pi values for 
the OXA-2 and OXA-3 enzymes were taken as the band in the 
isoelectric spectrum with the greatest intensity. The pi 
values for the OXA-2 and OXA-3 enzymes are plotted in figure 
24 and correspond to values of 8.65 and 7.9 respectively.
Each value is the mean of three separate determinations.
The 8.65 pi value for the OXA-2 beta-lactamase is consistent 
with previously recorded behaviour of this enzyme. Dale 
(PhD thesis,1970) reported that the OXA-2 enzyme was positively 
charged at pH 8.3.
Plates 5-8 are photographs of the ief gels which were 
used to investigate the postulated hybrid OXA-2/OXA-3 enzyme. 
The purity of the samples represented in plates 5-8 are 
indicated as P = pure, C = crude.
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Plate 5
OXA-2 (P) 7 5 A ig /m l protein concentration, OXA-3 (C) 2mg/ml, 
OXA-2 (C) 2mg/ml, OXA-2/OXA-3(C) 2mg/ml.
Development time = 2.5 minutes.
Plage 6
Same as plate 5. Photograph was enlarged and the OXA-2 
crude sample was not included. Development time = 5 minutes.
Plate 7
OXA-2 (P) 250jug/ml, OXA-3 (C) 6mg/ml, OXA-2 (C) 6mg/ml, 
OXA-2/OXA-3(C) 6mg/ml.
Development time = 2.5 minutes.
Plate 8
Same as plate 7. Development time = 1 0  minutes.
The specific activities of the enzyme preparations were:-
OXA-2(P) = 230 Units/mg of protein
OXA-3(C) = 0.26 Units/mg of protein
OXA-2(C) = 0.79 Units/mg of protein
OXA-2/OXA-3 (C) = 1.11 Units/mg of protein
Each enzyme sample produces an isoelectric spectrum 
consisting of one main band representing the pi of the sample 
and several minor or satellite bands. Certain information 
can be gained from an examination of the chromatograms 
illustrated in plates 5-^ 8. A comparison of the isoelectric 
spectrum produced by the pure OXA-2 enzyme sample illustrated 
in plates 5 and 7 indicated that the number and intensity of 
the satellite bands was dependent on the protein
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concentration of the samples. By lowering the protein 
concentration of the OXA-2 enzyme sample by approximately 
two thirds, the number of satellite bands was reduced from 
6 to 2. Plate 7 illustrates the isoelectric spectrum 
produced by a crude and purified OXA-2 enzyme sample.
The pure sample/ which has a much higher specific activity 
than its crude counterpart, produces 4 additional bands 
in its isoelectric spectrum. The chromatograms were 
developed in terms of enzyme activity against a nitrocefin 
substrate. The additional bands in the spectrum produced 
by the pure enzyme sample may be attributed to the 
purification procedure which may itself introduce charge 
heterogeneity into the sample. A more likely explanation, 
however, is that the additional bands were due to the higher 
specific activity and hence the higher enzyme concentration 
of the purified preparation.
The loading positions of the samples onto the PAGE 
plates were found to influence the resulting isoelectric 
spectra. When loaded at the anode end of the gel, the OXA-2 
enzyme did not produce an isoelectric spectrum. Presumably, 
the enzyme was inactivated at acid pH. The samples in this 
study were applied at the centre of the gel in order to 
avoid the pH extremes of the gradient. If strain 26 
produces a hybrid OXA-2/OXA-3 enzyme, then a band(s) 
corresponding to this enzyme should be visible in the 
relevant isoelectric spectrum in addition to those bands 
produced by the parent enzymes. On examination of plates 5 
and 6 this appears to be the case. Two new bands (marked by an 
arrow in plates 5 and 6) are visible in the chromatogram 
produced by the hybrid strain which are not produced by 
either the OXA-2 or OXA-3 enzymes. Plates 7 and 8 illustrate 
the same enzyme samples as those in plates 5 and 6, but 
at higher protein concentrations. If the isoelectric 
spectrum produced by the hybrid strain is now compared with 
the relevant spectra from a crude OXA-3 and a pure OXA-2
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sample under these conditions of increased protein 
concentrations, then all the bands present in the hybrid 
spectrum can be correlated with those produced by the 
two parent enzymes, although the intensity of the bands 
in the spectra produced by the hybrid strain has been altered 
considerably t o 'those of the parent OXA-2 and OXA-3 
enzymes. The two new bands which were apparent in the 
spectrum of the hybrid strain in plates 5 and 6 can be 
seen in plates 7 and 8 to correspond to a minor band 
produced by the OXA-3 enzyme (marked by arrow in plate 7) 
and a satellite band produced by the pure OXA-2 enzyme 
sample. (Marked by arrow in plate 7). Plates 7 and 8 are 
photographs of the same isoelectric focusing gel except 
that in plate 8 the gel has had a longer development period. 
The differences in the development time indicate that an 
OXA-3 satellite band, which is only just visible after 
2.5 minutes (band marked by arrows in plates 7 and 8), 
becomes more defined after a longer development period.
The results of the isoelectric focusing studies are 
anomolous and obviously open to interpretation. The negative 
cross-linkage results in conjunction with the inconclusive 
isoelectric focusing studies have failed to substantiate 
the postulated dimeric structure of the OXA-2 enzyme.
Further investigation into this phenomenon is necessary.
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12.4 Amino Acid Analysis of the OXA-2 Beta-lactamase
An essential preliminary for all sequence analysis is 
to determine the amino acid composition of the subject protein. 
This is achieved by hydrolysing the peptide chain to its 
constituent amino acids followed by their quantitative 
estimation, usually by means of an automated amino acid 
analyser. The original single amino acid analysis of the 
OXA-2 beta-lactamase reported by Dale (1971) was performed 
on a small quantity of purified enzyme. Large amounts of 
purified enzyme were available in this study to permit 
several independent analyses to be performed. Correlation 
of the data from separate analyses would allow for a more 
accurate measurement of the amino acid composition of the 
OXA-2 enzyme. Furthermore, the specific activity of the 
enzyme sample used in this study was approximately 230 Units/ 
mg of protein compared with a specific activity of 143 Units/ 
mg used for the original analysis. The original analysis 
did not include a value for cysteic acid and, in addition, 
tryptophan was determined spectrophotometrically. This 
analysis permitted an accurate evaluation of both cysteic 
acid and tryptophan. The analyses w ere performed by 
R.P. Ambler.
Procedure
Amino acid analysis was performed on freeze-dried salt 
free OXA-2 enzyme samples of specific activity 230 Units/mg 
of protein in a Beckman 120C amino acid analyser using the 
methodology of Spackman (1963). Analysis was performed 
on two independent enzyme samples A and B which were 
purified in separate batches. Sample A was divided into two 
portions, the first being oxidised with performic acid and 
hydrolysed with 6M HCl for 24 hours and the second being 
hydrolysed unoxidised for 96 hours. Sample B was divided 
into three portions. Two were oxidised with performic acid 
and hydrolysed for 24 and 72 hours respectively and the
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other portion of sample B was hydrolysed with 3M 
mercaptoethane sulphonic acid (Penke et al.,1974). Acid 
hydrolysis with HC1 tends to destroy tryptophan.
Hydrolysis with mercaptoethane sulphonic acid tends to 
protect tryptophan and allows for an accurate evaluation 
of this amino gcid to be made. The amino acid composition 
of samples A and B listed in table 23, are calculated from 
the data generated by each individual analysis.
The amino acid analysis of the OXA-2 enzyme published 
by Dale (1971) was based on the gel filtration molecular 
weight value of 44,600. This value does not represent the 
true molecular weight of the enzyme. The dimeric nature of 
this enzyme has not been resolved. It is known, however, 
that the enzyme is either a monomer of molecular weight 
32,170 or a dimer of composite molecular weight of approximately 
64,000. Amino acid analysis data should, therefore, be 
based on a molecular weight of 32,170. The analysis reported 
by Dale (1971) has therefore been recalculated on this basis.
Table 23 lists the amino acid composition of the OXA-2 
enzyme as determined in this study in comparison to the 
data reported by Dale (1971). The results indicate 
significant discrepancies between the two analyses. The 
figures marked by an asterisk represent those residues for 
which there is a greater than 10% difference in composition 
between the two analyses. The difference in tryptophan 
values are to be expected since the spectrophotometric 
measurement of this residue is not as accurate as the assay 
described by Penke et al,(1974) used in this study. The 
amino acid residue with the most marked difference is 
proline. The reason for the low value recorded by Dale 
(1971) is unknown, since proline is very stable to amino 
acid analysis (R.P. Ambler, personal communication). The 
various differences between the two analyses may in fact be 
partly due to the different specific activities of the 
enzyme samples used in each study.
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Table 23:'The Amino acid composition of the OXA-2 beta-lactamase
Amino Acid 
Residue
Number of residues per enzyme molecule Analysis 
of Dale (1971)Sanple A Sample B Average
Lysine 14.78 14.92 15 16
Histidine 3.51 3.41 3 3
Arginine 20.6 20.08 . 20 24*
Tryptophan 5.4 5.43 5 11*
Cysteic acid 0.91 0.68 1 0
Aspartic acid 28.22 27.52 28 26
Threonine 10.89 10.95 11 8*
Serine 13.18 14.2 14 13
Glutamic acid 26.31 27.04 27 24*
Proline 9 7.93 8 2*
Glycine 17.41 18.26 18 16*
Alanine 24.61 24.10 24 23
Valine 16.51 16.97 17 16
Methionine 5.16 5.20 5 4
Isoleucine 13.46 13.19 13 14
Leucine 19.21 19.32 19 19
Tyrosine 6.27 6.13 6 5
Phenylanine 11 .99 11 .46 12 15*
All values were calculated on the basis of a molecular weight 
of 32,170.
The values marked by an asterisk represent the amino acid 
residues for which there is more than a 10% difference in 
composition between the analysis performed in this study and 
that carried out by Dale (1971).
The average values from samples A and B have been approximated 
to the nearest whole number.
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12,5 N-terminal amino acid analysis
The presence of an unblocked N-terminus is a necessary 
prerequisite for the successful amino acid sequencing of the 
N-terminal region of a protein. The identification of an 
N-terminal residue using the dansyl chloride method of 
Gray and Hartley (1965) is verification of an unblocked 
terminal region. SDS-PAGE of the OXA-2 enzyme has indicated 
that, if the enzyme is dimeric, then the two subunits must 
be equal in size. The identification of an unique N- 
terminal residue is indicative of identity between the two 
subunits of a dimeric protein.
Procedure
A freeze-dried salt-free OXA-2 enzyme sample of specific 
activity 230 U/mg of protein, was used for N-terminal 
analysis in accordance with the method described in section 
9.9. The OXA-2 N-terminal residue was identified in 
comparison with the relative positions of a set of dansylated 
amino acid standards separated on thin layer chromatograms 
developed in various buffer systems. The samples (OXA-2 
enzyme + dansylated markers) were developed in buffer 
system A and a tentative assignment of either histidine or 
arginine was made for the N-terminal residue of the OXA-2 
enzyme. The samples were then developed in solvent system 
B which was chosen to optimise the separation between 
arginine and histidine. The OXA-2 N-terminal residue ran 
as histidine in solvent system B. The Rf values of the 
OXA-2 N-terminal residue and the dansyl amino acid standards 
were compared with the predetermined Rf values listed by 
Metrione (1978). The two sets of figures were comparable 
(Rf values listed in table 24) with the N-terminal OXA-2 
residue having an Rf value equivalent to Dansyl-histidine.
As a further confirmation of the N-terminal residue of the 
OXA-2 enzyme, a sample of histidine was dansylated according 
to the method described in section 9.9. The Rf values for
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Dansyl -.Histidine and the N-terminal OXA-2 residue were 
comparable. The results indicate that the OXA-2 enzyme 
appears to have an unblocked histidine N-terminal residue.
Plates 9-11 are photographs of the thin layer 
chromatography'-plates which illustrate the N-terminal residue 
of the OXA-2 enzyme relative to a set of dansylated 
standards. The positions of each of the dansyl-residues 
have been labelled using the following set of abbreviations:
Dns = Dansyl, Dns-Arg (Arginine), Dns-Gly (glycine)
2
Dns-Glu ( Glutamic acid), N - Dns-His (histidine),
Dns-Phe (phenylanine), Dns-Pro (proline), Dns-Thr (threonine), 
Dns-OXA-2 = Dansyl N-terminal residue of OXA-2 enzyme.
Dansylamine , Dns-NI^ and dansyl hydroxide , Dns-OH, are 
side products of the dansylation reaction. Dns-NI^ is a 
product formed by the interaction of dansyl chloride with 
traces of ammonia in the sample. Dns-OH is formed from 
the hydrolysis of the excess dansyl chloride used in the 
reaction.
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12.6 N-terminal Amino Acid Sequencing
Amino acid sequencing was performed via the Edman 
degradation method, using a Beckman 890G spinning cup sequencer 
connected to a Sequemat P-6 automatic converter. Sequencing 
via Edman degradation involves the sequential labelling of 
the N-terminal amino acid residue of a protein with 
phenylisothiocyanate. The labelled residue is cleaved off 
from the peptide chain by acid hydrolysis to produce a 
thiazolinone amino acid derivitive. This derivitive is 
unstable and is consequently converted either automatically 
(i.e. using a Sequemat P-6) or manually, to the more stable 
phenylthiohydantoin (PTH) amino acid derivitive. A variety 
of methods are available for the identification of PTH-amino 
acids. This study utilised a combination of TLC and HPLC 
analysis to ensure unequivocal identification.
Spinning cup sequencing
Procedure: Two separate sequencing runs were performed using
the Beckman 89 0C spinning cup sequencer. 10mg of salt-free 
freeze-dried OXA-2 beta-lactamase of specific activity 230 
Units/mg of protein, was dissolved in 400 jal of formic acid 
and mixed with 100yul of Polybrene. The sample was added 
to the spinning cup of the sequencer and dried under vacuum 
using a subroutine drying programme prior to the start of 
the sequencing run. Sequencing was carried out using a 
dilute Quadrol programme. The automatic converter was used 
for the first sequencing run but since the converter did 
not perform reliably, it was disconnected for the second run 
and the thiazolinone derivitives were converted manually.
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Figure 25 : Amino acid sequence analysis by Edman degradation
Chem istry  of Edman degradation
P h - N =  O S  +
Phenyl isothiocyanate
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I I I
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H H, ^  1^ 2 1^ 3
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Manual conversion of thiazolinone derivitives to PTH-amino acids
Procedure The thiazolinone derivitives were dried under 
nitrogen in 5 x 0.5cm test tubes. A 40ai1 aliquot of 20%
Trifluoracetic acid (TFA) was added to each sample. The 
tubes were flushed with nitrogen, sealed with silicon bungs 
and incubated at 70°C for 12 months. The converted PTH- 
amino acids were dessicated and stored at 4°C prior to 
identif ication.
Identification of PTH-amino acids
Dual identification was performed using a combination of 
HPLC and TLC. Following conversion, the samples were 
resuspended in 200ju1 of TFA. Usually, 10 Ail aliquots of the 
sample were used for TLC analysis, whereas 20 Ail were used 
for HPLC identification. The quantities of the sample used 
for identification did vary, however, depending upon the 
concentration of the PTH-derivitives recovered from the 
sequencing runs.
A Identification of PTH-amino acids by one-dimensional TLC
TLC was carried out on silica gel plates containing PBD 1, 3, 
4 - oxidiazole, a fluorescent indicator. Chromatography 
was performed by the ascending technique in glass tanks lined 
with 3MM Whatman chromatography paper. To enhance the 
separation of PTH-amino acids, particularly at the lower end 
of the plate, two solvent systems were utilised. The 
principle solvent was trichloromethane containing 3% ethanol. 
The PTH-amino acids from the sequencing run and a set of 
PTH-amino acid standards were applied at 1cm intervals along 
the bottom edge of the chromatography plate. The 
chromatogram was developed in the first solvent system until 
the solvent front had reached within 2.5cm of the top edge
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of the plate. The plate was then dried in a fume cupboard 
for 1 hour before running the chromatogram in the second 
solvent system of trichloromethane : methanol at a 9:1 ratio.
The chromatogram was redried and observed via longwave uv 
illumination. The unknown PTH-amino acids were identified 
according to their positions on the chromatograms relative 
to those of the PTH-amino acid standards. Figure 26 illustrates 
the relative positions of the PTH-amino acids following 
chromatography in the two solvent systems utilised in this 
study.
Figure 26 : The separation of PTH-amino acids by one-dimensional
TLG
•  pro
Resin------ - •
A rte fact •  lys•  ala
•  trp
• g l y
•  tyr
•  pro
•  the
•  leu •  ser
•  ileu
•  val
•  phe
•  met
•  gin
•  ala •  asn
•  trp •
• g l y •  glu
•  lys
•  tyr •  asp
Solvent I Solvent 2
CHCI3+  3 %  ETOH CHCIg. MEOH
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Identification of PTH-amino acids by HPLC
The Du pont model 830 liquid chromatograph was used for
HPLC analysis. A 20 m 1 aliquot of each PTH-amino acid
sample from the sequencing runs was injected into a
2
stainless steel^column of dimensions 30 cm x 2 cm packed 
with Partisil 5. Injection was automatic via a Wisp 7108 
(Waters Associates). The column was linked to an 850 Du pont 
uv monitor and 870 model pump. The column was purged with 
50% methanol prior to chromatography. The eluting solvent 
was acetonitrile-sodium acetate pH 4.0. The PTH-amino acids 
were detected via uv absorption and identified according to 
their retention times relative to a set of PTH-amino acid 
standards.
The N-terminal sequence of the OXA-2 beta-lactamase
The following N-terminal sequence was derived from the 
results of the PTH-amino acid HPLC and TLC analyses listed 
in table 25.
Figure 27 : N-terminal sequence of the OXA-2 beta-lactamase
1 2 "  3 4 5 6  7 8 9  10 11 12
Gln-Glu-Gly-Thr-Leu-Glu-Arg-Ser-Asp-(Trp)- (Arg)- (Arg)
The abbreviations are those recommended by the IUPAG- 
IUB Commission on Biochemical Nomenclature. The residues in 
parethenses are only tentative assignments due to the 
ambiguity of the sequencing data. In addition there was 
also some ambiguity concerning the amino acid residue at 
position 9 in the sequence. In the first sequencing run, an 
alanine residue was identified by TLC at this position. In 
the second sequencing run, however, both TLC and two HPLC 
analyses recorded an asparagine residue at this position.
On consideration of the data, it was decided that the asparagine 
residue was the correct designation at this position in the
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sequence and that the alanine recorded at position 9 in the 
first sequencing run was a misidentification of asparagine 
as alanine.
Unfortunately, only a short N-terminal sequence was 
determined. Analysis of the sequencing data indicated that 
the repetitive yield of the sequence at residues 8-^ 9 had 
dropped drastically. The repetitive yield of a sequence is 
the yield of the PTH-derivitives which are consecutively 
cleaved off from the N-terminal region. When the yield falls 
below 30% the sequence cannot be reliably identified.
Certain amino acids or particular amino acid sequences are 
difficult to analyse and are characterised by a sharp drop in 
the repetitive yield at their position in the sequence. 
Presumably, the sequence around residues 8 and 9 represents 
such a 'difficult' sequence. The N-terminal sequence of the 
OXA-2 enzyme could possibly be extended if a higher repetitive 
yield could be maintained. Solid-phase sequencing permits 
higher repetitive yields than the spinning cup method.
It was therefore decided to analyse the OXA-2 enzyme via 
solid-phase sequencing. The general principle of solid-phase 
sequencing is to attach covalently the protein in question 
to an insoluable matrix. The reagents for Edman degradation 
are then pumped over the immobilized protein and the 
appropriate fractions containing the thiazolinone derivitives 
are collected. The gradual leeching of the protein by the 
sequencing reagents, which occurs during the spinning cup 
technique, is avoided during solid phase analysis resulting 
in the maintenance of higher repetitive yields.
Solid-Phase Sequencing
Solid-phase sequencing was carried out using a Rank 
Hilger APS 240 sequencer. The solid-phase matrix chosen 
for the anlaysis was PITC activated glass beads of 70 2 
pore size. PITC (p-phenylene di-isothiocyanate) is a
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bifunctional reagent which is used to bind proteins or 
peptides to animated supports for solid-phase sequencing.
The coupling procedure is illustrated in figure 28.
Figure 28 : Coupling of peptides to porous glass beads which 
have been activated with PITC
0 - —  Si.(C H2) 3 NH2 
0
3-a m in o  propyl glass beads
+  s =  C =  N N = C = S
p-phenylene d iisoth iocyanate
C X ° ;Si. (CH2 ) 3 NH CS • N H N = C = S
+  Protein (NH2)n
° \
0  — Si. (CH2)3 NH • CS • N H
0 ^
NHC Protein
H—>
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Procedure'
5 mg of freeze-dried salt-free OXA-2 enzyme of specific 
activity 230 Units/mg protein was dissolved in 500 ;ul of 
sodium bicarbonate containing 10% proponal and 1% sodium 
dodecyl sulphate. The dissolved enzyme was mixed with 500mg 
of PITC activated 3-amino propyl glass beads and incubated 
at 57°C for 6 hours. Following incubation, the beads were 
packed into the microbore column of the solid-phase sequencer 
and the sequencing reaction was started. The thiazolinone 
derivitives were collected and converted manually to PTH- 
amino acids which were identified by HPLC and TLC analysis.
The solid-phase sequencing run failed since no PTH- 
derivitives were identified. The reasons for this failure 
were not rigourously pursued but probably stem from a 
failure to couple the enzyme to the support matrix.
The OXA-2 N-terminal amino acid residue
Further analysis of the data from the spinning cup 
sequencing runs indicated that the recovery of the N-terminal 
gin residue from the sequence was approximately one third 
of the expected value (calculated on the basis of the 
concentration of pure enzyme applied to the automatic 
sequencer). This implies that the OXA-2 enzyme contains a 
partially blocked N-terminal residue. In view of the assignment 
of a glutamine (gin)residue at this position in the sequence, 
the blockage probably stems from the partial replacement 
of the gin residue with pyroglutamic acid or glp. Gin is 
converted to glp in acidic conditions due to the cyclization 
of the precursor glutaminyl residue. This reaction is 
illustrated in figure 29.
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Figure 29,: Conversion of glutamine to pyroglutamic acid 
via cyclization of the glutaminyl precursor
GLUTAMINYL PRECURSOR PYROGLUTAMIC AC ID
P = PEPTIDE
The cyclic nature of the glp residue blocks the sequencing 
reaction of Edman degradation due to the unavailability of 
a free cx-amino group to react with phenylisothiocyanate.
The short N-terminal sequence of the OXA-2 beta-lactamase 
identified by sequence analysis reflects the poor initial 
yield of the PTH-derivitives due to the blocked N-terminal 
residue and the sudden drop in the repetitive yield of the 
sequence at positions Q-?9. Attempts were made to extend the 
sequence by removing the putative glp residue from the N- 
terminal of the enzyme using pyroglutamate aminopeptidase 
isolated from calf liver (Podell and Abraham,19 78).
Figure 30: Cleavage of pyroglutamic acid from a peptide chain 
using pyroglutamate aminopeptidase
pyroglutamate
aminopeptidase
:ONHAA/P COOH
H
+  h n a A /p
H
PEPTIDE WITH N-TERMINAL  
PYROGLUTAMIC ACID
P = PEPTIDE
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Procedure for removal of the pyroglutamic acid N-terminal
residue from the OXA-2 enzyme
10 mg of purified salt-free freeze-dried OXA-2 beta- 
lactamase was dissolved in sodium phosphate buffer containing 
pyroglutamate aminopeptidase and 10% glycerol and incubated 
overnight at 4°C. The enzyme, however, was not completely 
soluble in this buffer. The enzyme was then applied to the 
spinning cup of the Beckman 890C automatic sequencer for 
sequence analysis. During the sequencing reaction the enzyme 
retained some of the quadrol sequencing buffer. Successful 
sequence analysis of a protein is dependent on insoluability 
of the protein in question in the quadrol sequencing buffer, 
otherwise the protein is leeched away during the sequencing 
reaction and the repetitive yield drops drastically. The 
insolubility of the OXA-2 enzyme in the cleavage buffer combined 
with its solubility in quadrol buffer resulted in the failure 
of the sequencing run. Consequently, an extension of the 
OXA-2 N-terminal sequence was not achieved.
Several other methods are available for unblocking an 
N-terminal pyroglutamic acid residue. Methanolysis provides 
a method for opening the pyrolidine ring of pyroglutamic 
acid to produce a oC -methylglutaminyl ester which is susceptible 
to Edman degradation (Van Beynum et al. ,1977). Williams and 
his coworkers have reported the occurrence of peptides which 
are difficult to sequence (Williams et al.,1981). Included 
in this group of 'difficult' peptides are those which 
contain N-terminal pyroglutamic acid. The authors suggest 
that such sequences are more easily identified by mass 
spectrophotometry (Morris et al.. ,1974 : Auffret et al. , 1978) . 
There are therefore several options available which may 
extend the N-terminal sequence of the OXA-2 enzyme. Further 
data, however, will probably be more forthcoming by cleavage 
of the OXA-2 protein and subsequent sequencing of the 
individual peptide fragments. DNA sequencing, of the OXA-2 bla 
gene is currently in progress. The amino acid sequencing 
data from the OXA-2 enzyme was originally intended to provide
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a basis for the more detailed DNA sequencing studies to aid 
the recognition of the primary transcription/translation 
products of the OXA-2 bla gene and to help to identify a 
possible single region in conjunction with the DNA sequencing 
data. Sufficient amino acid sequence is available for 
these purposes.'"' Further amino acid sequencing of the OXA-2 
beta-lactamase will therefore probably be unnecessary except 
in the case of the active site region of the enzyme.
The identification of a unique N-terminal region for the 
OXA-2 enzyme indicates that, if the enzyme is dimeric, then 
the two subunits are identical. In addition, the sequencing 
data indicated the homogeneity of the enzyme preparations 
due to the lack of contaminants visible on the HPLC scan 
following analysis of the PTH-amino acid derivitives. The 
OXA-2 N-terminal residue was misidentified as histidine 
using the dansyl chloride method of analysis. This 
misidentification is puzzling since histidine was definitely 
identified on the thin layer chromatograms following 
dansylation of the OXA-2 enzyme. Presumably, this error 
was partially due to the blockage at the N-terminal of the 
enzyme. In addition, the basic nature of the enzyme itself 
may be partially responsible. Histidine is a weakly 
basic amino acid. At pH7, less than 10% of histidine 
molecules possess a protonated positively charged R group. 
Above pH7, the amino acid becomes negatively charged.
The majority of the steps in the OXA-2 enzyme purification 
protocol were performed at pH7.4 or above. At this pH 
the OXA-2 enzyme is positively charged due to its high 
isoelectric point at pH8.65. Histidine may therefore have 
formed a non-covalent association with the OXA-2 enzyme 
during its purification. The dansylation procedure would 
have released the bound histidine resulting in the 
misidentification of the N-terminal amino acid.residue. 
Analysis of the amino acid composition of the OXA-2 enzyme 
indicated that the enzyme contains three histidine residues.
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Although the side chain DNS-histidine derivitive will be 
formed during dansylation if histidine is present in the 
sequence, this derivitive is unstable to acid and is 
not usually seen during N-terminal analysis. The 
identification of N-terminal histidine for the OXA-2 enzyme 
may, however, have been due to the production of side chain 
histidine derivitives which were not destroyed during acid 
hydrolysis.
Using the N-terminal sequence of the OXA-2 enzyme 
obtained in this study Dale and Saunders (unpublished data) 
have been able to identify the corresponding region of the 
OXA-2 bla gene. The transposed amino acid sequence from 
this region is virtually identical to the N-terminal amino 
acid sequencing data, except for the designation of an . 
asparagine residue at position 6 and an alanine residue 
at position 9 (figure 31). The DNA sequencing data is, 
however, only a preliminary assignment at this point based 
on a single sequence read from one individual experiment. 
Some ambiguity in the DNA sequencing data has been 
introduced due to the presence of a restriction endonuclease 
recognition site which should not be present in that region 
of the DNA sequence. The discrepancies between the DNA 
and amino acid sequencing data may therefore be due to the 
preliminary nature of the DNA sequencing data.
Figure 31 : A comparison between the N-terminal amino acid
sequence of the OXA-2 beta-lactamase obtained by A) amino 
acid sequencing studies and B) DNA sequencing studies
*CAG1 GAA2 GGT3 ACC4 TTG5 GAC6 CGA7 AGC8 GCT9 GAT10 
B; Gln-Glu-Gly-Thr-Leu-Asp-Arg-Ser-Ala-Asp10
*DNA sequence of bases from which the amino acid sequence 
B was derived.
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A; Gln-Glu-Gly-Thr-Leu-Asn-Arg-Ser-Asp^Trp] - (At'Cj]
Two individual amino acid sequencing runs were performed 
in order to identify the N-terminal sequence of the OXA-2 
enzyme. The sequencing data indicated some ambiguity 
concerning the designation at position 9 in the sequence.
An alanine residue at this position was identified but 
was later confirmed to be a misidentification of alanine as 
asparagine. It may be the case that the amino acid sequencing 
data is incorrect and the correct designation at position 
9 in the sequence is alanine as indicated in the DNA 
sequence. Further DNA sequencing data are awaited to 
confirm the designation of position 9 in the sequence.
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Section 13 : Inhibition of the OXA-2 beta-lactamase
The principle of combining a beta-lactamase inhibitor 
with a labile beta-lactam antibiotic to protect the 
antibiotic from inactivation has re-emerged as a viable 
concept due to the discovery of a group of effective and 
specific beta-lactamase inhibitors. This group of compounds, 
which includes clavulanic acid, the olivanic acids and 
penicillanic acid sulphone, all possess a novel beta-lactam 
structure. The beta-lactamase inhibitors constitute a 
group of extremely potent antimicrobial agents in that they 
provide high levels of protection for a variety of conventional 
beta-lactam antibiotics against a broad range of beta- 
lactamases. The level of inhibition produced by each 
compound is variable and is obviously dependent on the 
inhibitor and beta-lactamase in question. Detailed studies 
into the extent of the inhibitory activity of each inhibitor 
against individual beta-lactamases are therefore necessary in 
order to establish the effective range of each compound.
An inhibition profile of the OXA-2 beta-lactamase using a 
variety of potential inhibitors was determined with particular 
emphasis on the mechanism of clavulanate - mediated inhibition. 
An understanding of mechanisms of inhibition are a necessary 
prerequisite, not only to provide a rational basis for the 
development of more effective enzyme inactivators, but also 
to examine the potential of certain inhibitors for labelling 
beta-lactamase active site regions. Studies based on the 
interaction of the TEM-2 and St.aureus beta-lactamases 
with clavulanic acid have indicated that inhibition may 
proceed via an acyl-enzyme mechanism analagous to the 
beta-lactamase - mediated hydrolytic pathway. Clavulanate - 
mediated inhibition of the OXA-2 enzyme was therefore 
examined in order to determine whether or not it follows 
a similar reaction mechanism.
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13.1 Determination of inhibition profiles of the OXA-2 and
TEM-2 beta-lactamase
Inhibition profiles of the OXA-2 and TEM-2 beta-lactamases 
were determined for a range of potential beta-lactamase 
inhibitors listed in table 26. The relevant structure of 
each of these compounds is illustrated in figure 32. The 
profile of the TEM-2 enzyme was included as a comparison. 
Clavulanic acid is a naturally occuring beta-lactamase 
inhibitor which has little intrinsic antibiotic activity but 
acts synergistically with a variety of conventional 
antibiotics against a broad range of organisms including 
certain anaerobes (Hunter £t al.,1980) Streptomyces olivaceus 
produces a range of compounds known as the olivanic acids 
which share a common structure based on the carbapenem ring 
(Basker et al..,1980). Both MM4550 and MM13902 have a broad 
spectrum of antibacterial activity in addition to their 
inherent inhibitory activity. Penicillanic acid sulphone 
is a novel semi-synthetic beta-lactam which is reported to 
have a lower inhibitory activity than clavulanic acid but 
greater beta-lactamase stability (English et al., 1978).
BRL14 37 or 2 isopropoxyl. - 1 - naphthyl - penicillin was 
shown to be the most active inhibitor of the E. coli B11 
beta-lactamase, from a range of over a 1000 semi-synthetic 
beta-lactams (Cole et slL.,1972). The stability of a compound 
to beta-lactamase - mediated hydrolysis is often an 
indication of its potential inhibitory activity. Compounds 
which exhibit a high level of stability towards a particular 
beta-lactamase may often act as effective inhibitors of the 
enzyme in question. It must be remembered, however, that 
this generalisation does not always apply. Carbenicillin 
and cephaloridine as poor substrates of the OXA-2 enzyme, 
were therefore included in this study. The OXA-2 and TEM-2 
profiles were based on I^q values, where I^q represents the 
concentration of the inhibitor which produces a 50% inhibition 
of the enzyme concerned.
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Procedure'
The effect of inhibitor concentration on the level of 
enzyme inhibition with and without a 5 minute preincubation 
period of inhibitor and enzyme, was determined using the 
spectrophotometric assay at 30°C. The level of inhibition 
was determined relative to a control reaction in which there 
was no inhibitor present. The TEM-2 and OXA-2 enzymesused 
for this study were purified preparations, the specific 
activity of the OXA-2 enzyme being approximately 200 Units/mg 
of protein and the specific activity of the TEM-2 beta- 
lactamase (commercial preparation) being approximately 3000 
Units/mg. Amoxicillin at 500 Aig/ml concentration was used 
as the substrate to assay the activity of each enzyme.
Both beta-lactamase samples were diluted in 25mM sodium 
phosphate buffer at pH7.4 to a concentration at which they 
completely hydrolysed the substrate within 20 minutes of the 
start of the reaction. In the preincubation situation 100 A i l  
of each enzyme preparation was mixed with 100 A i l  of different 
inhibitor concentrations and incubated at 30°C for 5 minutes. 
Following preincubation, the enzyme/inhibitor mixture was 
diluted into phosphate buffer and assayed for residual enzyme 
activity against amoxycillin at 500 jug/ml concentration 
using the spectrophotometric assay at 30°C. In the non­
preincubation situation, 100 jul of each enzyme sample was 
added directly to premixed inhibitor and substrate and 
assayed for residual enzyme activity. An appropriate range 
of concentrations of each inhibitor was chosen in order to 
provide different levels of enzyme inhibition. The 
concentration of each inhibitor giving a 50% inhibition of 
the enzyme in question (I^q value) was calculated from a 
plot of percentage inhibition against inhibitor concentration. 
The inhibitor concentrations used for the 1,-^  determinationsD U
were taken as that present with the* enzyme before dilution 
into the substrate.
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The inhibition profiles of the OXA-2 and TEM-2 beta- 
lactamases are listed in Table 25 on the basis of I^q values.
The results of this study indicate that the four novel 
beta-lactam compounds, namely, clavulanic acid, the two 
olivanic acids and penicillanic acid sulphone are better 
inhibitors of both the OXA-2 and TEM-2 beta-lactamases than 
the three conventional beta-lactam antibiotics carbenicillin, 
cephaloridine and BRL-1437. In certain cases the preincubation 
1^^ values differ considerably to those in the non-preincubation 
situation. The higher values needed in the absence of
preincubation indicate the protective effect of the substrate 
amoxycillin and suggest that inhibition in these cases is 
active-site directed. BRL-1437 is an effective inhibitor 
of the TEM-2 beta-lactamase but not of the OXA-2 enzyme.
... Of the group of compounds tested, 
the two olivanic acids MM4550 and MM13902 exhibited the 
highest level of inhibitory activity towards both the OXA-2 
and TEM-2 enzymes. Synergy experiments conducted by Basker 
and his coworkers have, however, indicated that the olivanic 
acids are not as effective towards gram-negative beta- 
lactamase producers as would be expected from inhibitory 
activities of these compounds when tested against cell-free 
enzyme preparations (Basker et al..,1980). Presumably, this 
discrepancy may be partially accounted for by a poor level 
of penetration of the olivanic acids through the cell wall 
of gram-negative bacteria.
The inherent inhibitory activity of a compound is obviously
14related to its chemical structure. Experiments with C- 
labelled clavulanic acid have indicated that the most 
important inhibitory region of the molecule is the left hand 
portion incorporating the C5, C6 and Cl carbon atoms in the 
beta-lactam ring (Charnas et al.,1978b). The results of this 
study indicate that the two olivanic acids are more effective
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inhibitors of cell-free preparations of the TEM-2 and OXA-2 
beta-lactamases than clavulanic acid and penicillanic acid 
sulphone. On examination of the relevant structures of 
these compounds listed in figure 32, it may be the case that 
the substitution^ at C6 in the beta-lactam ring may be 
responsible for the greater inhibitory activity of the olivanic 
acids. Rando (1975 a and b) has postulated that substitutions 
at C6 in the beta-lactam ring increase the inhibitory activity 
of certain beta-lactams against cell wall transpeptidases.
The substitutions are thought to react with binding sites 
within the transpeptidase molecule and in this way they 
function as handles through which the enzyme can apply extra 
strain into the beta-lactam structure to induce a conformation 
which is more prone to interaction with and subsequent 
inhibtion of the enzyme molecule. By applying a similar 
theory to the olivanic acids, the substitution at C6 in the 
beta-lactam ring may provide handles by which the beta-lactamase 
distorts the shape of the compound to a conformation that has 
a greater potential for interaction with and subsequent 
inhibition of the beta-lactamase concerned.
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13.2 The inhibition of the OXA-2 beta-lactamase by Clavulanic acid
The following series of experiments were conducted in order 
to investigate the mechanism of inhibition of the OXA-2 beta- 
lactamase by clavulanic acid.
VI
13.2.1 The time course of inhibition 
Procedure
Enzyme (80juM in 25mM sodium phosphate buffer pH 7.4) was 
mixed with various concentrations of clavulanic acid and 
incubated at 30°C. At regular time intervals 10Ojul aliquots 
were removed and added to test and reference spectrophotometric 
cells containing 2.4 ml of prewarmed phosphate buffer. In 
addition, the test cell contained 500 >ug/ml of benzylpenicillin. 
The residual enzyme activity of the inhibited enzyme was 
measured via the spectrophotometric assay at 30°C relative 
to a control reaction containing no inhibitor. The 
percentage inhibition at each inhibitor concentration was 
plotted as a function of time of preincubation and is 
illustrated in figure 33. The inhibitor concentrations were 
converted to molar ratios of inhibitor to enzyme concentration 
using a molecular weight of 32,000 for the OXA-2 enzyme and 
237 for the sodium salt of clavulanic acid.
Figure 33 indicates that the pattern of inhibition is 
similar at each inhibitor concentration. Inhibition is a rapid 
process with the maximum level of inhibition attained within 
the first few minutes of the reaction. No inhibition occured 
at zero time when the enzyme was added directly to premixed 
inhibitor and substrate. The inhibitor concentration was 
varied from a 0 -> 40 - fold molar excess of inhibitor : enzyme. 
The percentage inhibition was calculated for each molar ratio 
of inhibitor : enzyme and is illustrated in figure 34.
By extrapolation, approximately 30 moles of the inhibitor 
are required to inhibit 1 mole of the enzyme. No return in 
the catalytic activity of the enzyme was observed at limiting
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Figure 33: Time course of inhibition of the OXA-2 beta-
lactamase at different concentrations of clavulanic acid
100
UJ
?  75 
N 
Z 
Hi
<
ZD
a
co
UJ
cc
UJ
O
<
f—z
UJ 25 
O
0c
UJ
a.
(26 :Q
10
PREINCUBATION T IM E  fminutesJ
20O 3 0
The values In parentheses are molar ratios of inhibitor to enzyme
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inhibitor concentration (i.e. concentrations not sufficient 
to cause 100% inhibition) even after a 2 hour incubation 
period. The stability of the inhibited enzyme suggest that 
the enzyme may have been irreversibly inactivated. The fact 
that a molar excess of inhibitor is required to inactivate 
the enzyme suggests that enzyme-catalysed hydrolysis of the 
inhibitor is taking place. This was confirmed by infrared 
spectroscopy.
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13.2.2 Verification of enzyme-catalysed hydrolysis of 
clavulanic acid by infrared spectroscopy
The infrared spectrum of clavulanic acid was examined 
before and after its interaction with the OXA-2 beta- 
lactamase. The "infrared spectrum of the enzyme itself was 
also recorded to act as a control.
Procedure
Freeze-dried OXA-2 enzyme (specific activity 230 Units/mg 
of protein), and clavulanic acid (sodium salt) were each 
dissolved in 25mM sodium phosphate buffer pH 7.4 at a 
concentration of 2mg/ml. 1 ml aliquots of each sample were 
mixed together and incubated at 30°C for 30 minutes. The 
molar ratio of inhibitor to enzyme at these concentrations 
was approximately 135:1. Following incubation, the enzyme/ 
clavulanate mixture was freeze-dried. Three samples 
designated E + C (Enzyme/clavulanate reaction), E (enzyme alone) 
and C (clavulanic acid alone) were prepared for infrared 
analysis. 1 mg of samples E and C and 2mg of sample E + C 
were each mixed with 100mg of dry potassium bromide powder 
using a pestle and mortar. Each mixture was then pressed in 
a die at 15,000 pounds per square inch to produce 
transparent discs. The discs were formed in a vacuum to 
eliminate occluded air. Each disc was then placed in the 
sample compartment of a Perkin Elmer PE557 infrared 
spectrophotometer and the corresponding spectra were recorded. 
The three spectra from each sample are illustrated in figure 
35.
The interpretation of the infrared spectrum of clavulanic 
acid following its interaction with the OXA-2 enzyme is 
difficult in that the spectrum represents a complex mixture 
of reaction intermediates. The interaction of clavulanic 
acid with the TEM-2 beta-lactamase is thought to proceed via
185
FI
G
U
R
E 
35
: 
TH
E 
IN
FR
A
R
ED
 
S
P
E
C
TR
U
M
 
OF
 
C
L
A
V
U
LA
N
IC
 
AC
ID
 
FO
LL
O
W
IN
G
 
ITS
 
IN
T
E
R
A
C
T
IO
N
 
W
IT
H
5
x
DC
<
C L
I—O
LU
Q.
if)
O
CL
I-
2
o
o
DC
o
CQ
X
2
Q
2
<
LU
>
N
2
LU
X
H
O
LU
CL
<
CL
o
o
LU
(A)
<
0 
<  
_J
1
<I-
LU
CO
CM
I
<
X
o
LU
X
h-
\—
(J
LU
0.
if)
LU
5
>
N
2
LU
+
Q
O
<
o
2
<
_l
<
-J
o
I
2
X
C L
I—o
LU
0.
if)
Q
O
<
<J
2
<
_l
ID
>
<
(J
I
D
DC
I—O
LU
Q.
if)
LU
2
>
N
2
CMCD
( % )  3 0 N V ± 1 I  I/MSN V d l
186
18
00
 
16
00
 
14
00
 
12
00
 
10
00
 
80
0
W
A
V
E
N
U
M
B
E
R
 
(c
m
"1 
)
an acyl-enzyme intermediate which can undergo a different 
fate depending on how the reaction proceeds (Charnas et al., 
19 78 a). Figure 36 represents a possible scheme for the 
interaction of the TEM-2 enzyme with the inhibitor. The 
acyl-enzyme complex may undergo hydrolysis releasing free 
enzyme and a clavulanic hydrolytic derivitive analagous to 
the normal enzyme : substrate interaction, or it may become 
part of a conjugated acyl/enzyme system which serves to 
inhibit the enzyme.
Figure 36 : Possible scheme for the interaction of clavulanic
acid with the TEM-2 beta-lactamase
T E M -2  +
£
H
( A
OH
C lavu lan ic  acid
COOH COOH X  
A cy l-E n zy m e  Complex
co
4->(0c
1
UJI
CO
n
P ro d u ct of c lavulanate  
hydrolysis
COOH
nr
S ta b le  rearranged Acyl-Enzyme
Complex
187
The <infrared spectrum of the clavulanate/OXA-2 sample
probably represents a complex mixture of reaction
intermediates similar to structures I, II and III illustrated
in figure 36. An unfused 4-membered beta-lactam carbonyl
exhibits a characteristic absorbance within the range 
-1
1 760 1 730 cm " . When the beta-lactam ring is fused to a
thiazolidine ring as is the case with clavulanic acid
-i
the frequency of this absorbance is shifted to 1790 1780 cm
The absorbance characteristic of the clavulanate beta-lactam
-i
carbonyl can therefore be identified at 1785 cm . On 
examination of the infrared spectra illustrated in figure 
34 it can be seen that the beta-lactam carbonyl peak in the 
clavulanate/enzyme spectrum is significantly smaller when 
compared with the carbonyl peak in the control clavulanate 
spectrum. The extent of the loss of the beta-lactam 
carbonyl in the clavulanate/enzyme spectrum was calculated 
at approximately 59% according to the method described in 
figure 37. This disappearance in the beta-lactam carbonyl 
provides strong evidence that enzyme-catalyzed hydrolysis 
of the inhibitor molecule accompanies the inhibition of the 
OXA-2 enzyme by clavulanic acid. Recent evidence indicates 
that 6 beta-bromopenicillanic acid, a powerful inhibitor of 
the beta-lactamase I from B.cereus, reacts with a serine 
active site residue in the enzyme and is bound via an 
ester linkage as a dihydrothiazine moiety (Orlek et al.,1980). 
The infrared spectrum of the clavulanate/enzyme sample exhibits 
a strong peak at 1260 cm which is characteristic of an 
ester C-O-R stretching peak. This peak which is not present 
in either of the enzyme or clavulanate control spectra, may 
represent an ester linkage between the enzyme/inhibitor complex.
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Figure 31' : Calculation of the loss of the beta-lactam
carbonyl from clavulanic acid following enzyme/
catalysed hydrolysis
c 5CL
Wavelength
If A equals the size of the clavulanate carbonyl peak. 
Then A = log^Q
P
Let Ax = height of the beta-lactam carbonyl prior to hydrolysis 
Let Ay = height of the beta-lactam carbonyl after hydrolysis
Then Ax = log1Q Po(x) = 0 .705
P(x)
Then Ay = log10 Po(y) = 0>292
P ( y )
The values for Po(x) and P(x) were read from the clavunate 
control infrared spectrum. Similarly, the values for Po(y) 
and P(y) were read from the enzyme/clavulanate spectrum.
The disappearance of the clavulanate beta-lactam carbonyl 
following enzyme-catalysed hydrolysis was given by the 
expression:-
100- A^ x 100 = 100 - 41.4 = 58.6
Ax
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13.2.3 The Ultraviolet spectrum of the clavulanate-inhibited
OXA-2 beta-lactamase
The development of a new component in the uv spectrum 
of an inhibited enzyme argues strongly for the covalent 
modification of that enzyme (Loosemore et al.,1980). The 
inhibition of the TEM-2 beta-lactamase by clavulanic acid 
produces two inhibited enzyme species; a transiently inhibited 
complex and an irreversibly inactivated form (Charnas et al., 
1978a). Both inhibited complexes develop a new component 
in their uv spectra in that they both exhibit an increased 
absorbance at approximately 280 nm. The transient complex 
exhibits an increase in absorbance of about 0.067 absorbance 
units, whereas its irreversibly inactivated counterpart 
exhibits an increase of about 0.04 absorbance units.
Similarly, Kelly et al., (1981) have shown that the 
Actionomadura R39 beta-lactamase inhibited by clavulanic acid 
exhibits a characteristic absorbance peak at 280nm of 
approximately 0.05 absorbance units. The development of 
the new components in the uv spectra of these inhibited 
enzymes is attributed to the covalent modification of the 
enzymes via formation of an acyl-enzyme complex. The uv 
spectrum of clavulanate-inhibited OXA-2 enzyme was therefore 
examined for evidence of a similar modification.
Procedure
Enzyme at a 75juM concentration in 25mM sodium phosphate 
buffer pH 7.4 was mixed with an equal volume of 2.8mM 
clavulanic acid also in the same buffer and incubated at 
30°C for 15 minutes. At these concentrations the molar ratio 
of inhibitor:enzyme was approximately 35:1. Following 
incubation, 100ul was added to 2*4ral of 25mM sodium phosphate 
buffer and the uv spectrum of the inhibited enzyme was 
recorded. The final concentration of the inhibited enzyme 
was approximately 1.5juM. The uv spectrum of an uninhibited 
enzyme sample (final concentration 1.5uM) and a clavulanic 
acid sample (2.8mM) were also recorded to act as controls.
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Figure 38 illustrates the uv spectrum of the inhibited 
OXA-2 enzyme in comparison with that of the untreated enzyme 
control. Clavulanic acid at the concentration tested did 
not absorb significantly in the uv region in which the 
enzyme spectra were recorded and consequently the effect of
the inhibitor on the resulting spectra of the inhibited 
enzyme sample was deemed to be negligible. The uv spectrum 
of the inhibited enzyme exhibited an increase in absorbance 
at 280nm of approximately 0.022 absorbance units. This 
increase in absorbance is not as great as that exhibited by 
the clavulanate-inhibited TEM-2 or R39 enzymes. Presumably 
however, the relative uv spectrum of a beta-lactamase and 
the extent of the development of a new component in that 
spectrum following inhibition, is an inherent property of 
the enzyme itself. Consequently, the differences in the 
size of the new uv components displayed by the OXA-2, TEM-2 
and R39 beta-lactamases is probably attributable, at least 
in part, to the different compositions of each enzyme.
The presence of a new component in the uv spectrum.of the 
OXA-2 enzyme following inhibition by clavulanic acid is 
evidence of the covalent modification of the enzyme via 
acyl-enzyme formation.
FIGURE 3 8 :  ULTRAVIOLET SPECTRUM OF C LA V U LA N A TE -IN H IB ITE D  O X A -2  
ENZYME IN COMPARISON WITH THAT OF AN UNINH IB ITED ENZYME CONTROL
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13.2.4 The stability of the inhibited enzyme complex
The results from the time course studies listed in 
section 13 . 2 .1 .indicated that the clavulanate-inhibited 
OXA-2 enzyme complex was very stable since no regeneration 
in the catalytic activity of the enzyme was visible after a 
two hour reaction period. The stability of the inhibited 
enzyme suggested that the enzyme may have been irreversibly 
inactivated. Verification of this was sought. The original 
experiments in this study, which were designed to investigate 
this phenomenon, indicated that the OXA-2 enzyme was 
apparently irreversibly inactivated by clavulanic acid.
These experiments were conducted with low enzyme concentrations 
since at that time the large scale batch fermentation had 
not been carried out and consequently only small amounts 
of purified enzyme were available. The low enxyme 
concentrations tended to result in enzyme instability which 
complicated the interpretation of the data. The experiments 
were repeated, as described below, using higher enzyme 
concentrations. The results of these experiments indicated 
that some regeneration of enzyme activity did take place, 
albeit at a very low rate (i.e. 1.15% per hour).
Procedure
Inhibited OXA-2 enzyme free of excess clavulanic acid 
was prepared. Enzyme at a 75;uM concentration in 25mM 
sodium phosphate buffer pH 7.4, was mixed with 200-fold 
molar excess of clavulanic acid (3.5 mg/ml in the same buffer) 
and incubated at 30°C for 30 minutes. The inactivated 
enzyme was dialysed exhaustively against 25mM sodium 
phosphate buffer pH 7.4 at 4°C, in order to remove the 
excess inhibitor. The inactivated enzyme was then incubated 
at 30°C and, at regular time intervals, 50 Ail samples 
were removed and assayed for enzyme activity by the 
spectrophotometric assay with benzylpenicillin at 500 Aig/ml 
as the substrate. An uninhibited enzyme sample was set up
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in parallel to act as a control. The percentage regeneration 
in enzyme activity of the inhibited enzyme at 30°C was 
calculated relative to the uninhibited control and the 
figures from these calculations are listed in table 27.
Table 2 7 Regeneration of enzyme activity from clavulanate- 
inhibited OXA-2 enzyme at pH7.4 and 30°C
Incubation time 
(minutes)
Inhib enzyme 
Enzyme Activity 
Units
Unlnhib enzyme 
Enzyme Activity 
Units
%age enzyme 
regeneration
30 0.043 14.7 0.29
60 0.213 14.8 1.44
120 0.33 14.7 2.27
180 0.55 14.5 3.78
240 0.719 14.7 4.89
360 1.033 14.7 7.03
420 1.151 14.3 8.05
480 1.127 14.0 8.05
540 1.09 13.7 7.99
Inhib^= Inhibited.
The results listed in table 27 indicate that clavulanic 
acid does not result in the complete irreversible inactivation 
of the OXA-2 enzyme. The inhibited enzyme regenerates 
active enzyme at a rate of approximately 1.15% per hour.
The regeneration reaction was followed for 9 hours and at 
this point regeneration had apparently tailed off to reach 
a maximum value of approximately 8%.
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13.2.5 The regeneration of enzyme activity from clavulanate 
inhibited OXA-2 enzyme by hydroxylamine
Hydroxylamine under certain conditions can attack the 
ester group of acyl-enzyme complexes to regenerate active 
enzyme (Inward and Jencks,1965).  ^ The regeneration of activity 
from clavulanate-inhibited beta-lactamase complexes following 
hydroxylamine treatment is evidence of the acyl-enzyme 
nature of the inhibited enzyme. Inhibited complexes which 
require chemical treatment, such as hydroxylaminolysis in 
order to restore catalytic activity, are usually described 
as being irreversibly inactivated.
Procedure
Inhibited OXA-2 enzyme free of excess clavulanic acid 
was prepared as described in section 13.2.4. Equal volumes of 
neutral aqueous hydroxylamine at pH. 7, (20mM in 25mM sodium 
phosphate buffer pH7.0) and inhibited enzyme (75 aiM in 25mM 
sodium phosphate buffer pH7.4) were mixed and incubated at 
30°C. 50 jal aliquots were removed at various intervals and
assayed for enzyme activity. An uninhibited enzyme sample 
was treated identically to act as a control. Enzyme activity 
was assayed against benzylpenicillin at 500 >ug/ml using the 
spectrophotometric method.
The enzyme activities of the inhibited enzyme samples 
following hydroxylamine treatment are listed in table 2 8 
in comparison with those from the hydroxylamine - treated 
uninhibited control. The percentage regeneration of enzyme 
activity following hydroxylamine treatment was calculated 
relative to the control and is plotted as a function of time 
of incubation in figure 3 9. Approximately 50% of the activity 
of the OXA-2 enzyme was regenerated by the hydroxylamine 
treatment. Concurrently, at least 50% of the enzyme was 
irreversibly inactivated by clavulanic acid. The failure of
194
hydroxylamine to restore the catalytic activity completely 
may indicate that multiple forms of the irreversibly inactivated 
enzyme exists and only one of these forms comprising 
approximately 50% of the total enzyme is susceptible to 
hydroxylamine.
Table 28 The regeneration of active enzyme from clavulanate- 
inhibited OXA-2 enzyme following hydroxylamine
treatment
Time of 
incubation 
(minutes)
Nf^OH treated 
inhibited enzyme 
Enzyme Activity (tl)
NH2OH treated 
control 
Enzyme Activity(U)
% regeneration 
of enzyme 
activity
15 1.09 7.05 15.5
30 1.33 6.74 19.75
60 1.73 6.74 25.6
90 2.15 7.05 30.5
120 2.51 6.89 36.4
180 2.66 6.6 8 39.8
240 2.97 6.25 47.5
300 3.60 6.74 53.4
360 3.44 6.57 52.4
390 3.31 6.46 51.2
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Figure 39: The percentage regeneration of active enzyme from 
clavulanate-inhibited OXA-2 beta-lactamase following 
hydroxylamine treatment plotted as a function of time
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13.3 The * interaction of the OXA-2 beta-lactamase with
clavulanic acid
Experiments designed to study the interaction of the 
OXA-2 beta-lactamase with clavulanic acid were described 
in sections 13.2.1 - 13.2.5. The results of these 
investigations are summarised below.
1. The inhibited OXA-2 enzyme exhibits an increase in 
absorbance at 280nm which is consistent with the covalent 
modification of the enzyme via formation of an acyl-enzyme 
complex.
2. Infrared spectroscopic data indicates that inhibition
is accompanied by enzyme-catalysed depletion of clavulanic
acid via hydrolysis of the beta-lactam ring. Furthermore,
the infrared spectrum of clavulanic acid following its
interaction with the OXA-2 beta-lactamase exhibited a strong 
- 1
peak at 1260 cm which may represent an ester linkage 
between the acyl-enzyme complex.
3. Approximately 30 molecules of inhibitor are required 
to inactivate 1 molecule of the enzyme, i.e. the 
stoichiometry of the reaction is 30:1.
4. The inhibited enzyme free of excess clavulanic acid 
regenerates active enzyme at 30°C and pH7.4, at a very slow 
rate of approximately 1.15% per hour. The regeneration of 
active enzyme appeared to reach a maximum value after 9 hours 
of approximately 8%.
5. Treatment of the inhibited enzyme with hydroxylamine 
produces approximately a 50% regeneration of enzyme activity 
indicating that at least 50% of the enzyme had been 
irreversibly inactivated.
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The information from points 1-^ 5 can be correlated into 
a minimal scheme for the inhibition of the OXA-2 enzyme by 
clavulanic acid.
Scheme 1 : The interaction of the OXA-2 enzyme with
clavulanic acid
E + P1
E = free enzyme; C = clavulanic acid; E.C = the Michaelis 
complex of E and C; P = the product from hydrolytic turnover 
of clavulanic acid; ET = transiently inhibited complex;
i
P = the clavulanate - derived product from decomposition 
of ET; EX and EY irreversibly inactivated enzyme species.
EC* = Acyl-enzyme intermediate.
The interaction of the OXA-2 beta-lactamase with 
clavulanic acid as shown in scheme 1 is a complex phenomenon. 
It involves i) the formation of the acyl-enzyme intermediate 
EC* via the normal hydrolytic pathway of the enzyme. This 
leads to enzyme-catalysed depletion of the inhibitor and the 
formation of the hydrolytic product P, ii) the rearrangement 
of acyl-enzyme complex EC* to a 'transiently' inhibited 
complex, ET, which regenerates active enzyme very slowly at 
30°C and pH7.4 and produces a hydrolytic product P^ and 
iii) the formation of one or possibly several irreversibly 
inactivated derivities, EX and EY, of which only EX can be 
reactivated with hydroxylamine. In scheme 1 the formation 
of the three inhibited complexes ET, EX and EY are competing 
events for the acyl-enzyme intermediate, EC*. Approximately 
30 molecules of clavulanic acid are required to inhibit 1 
molecule of the OXA-2 beta-lactamase.
E + P
t
E + C  ---* E. C  > EC*  > ET
EX EY
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The designation of ET as a 'transiently' inhibited 
complex is rather inappropriate since the complex is very 
stable and has a regeneration rate of approximately 1.15% 
per hour at 30°C and pH 7.4. By extrapolation the half- 
life of this complex would be about 44 hours. Since, however, 
the regeneration of activity from ET was followed for only 
9 hours when it appeared to have tailed off to reach a 
maximum value of 8%, it is probably invalid to presume further 
regeneration and therefore to assign a half-life to this complex. 
The production of the complex EY, an irreversibly inactivated 
form of the inhibited enzyme not reactivated by hydroxylamine, 
is suggested by the fact that only 50% of the enzyme was 
regenerated by hydroxylamine treatment. Presumably, several 
different types of EY are possible. Charnas et al.,(1978a) 
identified by isoelectric focusing, three irreversibly 
inactivated species which were produced following interaction 
of the TEM-2 beta-lactamase with clavulanic acid, only one 
of which, comprising approximately 33% of the total, was 
reactivated by hydroxylamine. Each inactivated complex had 
a lower pi than the native enzyme. One species was shown 
to revert to the native pi of the enzyme following 
reactivation. Attempts were made to study the inactivated 
OXA-2 enzyme by isoelectric focusing, however, the multiplicity 
of the bands produced by the purified OXA-2 enzyme made 
the identification of inactivated species impracticable.
It is possible that the two inhibted complexes, ET and 
EX, are equivalent. In this case scheme 2 would apply.
EY
t
E + C E . C----- > EG* ---- > ET------ > E + P 1
I
E + P
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In scheme 2 rET represents a complex which regenerated 
enzyme slowly at pH7.4 and 30°C, but at a much faster rate 
following hydroxylamine treatment. Scheme 2 seems unlikely 
considering that reactivation at 30°C pH7.4 apparently 
produced a maximum regeneration of enzyme activity of 8%.
The interaction of the OXA-2 beta-lactamase with 
clavulanic acid was investigated in 1980. Since that time, 
the interaction of clavulanic acid with several other beta- 
lactamases have been studied. The available information 
on these systems has been collated in table 29, which was 
constructed on the premise that the interaction with 
clavulanic acid may provide a useful parameter for the 
classification of beta-lactamases. Only two enzymes to date 
(Ps.aeruginosa and the Amp C beta-lactamase) have been 
assigned to class C group of beta-lactamases. The assignment 
of the E.cloacea and klebsiella enzymes to this group is 
therefore presumptive. The information listed in table 29 
indicates that the features pertaining to the interaction of 
the Staph aureus enzyme, a class A beta-lactamase, are 
analagous to those of the E.cloacea enzyme (class C ) . It 
therefore seems unlikely that the features of the interaction 
of clavulanic acid with beta-lactamases will be a useful 
classification parameter. This does not, however, discredit 
the use of other beta-lactamase inhibitors such as 
6beta-bromopenicillanic acid or penicillanic acid sulphone, 
for classification purposes.
In conclusion, it would appear that in the 'in vitro' 
situation, clavulanic acid acts as an effective inhibitor 
of the OXA-2 beta-lactamase, provided that preincubation of 
the inhibitor and enzyme is allowed. In the absence of 
preincubation, much larger concentrations of inhibitor are 
required for inhibition. The results listed in table 25 
(section 13.1) indicate that approximately 60 times the 
concentration of clavulanic acid is required to inhibit the
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1
OXA-2 enzyme in the absence of preincubation. This situation 
is mimicked by all the other beta-lactamases examined to 
date. From studies based on the interaction of clavulanic 
acid with cell free enzyme extracts, it is difficult to 
judge how effective the compound will be against intact 
OXA-2 beta-lactamase-producing bacterial strains. Recent 
studies, however, conducted by Reading et al.,(1983) and 
Hunter et al.,(1980) have indicated that clavulanic acid 
can penetrate the outer membrane of gram-negative bacteria 
to produce a synergistic effect in combination with a 
variety of conventional beta-lactam antibiotics against 
OXA-2 beta-lactamase producers.
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Section 14: Immunochemical comparison between the OXA-2
beta-lactamase as specified by the chimaeric 
plasmid. pSu3 and obher plasmid-mediated beta-
lactamases
An immunochemical comparison between the OXA-2 enzyme 
and a range of R-factor-mediated beta-lactamases was performed 
in order to investigate the possibility of a phylogentic 
relationship between these groups of enzymes. Antiserum was 
raised against purified OXA-2 enzyme and used to detect 
cross-reactivity with other plasmid-mediated beta-lactamases 
via cross-precipitation, cross-neutralisation and 
radioimmunoassay techniques.
R-factor-mediated beta-lactamases
The following series of plasmid-mediated enzymes were 
tested for cross-reactivity with anti-0XA-2-serum.
Strain number
9 = E.coli J6-2 (pSu3) - OXA-2
16 = IV J5-3 (pR997) - HMS-1
17 = vr E5-2 (pRPL11) - PSE-1
18 = IV E5-2 (pRl 51). - PSE-2
19 = IV E5-2 (pRMS149) - PSE-3
20 = IV E5-2 (pMG19) - PSE-4
21 = IV E5-2 (p4 53) - SHV-1
22 = IV J6-2 (RGN238) - OXA-1
23 = It J6-2 (R57B) - OXA-3
24 = I JT-4 (R+) - TEM-1
25 = It J5-3 (RP1) - TEM-2
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Preparation of beta-lactamase extracts
Crude cell extracts were prepared from each of the 
strains listed above using the method described in section 
9.3 except that 150ml culture volumes in 500ml conical flasks 
were utilised. ^The extracts were precipitated with 
ammonium sulphate at 55% saturation resuspended in 5ml of 
25mM sodium phosphate buffer pH 7.4 and dialysed against 
1 x 2.5 litres of the same buffer at 4°C. The extracts were 
stored at 4°C.
Preparation of anti-OXA-2 serum
The anti-serum against the purified OXA-2 enzyme at a 
specific activity of 230 Units/mg of protein was prepared 
by using a New Zealand white male rabbit according to the 
following immunisation protocol.
Immunisation protocol
1st injection:- A 400;ul aliquot of the OXA-2 enzyme at 
1mg/ml concentration was mixed with an equal volume of 
Freund's adjuvant (Difco). The sample was divided into three 
aliquots, two of which were injected intramuscularly and 
the third subcutaneously.
2nd injection:- This was identical to the 1st injection,
,12 days later.
3rd booster injection;- A 300ai1 aliquot of the OXA-2 enzyme 
(1mg/ml) was mixed with an equal volume of Freund's adjuvant 
and injected as before, 49 days after the start of the 
immunisation protocol.
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4th booster injection:- A 280>ul aliquot of the OXA-2 enzyme 
(1mg/ml) was mixed with an equal volume of Freund's adjuvant 
and injected as before, 60 days after the start of the 
immunisation protocol.
The rabbitlVwas bled 5 times at regular intervals 
throughout the immunisation procedure.
Purification of IgG
The antibody activity detected after an initial 
immunisation, followed by one or more booster injections, 
will be largely associated with the IgG serum fraction 
(Nossal and Ada, 1971). It was therefore decided to purify 
the IgG fraction from the anti-OXA-2-serum.
Procedure
All of the stages in the purification procedure were
performed at 4°C. The serum fraction from each of the 5
bleeds was pooled giving a total volume of 15.5ml and
precipitated with ammonium sulphate at 50% saturation.
The precipitate was collected by centrifugation and
resuspended in 15.5ml of 10mM potassium phosphate buffer
pH7.3 and dialysed against 3 x 2  litres of the same buffer.
The sample was applied to the top of a chromatography
2
column (60 x 1.1 cm ) packed with 250ml wet settled volume 
of DE-52 (i.e. approximately 15ml for each 1 ml of serum 
to be fractionated) equilibrated in 1 OmM potassium phosphate 
buffer pH 7.3. The sample was eluted in the same buffer 
and the elution position of the IgG was detected by 
measuring the E280nm e^uent* fractions
containing the IgG were pooled and precipitated with 
ammonium sulphate at 60% saturation. The precipitate was 
collected by centrifugation resuspended in 5ml of 1OmM 
potassium phosphate buffer pH 7.0 and dialysed against 
2 litres of the same buffer. The total concentration of
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the IgG was calculated by measuring the E280nm of t i^e samP^ -e *
A 1 mg/ml solution of IgG gives 'a characteristic absorbance 
at 280nm of 1.46 at neutral pH. The 6ml of anti-OXA-2- 
IgG at 34mg/ml concentration was stored at -20°C.
.14.1 Detection of cross-reactivity between the OXA-2
beta-lactamase and other R factor-mediated enzymes by
immunoprec ipitation
Immunoprecipitation was detected using the double 
immunodiffusion technique described by Ouchterlony & Nilsson (1978) • 
The diffusion matrix was composed of 1% (w/v) agarose 
dissolved in 25mM sodium phosphate buffer pH 7.4 and poured 
to a constant 5mm thickness in 5cm diameter petri dishes.
Six wells of 5mm diameter were cut from the agarose in a 
circular configuration surrounding a central well. 10Qul of 
each of the antigen preparations to be tested were pipetted 
into individual outer wells and 50jul of purified anti-OXA-2- 
IgG (10 g/ml) into the inner well. The plates were stored 
at 4°C to allow the precipitins to develops
Initial experiments to measure the titre of the IgG 
in the serum fraction from each bleed, indicated a single 
precipitin line produced between the purified OXA-2 enzyme 
and each of the serum samples after an 18 hour reaction 
period. The titre of anti-OXA-2-serum rose 8-fold between 
the 1st and the 5th bleed. When the Ouchterlony plates 
were left at 4°C for 56 hours, a second precipitin line 
developed between the OXA-2 enzyme and the antiserum which 
was distinct from the first (see figure 40). Similarly, 
all the crude beta-lactamase preparations produced a single 
precipitin when tested against the anti-OXA-2-IgG after a 
56 hour reaction period which was identical to the second 
precipitin produced by the purified OXA-2 enzyme. The 
precipitin line produced by the crude beta-lactamase extracts 
and the second precipitin produced by the OXA-2 enzyme made 
a complete fusion in the central area between the wells 
(s6e figure 40). This reaction indicates the presence of
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Figure 40: Double immunodiffusion of plasmid-mediated beta- 
lactamase extracts and a beta-lactamase negative extract tested 
against anti-OXA-2 - IgG
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identical'immunochemical determinants in the compared 
reactants. The anti-0XA-2-IgG therefore apparently contained 
two antibody components. The first component which was 
presumably specific to the OXA-2 enzyme produced the first 
and major precipitin with that enzyme. The second component 
produced the second or minor precipitin with the OXA-2 
enzyme and in addition cross-precipitated with the other 
plasmid-mediated beta-lactamases. To test whether this 
cross-reacting component was specific or non-specific to 
the OXA-2 enzyme and that the cross-precipitation with other 
plasmid-mediated enzymes indicated a true relationship 
between these beta-lactamases and the OXA-2 enzyme, a crude 
cell extract from a beta-lactamase negative strain 
(E.coli E D 8 6 5 4  ) was prepared and tested for
cross-precipitation with the anti-0XA-2-IgG. The beta- 
lactamase negative extract produced a negative nitrocefin test 
The extract produced a single precipitation line after a 
56 hour reaction period identical to that produced by the 
crude beta-lactamase preparations. The cross-precipitation 
between the R factor-mediated beta-lactamases and the 
anti-0XA-2-IgG was therefore due to a non-specific component 
in the IgG preparation which was apparently unrelated to 
the OXA-2 enzyme. No relationship between the OXA-2 enzyme 
and other plasmid-mediated beta-lactamase was therefore 
indicated in this study.
Several interpretations are possible which explain the 
non-specific cross-reaction of the anti-0XA-2-IgG with the 
R factor-mediated beta-lactamases. These include:-
a) The purified enzyme preparation contained an impurity 
which produced a non-specific cross-reacting fraction in the 
anti-0XA-2-IgG. If this explanation is correct then the 
concentration of this fraction in the IgG fraction must 
have been relatively small since it produced a. weak precipitin 
which only developed after an extended reaction period.
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b) The OxA-2 beta-lactamase may be related to some E.coli 
cellular protein (e.g. transpeptidase, or D-ala carboxypeptidase) 
in such a way that the anti-0XA-2-IgG cross-reacts via 
precipitation with a cellular protein present in each of
the crude enzyme preparations and in the beta-lactamase 
negative cell extract. This explanation seems unlikely, 
however, in view of the production of an identical precipitin 
by the purified OXA-2 sample.
c) The rabbit in which the serum was raised may have 
contracted an E.coli infection prior to immunisation. It 
therefore would be preimmunised against E.coli cellular 
proteins and contain antibody against these components prior 
to exposure to the OXA-2 enzyme. The anti-0XA-2-IgG would 
therefore contain an anti-E.coli cell protein fraction.
Given the premise that beta-lactamases in general are related 
to some E.coli proteins, then the anti-E.coli cell protein 
fraction may produce a non-specific cross-reaction with
the crude beta-lactamase extracts and the purified OXA-2 
enzyme. Unfortunately, the immunological status of the 
rabbit was not investigated prior to immunisation. This 
interpretation does not, however, explain the production of 
an identical precipitin as that produced with the crude and 
pure enzymes samples, by the beta-lactamase negative extract.
Of the 3 explanations for the non-specific cross-reactivity 
displayed by the anti-0XA-2-IgG, only the first appears to 
be feasible. The purified OXA-2 beta-lactamase used for the 
immunisation protocol produced a single band on SDS-PAGE.
Any impurity present in the preparation must, therefore, have 
either been at too low a concentration to register on the 
polyacrylamide gel or must have had a molecular weight of 
32,000, equal to that of the OXA-2 enzyme. The impurity 
would not have been at a very high concentration, since the 
relative homogeneity of the sample was displayed by the amino 
acid sequencing data. The impurity must, therefore, have 
been highly antigenic in order to initiate the production of 
.the corresponding antibody.
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14.2 Detection of cross-reactivity between the OXA-2 enzyme 
and other R factor-mediated beta-lactamases by 
cross-neutralisation
Anti-0XA-2-IgG was tested for immunochemical cross­
reactivity with a range of plasmid-mediated beta-lactamases 
by cross-neutralisation of enzyme activity. It was decided 
that the removal of the non-specific cross-reacting fraction 
present in the IgG was unnecessary for the purposes of this 
experiment due to its low concentration. This was verified 
by the demonstration that the non-specific fraction which 
cross-precipitated with the four PSE beta-lactamases did not 
inhibit the activities of these enzymes at an IgG concentration 
which was sufficient to cause 100% inhibition of the OXA-2 
enzyme.
Cross-neutralisation by constant antigen titration ; Procedure
A 100ul aliquots of each of the enzyme preparations at 
2-5 units/ml in 25mM sodium phosphate buffer pH 7.4 were 
mixed with 100nl of anti-OXA-2-IgG at various concentrations 
and incubated at 30°C for 30 minutes. Following incubation, 
the residual enzyme activity of the sample was measured 
spectrophotometrically at 30°C against ampicillin at 500jug/ml. 
The enzyme samples were treated identically with normal 
rabbit serum at the same concentrations as the anti-OXA-2-IgG 
to act as a control. The normal rabbit serum had no effect 
on the activities of any of the enzymes in question.
The results of the cross-neutralisation experiment are 
illustrated in figure 41.
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Figure 41: Neutralisation of pure OXA-2 and a crude OXA-3
beta-lactamase samples by Anti-OXA-2 - IgG using a constant 
antigen titration
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The residual enzyme activ ity  was measured after treatment with antibody
Anti-0XA-2-IgG produced a cross-neutralisation reaction 
with the purified OXA-2 and crude OXA-3 enzymes but had 
no effect on the activity of any of the other beta-lactamases 
tested. The antiserum produced a 100% inhibition of the 
OXA-2 enzyme but only an 80% inhibition of the OXA-3 
beta-lactamase. To verify that the non-specific fraction 
present in the anti-0XA-2-IgG was not involved in the 
cross-neutralisation reaction, the non-specific component 
was removed from the IgG by absorbtion with a beta-lactamase 
negative extract (as described in section 14.3) and the 
absorbed IgG was tested for cross-neutralisation of the OXA-3 
beta-lactamase. The absorbed serum was shown -to inhibit 
the OXA-3 enzyme. The equivalent points of the anti— 0XA-2- 
IgG were obviously different for the OXA-2 and OXA-3 enzymes,
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in that a' greater proportion of IgG was required, to inhibit 
the OXA-3 enzyme as compared with the OXA-2 beta-lactamase. 
Furthermore, 100% inhibition of the OXA-2 enzyme was 
produced compared with the 80% inhibition of the OXA-3 
enzyme. The cross-reactivity between the anti-OXA-2-IgG 
and the OXA-3 enzyme was not detected by immunoprecipitation. 
An inhibitory antibody does not necessarily produce a 
precipitation reaction. Precipitation requires aggregate 
formation between the antigen and antibody in question.
The degree of the interaction between OXA-3 beta-lactamase 
and the anti-OXA-2-IgG may have been insufficient for 
aggregation and subsequent precipitation. The immunochemical 
cross-reaction between the OXA-2 and OXA-3 beta-lactamases 
indicates that the two enzymes are related. The closeness 
of this relationship is, however, difficult to quantify 
from the data. In a study of 14 different oxacillin- 
hydrolysing enzymes, Dale and Smith (1974) reported that the 
OXA-2 and OXA-3 beta-lactamases may be related due to the 
similarity of their biochemical and physical properties.
Both types of enzymes are high molecular weight oxacillin- 
hydrolysing beta-lactamases but the OXA-3 enzyme, however, 
has a slightly lower molecular weight than its OXA-2 
counterpart and its electrophoretic mobility is different.
The OXA-3 enzyme may have derived from the OXA-2 beta- 
lactamase by modification of the OXA-2 bla gene, perhaps 
by a deletion event which would account for the different 
properties exhibited by the OXA-3 enzyme.
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14.3 Immunochemical comparison between the OXA-2 beta-
lactamase and other plasmid-mediated beta-lactamases 
by means of a radioimmunoassay technique
Cross»-neutralisation enzyme assays are relatively time- 
consuming in that each antigen preparation has to be 
extracted from the strain in question. The sensitivity 
of the assay depends on the antibody and antigen combining 
in such a way that the activity of the enzyme is inhibited. 
Presumably, any antigen/antibody interaction which does not 
affect the catalytic activity of the enzyme will not be 
detected. Although cross-neutralisation is indicative of 
the relationship between enzyme types, a negative result 
does not necessarily indicate non-identity. Cross­
precipitation is an insensitive technique for detecting 
cross-reactivity between proteins due to the low 
concentrations of antigen and antibody which can be utilised 
in the technique. Additionally, precipitation requires 
aggregate formation between antigen and antibody complexes. 
The degree of interaction between an antigen and antibody 
is not always sufficient for aggregate formation. A 
radioimmunoassay technique was therefore devised as an 
extremely sensitive and rapid method of detecting 
immunochemical cross-relationships between beta-lactamases. 
The assay detects the antigen molecules 'in situ' on an agar 
plate and the technique is only limited by the number of 
colonies that can be grown on a single plate. The technique 
is based on the method devised by Broome and Gilbert (1978) 
for detecting cloned DNA fragments. It provides a 
sensitive method to detect as antigens, the presence of 
specific proteins within bacterial colonies. Antibodies are 
raised to specific proteins (in this case the OXA-2 beta- 
lactamase) , which are then used to detect similar or 
cross-reacting proteins. The method utilises plastic sheets 
which are coated with the antibody preparation. The sheet 
is then exposed to lysed bacterial cells so that the released 
antigens can bind to the antibody. The immobilised antigen
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is labelled with radioiodinated antibody and 
autoradiography is then utilised to pick out the antigen 
containing colonies.
Absorbtion of non-specific cross-reacting antibody from 
anti-0XA-2-IgG
Since the radioimmunoassay technique will depend on the 
binding of the antigen to the antibody molecule, it was 
necessary to remove the non-specific cross-reacting fraction 
from the anti-0XA-2-IgG.
Procedure
Equal volumes of IgG and a crude cell extract from the 
beta-lactamase negative strain were mixed together and left 
at 4°C overnight with agitation. The sample was then 
centrifuged at 25,000g for 20 minutes to remove the antigen/ 
antibody precipitate. The supernatant containing the 
absorbed anti-OXA-2-IgG was decanted and tested for cross­
precipitation with a beta-lactamase negative extract using 
the double immunodiffusion technique described in section 14.1. 
The removal of the non-specific component from the anti- 
OXA-2-IgG was successful.
Iodination of absorbed anti-OXA-2-IgG
The iodination reaction was performed in an Amersham
microvial behind lead shielding in a fume cupboard, in
accordance with a modification of the method described by
125Hunter and Greenwood (1964). *10jli1 of carrier free I at
a specific activity (quoted as unit radioactivity per unit 
mass) 15.8mCi/ug of iodine was mixed with 10JU1 of 10mM 
potassium phosphate buffer pH7.5, 150jug of absorbed anti- 
OXA-2-IgG and 10jul of chloramine T at a concentration of 
2mg/ml dissolved in the same buffer. The mixture was stirred 
using a microflee (the tip of a paperclip enclosed in the
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end of a drawn out capillary tube) and the reaction was
allowed to proceed for 2 minutes at room temperature.
The reaction was stopped by the addition of 280jug of sodium
metabisulphite in 25ul of phosphate buffered saline (PBS)
followed by the further addition of 20Q/ul of PBS containing
2% normal rabbit serum and 120ju1 of 10mM potassium iodine.
The iodinated IgG was separated from the unreacted iodine
2by gel filtration on a column (20 x 0.9 cm ) filled with
sephadex G-50-40. The column was prequilibrated in PBS
containing 2% normal rabbit serum and the elution position
of the IgG was predetermined. 1ml fractions of the column
effluent were collected and the activity of each fraction
was counted in duplicate using a LKB Wallac 80,000 gamma
125scintillation counter. The I-IgG fractions were pooled, 
filtered through a sterile millipore VC filter (0.1 Aim pore 
size), divided into aliquots and stored at -20°C. The 
specific activity of the iodinated preparation was
g
calculated as 1 x 10 cpm (counts per minute ) per Aig of IgG.
125The elution profile of the I-IgG from the sephadex 
column is illustrated in figure 42.
1 25Figure 42: Elution profile of____ I-IgG from the sephadex
G50-40 column
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Growth and release of antigen from cells in bacterial colonies
The beta-lactamase strains to be tested for cross­
reactivity with the anti-OXA-2-IgG were streaked out onto 
L agar plates containing 1 Ojug/ml of ampicillin and grown 
overnight at 37°C. Using sterilised tooth picks, single 
colonies were picked from the master plates and innoculated 
onto well dried L agar plates. For convenience, it was 
found that 10 colonies per plate was the optimum for the 
purposes of this experiment. The plates were incubated at 
37°C overnight and refrigerated at 4°C until required.
Prior to use, the cells were lysed 'in situ' with chloroform. 
20ml of chloroform was poured into the bottom of a tic tank 
and the open petri dish suspended face down on supports 
above the surface of the chloroform. The cells were exposed 
to the chloroform treatment for 10 minutes following which, 
the excess chloroform was removed by drying the plates 
under vacuum.
Preparation of IgG coated polyvinyl discs
8.25cm diameter discs were cut from clear flexible 
polyvinyl sheets (double glazing plastic obtained from 
R. Dyas Ltd) and stored flat. 10ml of 0.2M sodium 
bicarbonate buffer pH 9.2 containing 60jug of IgG per ml 
was poured into a glass petri dish and a polyvinyl disc was 
floated on the surface of the buffer. Approximately 10 
discs can be coated with the same IgG solution.
The discs were left in contact with the buffer and 
IgG solution for 2 minutes and then washed gently in 
2 x 10ml of cold wash buffer (phosphate buffered saline 
containing 0.5% normal rabbit serum v/v and 0.1% bovine 
serum albumin (w/v) at 4°C). The discs were then hung up 
to dry.
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Immunoabsorption of the antigen onto the polyvinyl discs
The IgG coated discs were placed in contact with lysed 
colonies on the L agar plates. The plates were left at 
4°C for 3 hours, after which the discs were carefully 
removed and washed in 3 x 10ml of cold wash buffer. Any 
cellular material adhering to the discs was aspirated off 
with cold wash buffer. The discs were allowed to dry at 
room temperature and each was labelled unambigously so that 
the positions of the colonies relative to the master plates 
could be easily lined up.
1 25Reaction of I-labelled IgG with solid phase antigen
5
1.5ml of cold wash buffer containing 5 x 10 cpm of
125 I-labelled IgG was pipetted onto the centre of an 8.25cm 
diameter flat disc of nylon mesh placed in the bottom of 
a glass petri dish. A polyvinyl disc was placed onto the 
mesh so that the immobilised antigen-antibody complexes 
were exposed to the radioactive IgG. By repeating the 
layering process thus generating a stack of alternating 
nylon mesh and polyvinyl discs, 15-^20 polyvinyl discs can be
5
incubated in a single petri dish with 5 x 1 0  cpm of
*1 2 5 oI-IgG each. The petri dish was incubated at 4 C overnight.
The discs were then removed and each washed in 2 x 10ml
of cold wash buffer and 2 x 10ml of distilled water. The
discs were allowed to dry at room temperature.
Autoradiography
The polyvinyl discs were mounted on pieces of 3MM 
Whatman paper and placed in contact with a quarter of a 
sheet of Kodak XRP5- X-ray film. The film and discs were 
inserted into a light proof cassette.which was sealed with 
tape. The cassette was stored at room temperature for 1 
week and the film was then developed in accordance with 
the manufacturer's instructions. The autoradiographs were 
photographed using Kodalith film.
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Plate 12 represents a photograph from a typical 
autoradiograph. Figure 43 represents the relative positions 
of the beta-lactamase producing strains on the master plate 
relative to the autoradiograph. A positive radioimmunoassay 
result was obtained only in the case of the OXA-2 beta- 
lactamase strain (indicated by the black dot on the 
autoradiograph). No cross-reaction between the anti-0XA-2-IgG 
and the other plasmid-mediated beta-lactamase was detected 
by the radioimmunoassay techniques. The radioimmunoassay 
system is therefore apparently less sensitive than the 
cross-neutralisation technique which detected cross­
neutralisation between the anti-OXA-2-IgG and both the 
OXA-2 and OXA-3 enzymes. The low sensitivity of the assay
may be due to several factors. The specific activity of 
125the I-IgG was approximately 10-fold lower than the 
value recommended by Broome and Gilbert (1978). This may 
account, in part, for the low sensitivity of the assay. 
Furthermore, the immunoreactivity of the anti-0XA-2-IgG 
may have been impaired by iodination damage. Three types 
of iodination damage have been demonstrated. These include
a) the damage caused by the introduction of iodine into 
the IgG molecule, b) radiation damage and c) chemical 
damage caused by the iodination reagents. In the first 
case, increasing levels of substitution of iodine.for. 
hydrogen in the IgG molecule may result in the loss of the 
binding capacity of an antibody. A direct correlation has 
been demonstrated between the uptake of iodine and the 
loss of the antigen binding capacity by the antibody 
(Koshland et al*/1963) due, presumably, to the modification 
of some components in the antibody molecule involved in the 
antibody/antigen interaction. Chlorimine T the oxidising 
reagent in the iodination reaction may caused the oxidation 
of sulphydryl groups in the antibody molecule resulting 
in the loss of binding capacity by the antibody. The loss 
of affinity of the antibody for the antigen will result
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in a loss of assay sensitivity (Ekins,1975). Despite the
low sensitivity of the radioimmunoassay, the results
indicate that the technique can be successfully applied
to the detection of OXA-2 beta-lactamase producers.
The technique will probably be of use for detecting cloned
DNA fragments which specify the OXA-2 enzyme. It is likely
that further attempts to iodinate the anti-0XA-2-IgG may 
1 25produce I-IgG at a higher specific activity than was 
obtained in this study which in turn may increase the 
sensitivity of the assay. Unfortunately, the costs of 
further iodination experiments were prohibitive within the 
context of this study.
Antibodies are produced in response to particular 
groups and arrangements of groups in an antigen. In studies 
on the effects of specific rabbit antisera on the biological 
properties of beta-lactamases with particular reference 
to the B .licheniformis enzyme (Pollock,1964), the antisera 
apparently contained at least two types of antibody. A 
stimulatory antibody which enhanced the activity of the 
enzyme and an inhibitory antibody which inhibited activity. 
Both antibody types are believed to combine with different 
antigenic groups on the enzyme molecule to produce 
different effects on the activity of the enzyme. The,two 
antibody types can be separated by differential absorption 
with the antigen. The stimulation of enzyme activity by 
antisera has also been reported for the Staphylococcal 
beta-lactamase (Richmond 1963, 1965). The effect of 
antipenicillinase sera on beta-lactamase activity is 
dependent upon the strain in question and the nature of the 
substrate utilised. In most cases, the effect consists of 
either inhibition or stimulation of activity in a monophasic 
system but both effects can, however, occur simultaneously 
in a biphasic system, for example, in the case of the 
B .licheniformis enzyme with benzylpenicillin as the
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substrate'. Antibodies to enzyme molecules affect the 
catalytic activity either by stearic hindrance, 
conformational change or a combination of both. (Arnon,1965). 
Inhibition by stearic hindrance has been demonstrated for 
four enzymes by the different inhibitory capacity of an 
antibody in the presence of substrates of different 
molecular weights (Arnon,1965). It is difficult to explain 
the stimulation of the activity of the B .licheniformis,
B.cereus and St.aureus enzymes by stearic hindrance. A 
more satisfactory hypothesis would be one based on the idea 
of a change in the conformation of the enzyme molecule 
resulting from its combination with the antibody (Pollock 
1964). The enzyme molecule, as a result of combination with 
a particular type of antibody, may undergo a distortion 
in its tertiary configuration to an extent which may alter 
the properties of the active site. It would, in a sense, 
become a slightly different enzyme with an altered pattern 
of relative affinities and activities for various 
substrates. In practise, there may be several different 
antibody combining sites on one enzyme molecule. Reaction 
at each of these would involve a different conformational 
change and hence a different effect on the active site. 
According to the conformational theory of antibody-antigen 
interactions, the affect of the antibody on the biological 
activity of the enzyme molecule would depend on a) the 
number of antibody combining sites on the antigen molecule,
b) the proportion of different antibodies present,
c) the affect, if any, of the antigenic sites and their 
complementary antibody on the function of the active site,
d) the type of substrate being dealt with at the active 
site and e) the proportion of antiserum to enzyme present.
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The anti-OXA-2-IgG produced a 100% inhibition of the 
OXA-2 enzyme with ampicillin as the substrate. Inhibition 
may have been due to stearic hindrance resulting in a 
blockage of the active site or due to a conformational 
adjustment of the enzyme molecule to a form which could 
no longer interact with the substrate molecule. The affect i 
of the anti-OXA-2-IgG against the OXA-2 enzyme was not 
tested with other substrates. It may be the case that a 
different effect on the activity of the enzyme would have 
taken place in the presence of a different substrate.
Several different types of antibody fractions have been 
identified in specific enzyme antisera (Arnon,1965). These 
include antibodies which combine but do not inhibit, 
antibodies which both combine and inhibit and non-inhibitory 
antibodies which compete with the inhibiting antibodies 
for binding sites on the enzyme molecule. An example of 
an antibody which combines but does not inhibit was 
demonstrated in the anti-OXA-2-IgG. This non-specific 
cross-reacting fraction combined with the OXA-2 antigen 
to produce precipitation but not neutralisation.
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Section 15 : Discussion
15.1 : The expression of the OXA-2 beta-lactamase specified
by the chimaeric plasmid pSu3
•A
The level of R factor-mediated beta-lactamase expression 
has a dual R factor and host specificity. Variation in 
expression can result from an alteration in either the bla 
gene copy number or the level of transcription/translation 
of the R factor DNA. The OXA-2 bla gene was cloned into 
the plasmid vector pMB9 to produce the chimaeric plasmid 
pSu3. pMB9 is a high copy number plasmid which is 
maintained at approximately 14 copies per host chromosome.
The basis behind the cloning experiment was to increase the 
number of plasmid copies which specified the OXA-2 bla 
gene, thereby creating a gene dosage effect such that 
the level of enzyme produced by cells carrying the chimaeric 
plasmid pSu3 would be increased relative to host cells 
carrying low copy number plasmids such as R46. Gene dosage 
effects rely on the efficient transcription and translation 
of the extra R factor DNA. In some cases gene expression 
is limited by a transcription/translation control system.
For example, a gene dosage effect was not observed for the 
gene coding for the ribosomal proteins of E.coli RNA 
polymerase when cloned into a high copy number plasmid, 
due to a post transcriptional control system (Fill et al.,1980). 
Limitations in expression are more often at the transcriptional 
rather than the translational level. In mose cases, the 
initiation of transcription has been shown to be the rate- 
limiting step in the expression of gene functions (Rose 
and Yanofsky, 1972). Synthesis of Staph.aureus beta-lactamase 
is limited by the availability of sites at which synthesis 
can occur (Richmond,1967). This limitation in expression 
seems to reflect localised restriction in some component 
essential for enzyme synthesis but not total protein 
synthesis. Richmond has suggested that the restricted 
component may be the ribosome translation machinery to which 
the messenger RNA binds.
The results listed in section 10 indicate'that a gene 
dosage effect with the pSu3 plasmid was probably achieved 
in most cases. The level to which enzyme production was 
increased relative to a control R46 strain, varied from 
approximately 2.5 -$>3.5 fold, depending into which strain 
pSu3 was transferred. It is difficult to relate the 
phenotypic beta-lactamase expression to copy number and to 
assess whether or not the copy number of pSu3 attained a
level comparable with that of the pMB9 vector plasmid.
Firstly, it is unknown whether or not the level of
beta-lactamase production by pSu3 is directly related to
copy number, as is the case with the plasmid R1 drd-19 
(Nordstrom et al.,1972, Uhlin and Nordstrom,1977); 
secondly, a direct measurement of the copy number of both 
the control R46 plasmid and pSu3 was not made. Due to 
the lack of copy number data, the effect on the copy number 
of the pMB9 vector plasmid, of inserting a region of DNA 
containing the bla gene, can only be postulated. A 9.3 
kilobase (6 megadalton) segment of R46 DNA containing the 
OXA-2 bla gene was inserted into pMB9. Construction of a 
restriction map of pSu3 (figure 13, section 10.6) indicated 
that the R4 6 insert also contained the replication origin 
of R4 6. In general, plasmids below 35 kilobases are under 
relaxed control and are maintained at a characteristic 
high copy number in the region of 10 plus, whereas 
plasmids above 35 kilobases in size are under stringent 
control and are maintained at a low copy number of between 
1 - 5  (Clowes,1972). Gelfand et al.,(1978) have suggested 
that the control of replication and hence copy number, is 
influenced by plasmid size. By inserting a 9.3 kilobase 
DNA fragment into the 5.4 kilobase pMB9 vector, the size 
of pMB9 was increased by a 3-fold factor. Consequently, 
the usual copy number attained by pMB9 may have been 
reduced simply due to the increase in the physical size of 
the plasmid.
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Copy number is regulated by a plasmid specific repressor 
protein which limits replication (Gelfand et al.., 1.978;
Shepherd et al.,1979; Twigg and Sherratt, 1980). The region coding 
for this repressor lies adjacent to the replication origin 
of the plasmid (Shepherd et al.,1979). Since pSu3 contains 
both the R46 and pMB9 replication origins, it may, 
consequently, produce both the repressor proteins. Provided 
that there is some degree of cross-reactivity between the 
two repressor proteins, the R46 repressor may act on the 
pSu3 plasmid to inhibit copy number. The level of copy 
number inhibition would be dependent upon the degree of 
this cross-reactivity. Several features of plasmid 
replication have recently been, observed which are consistent 
with the major tenets of the negative control model of 
replication put forward by Pritchard and his colleagues 
(Pritchard et al. ,1969; Pritchard, 1978)-. Genetic evidence for the 
existence of a repressor function in the replication of the 
plasmid R1 drd-19, has been established by the isolation of 
nonsense and temperature-sensitive plasmid copy number 
mutants (Gustafsson and Nordstrom, 1978; Uhlin and 
Nordstrom,1978). The copy number behaviour of composite 
plasmids of colE1 and pSC101 is also consistent with plasmid- 
specific negative control of replication (Cabello et al.,1976). 
Pritchard1s model couples the time of initiation of DNA 
replication to cell volume. The gene coding for the 
repressor protein is located close to the origin of 
replication and is only transcribed at the time of initiation 
of replication. The number of repressor molecules produced 
per initiation is constant for each plasmid or host cell 
strain. Immediately after replication, the concentration 
of inhibitor is high but falls as cell volume increases.
At a certain critical repressor concentration, a new round 
of replication is initiated. This relates the cell volume 
(Vc) per replicon by the equation Vc = a/hc. -According 
to the model, each replicon produces its own repressor and 
each replicon has a critical repressor concentration
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(a = number of repressor molecules produced per initiation, 
he = critical repressor concentration ) . In accordance 
with the Pritchard model, a decrease in the number of plasmid 
copies may be obtained by either an increase in a or a 
decrease in he.^ In the case of pSu3 the copy number may be 
limited by the production of both the pMB9 and the R46 
repressor proteins, i.e. an increase in a.
pMB9 is a colE1-like plasmid and as such can be amplified 
by chloramphenicol treatment (Hershfield et al.,1974) or by 
amino acid starvation. pMB9 is under 'relaxed' control which 
allows for continued plasmid replication when protein 
synthesis and chromosome replication have been shut down by 
chloramphenicol treatment. On a purely visual comparison 
of chloramphenicol treated and untreated cells, pSu3 was 
apparently not amplifiable in this manner. The insertion of 
foreign DNA into pMB9 may, therefore, have altered the 
replication properties of the vector plasmid. Furthermore, 
the presence of the R46 replication origin on pSu3 may be 
involved in this lack of amplification.
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Section 1*5.2 A comparison of the large scale -OXA-2 beta-
lactamase purification protocol with that 
devised by Dale and Smith (1971) for small 
scale purification
a
The large scale purification protocol can process 
approximately 136g of cellular protein from the crude extract, 
which is approximately 10-fold the amount which was processed 
by the original procedure. The recovery of purified enzyme 
is greater (i.e. approximately 15% on the large scale 
compared with 9% on the small scale) and the time scale of 
the process has been shortened considerably. Various steps 
from the original protocol have been altered or omitted.
The large scale process contains no protamine sulphate 
precipitation step since the disadvantages in terms of cost 
and efficiency outweigh the advantages in terms of the
removal of contaminating RNA species. No ammonium sulphate
preciptation step was required prior to the batch DEAE 
cellulose treatment. On the contrary, the more dilute the 
enzyme preparation the easier the batch method. The 
first DEAE cellulose column in the original protocol was 
replaced by a two step batch DEAE treatment at pH 7.4.
Since the large scale process was limited in terms of. cost, 
the batch treatment dispensed with the necessity of obtaining 
a large scale chromatography column. Furthermore, the batch
technique dispensed with the necessity of pouring,
equilibrating and running the column. The time scale of 
the purification process was therefore considerably shortened. 
The conditions of elution from the second DEAE cellulose 
column at pH 8.9 were altered. The bound enzyme was eluted 
with a one step 225mM sodium chloride treatment which was 
in contrast to the gradient elution used in the original 
purification protocol. Single step elution proved to be 
much simpler and quicker to use and, in addition, it limited 
the time to which the enzyme was exposed to the sodium 
chloride which has been shown to inhibit the OXA-2 beta- 
lactamase. The results listed in section 11 indicate that
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large scale enzyme purification was successful: The task
was obviously made easier than the small scale process by 
the higher specific activity of the starting crude enzyme 
preparation and the greater concentration of crude enzyme 
available. The handling of such large quantities of cell 
extract, however, proved to be difficult. Approximately 
90mg of pure enzyme was obtained from each 2.25 litres 
(22.5 litres of 400 litre batch culture) of starting material. 
Sufficient purified enzyme was therefore available to 
fulfill the needs of this project and those of future 
research.
An extremely simple and rapid purification process was 
devised for the OXA-2 enzyme which consisted of a combination 
of ammonium sulphate precipitation and affinity 
chromatography. The degree of purity attained with this 
technique was equivalent to that achieved by the more 
complex and time consuming original purification procedure 
devised by Dale and Smith (1971). Unfortunately, the process 
proved to be prohibitive in terms of both the cost of the 
affinity gel and by the low concentrations of enzyme which 
could be processed by the technique. The technique may, 
however, prove useful when only small amounts of purified 
enzyme are required.
2 2 8
Section 13.3 The interaction of the OXA-2 beta-lactamase with
Cibacron blue
Cibacron blue 3GA is a polyaromatic sulfonated dye with 
a structure as illustrated in figure 44.
Figure 44: The structure of Cibacron blue
It acts as a general ligand for the purification of a 
wide range of proteins by affinity chromatography. The 
dye binds most nucleotide requiring enzymes such as 
dehydrogenases and kinases and several non-enzymic proteins 
such as albumin and interferon. Of the 2000 or so enzymes 
currently catalogued, 31% require a nucleotide cofactor, 
which extends the use of the dye as an affinity ligand 
considerably (Mosbach,1977). Certain proteins interact 
biospecifically with Cibacron blue due to the dye's structural 
analogy to certain nucleotide cofactors. The dye can mimic 
the structure of a coenzyme such as nicotinamide adenine 
dinucleotide (NAD) and consequently bind to the protein at 
the nucleotide binding site or 'dinucleotide fold'
(Thompson et al.,1975 ; Stellwagen et al.,1975). The 
dinucleotide fold has been located within the structure of 
several enzymes by X-ray crystallography. It .is composed 
of about 120 amino acids in a beta-sheet core of five to 
six parallel strands, stabilised by oC -helical loops
o n h
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above and below the beta-sheet (Haff and Easterday,1978). 
Although the planar representation of the dye structure 
bears little resemblance to that of NAD, Cibacron blue is 
believed to mimic the nucleotide cofactor via conformational 
adjustment. With a little bond distortion the aromatic 
rings of the dye can stack up upon each other in a 
conformation similar to that of NAD, Thompson and 
Stellwagen (1976) have suggested that Cibacron blue may be 
used as a probe for the presence of a 'dinucleotide fold', 
using the assumption that all proteins which bind to the 
dye contain this supersecondary structure. This assumption 
may be invalid since several proteins are thought to bind 
to the dye in a less specific manner using hydrophobic 
forces (Beissner and Rudolph,1978) or a combination of 
hydrophobic and electrostatic forces (Beissner et al.,1979). 
Presumably, this interaction does not require a nucleotide 
binding site.
The specificity of the interaction of Cibacron blue with 
certain proteins is usually characterised by the conditions 
necessary for the desorption of the bound protein (Haff 
and Easterday,1978). Elution can be selective or non-selective. 
Non-selective desorption is usually achieved by a salt 
gradient or pH change. Selective desorbtion or affinity 
elution is usually effected with a reagent which competes 
with the bound protein for the ligand binding site, or 
conversely with the ligand for the protein binding site.
In the latter case, the elutent is usually a substrate 
cofactor or inhibitor of the bound protein or enzyme 
molecule. Biospecifically absorbed proteins containing a 
dinucleotide fold are characterised by elution with a 
low concentration of a free nucleotide cofactor (usually 
approximately 5mM). Less specifically bound proteins require 
the use of much higher concentrations of a cofactor. Salt 
elution can be utilised to desorb both types of bound proteins.
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In the case of the specifically bound protein, however, the 
salt concentration is much greater than required for its 
non-specific counterpart.
The results from affinity chromatography (section 11.2.2)
a
and inhibition studies (Monaghan et al.,1982) indicate that 
the OXA-2 beta-lactamase interacts with the dye Cibacron blue.
The enzyme can be brought to a high degree of purity by 
a simple purification process consisting of affinity 
chromatography on Blue Sepharose combined with ammonium 
sulphate precipitation. Desorption of the bound OXA-2 
enzyme from the affinity gel was achieved with 1.2M NaCl,
10mg/ml (27mM) benzylpenicillin, but not with a range of 
cofactors including ATP (5mM) NADH(1OmM) and FMN (10mM).
Failure to elute with low concentrations of nucleotide 
cofactors implies that the interaction between the dye and 
the enzyme was not biospecific. This is to be expected since the 
OXA-2 enzyme does not require a nucleotide cofactor for 
its catalytic activity and therefore presumably lacks a 
nucleotide binding site. Negative cofactor elution results 
must, however, be treated with caution since conditions 
must be chosen under which the cofactor would have a good 
affinity for the enzyme; pH and ionic strength would both 
affect this affinity. In fact, the high salt 
concentrations required to elute the OXA-2 enzyme indicate 
that its reaction with the dye complex is a highly specific 
one. The concept that specific protein interactions with 
Cibacron blue are mediated by a dinucleotide fold and that 
non-specific interactions are due to some other non-covalent 
association may be too rigid. The degree of specificity 
displayed by a dye-protein interaction may be dependent on 
the level of structural or conformational similarity to a 
conventional nucleotide binding site. The OXA-2 beta- 
lactamase which binds to the dye in what is apparently 
a highly specific manner may contain a supersecondary
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structure similar to a dinucleotide fold. Alternatively, 
it may be sufficiently flexible to allow for an adjustment 
approximating the required conformation. Purified OXA-2 
enzyme produced during this study has been made available 
to J R Knox for X-ray crystallographic studies. It will 
be interesting to see whether or not any supersecondary 
structures within the enzyme resemble a nucleotide binding 
site.
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Section 15.4 The Evolutionary origin and classification of
beta-lactamases
15.4.1 ; The Evolutionary origin of Beta-lactamases
It is altogether likely that the majority of proteins and 
certainly most enzymes, have evolved from a small number of 
archetypal proteins. This premise is based on the notion 
that it is simpler to duplicate and modify proteins 
genetically than it is to assemble appropriate amino acid 
combinations ’de novo1 from random beginnings. The 
production of new proteins depends on gene duplications as 
a result of various recombinational events. Duplications may 
lead to either elongated polypeptides or two separate copies 
of the protein. In the latter case for one copy there 
ought to be a relaxation of the evolutionary restraints 
imposed by natural selection. As such, it is free to mutate 
to a new form which is adapted to some new role. When 
creating a new protein via this route, the protein in question 
may retain many of its pre-existing features. For example, 
examination of the deep-rooted phylogenetic tree of serine 
proteases reveals that the fundamental, catalytic machinery 
is virtually identical for all these enzymes, but differences 
in the substrate binding site allows for elegant selectivity 
of action (Delabaere et al.,1975; McLachlan and Shotton,1971).
Evolutionary relationships between protein classes can 
be identified by examination of primary (1°), secondary (2°) 
or tertiary (3°) sequence homology. The systematic 
comparison of 1° sequences is in general the principal basis 
on which to determine homology between proteins. Similar 
sequences may of course appear in totally alien proteins 
as the result- of mere chance or occasionally by convergent 
evolution which provides for a particular secondary structure. 
Evolutionary relationships are generally predicted using 
a computer assisted comparison. The first step in the 
procedure is to search a protein sequence library for
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polypeptides which relate to the proteins in question.
These are then arranged in an optimal alignment, which 
impose a gap penalty every time a skip is made in one or other 
of the sequences in order to improve the degree of matching. 
Optimal alignment does not prove a common ancestral 
relationship. In order to ascertain whether or not the 
sequences are more similar than could be reasonably expected 
by chance alone, a set of scrambled sequences are generated 
by the computer. The scrambled sequences have the same 
amino acid composition and length as those of the aligned 
proteins. These are then subjected to the same alignment 
and scoring procedure. The maximum alignment scores of all 
the scrambled comparisons are determined and the average 
and standard deviation computed. The alignment scores obtained 
with the genuine sequences are then compared with the mean 
scrambled score and the number of standard deviations above 
and below are noted. Scores that are more than three standard 
deviations above the scrambled mean scores can be reasonably 
expected to represent authentic relationships. In some 
cases the results are indecisive and fall between 0*3 standard 
deviations above the mean value of the scrambled comparisons. 
This does not necessarily mean that proteins have not 
diverged from a common ancestral protein, but merely that 
similarities between them are too weak to be statistically 
significant.
As discussed in section 5.2 of the literature review 
the group A serine beta-lactamases may be evolutionary 
related to the penicillin-sensitive D-ala carboxypeptidases 
(CPases) involved in cell wall synthesis. Recently, Waxman 
and his coworkers (Waxman et al.,1982) have compared the 
N-terminal sequences of E.coli PBP5 and 6, with the two CPases 
from B .stearothermophilus (Yocum et a^ L. ,1980) and B.subtilis 
(Waxman and Strominger,1980), and with the four group A 
serine beta-lactamases (Ambler,1980). The comparison utilised 
a computer programme (see above) which was designed to 
search for homology between CPase - CPase, CPase-Beta-lactamase
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and Beta-lactamase - Beta-lactamase. A summary of the results 
of this study are shown in table 29. The results indicate a 
clear homology between the E.coli PBP5 and three out of 
the four beta-lactamases. The CPases are less homologous 
as a group than the beta-lactamases and on a pairwise 
comparison the two Bacilli CPases show little relationship 
to those from E.coli. The fact that the PBP5 from E.coli 
showed more homology to the group A beta-lactamases than the 
CPases from the Bacillus species may be significant in that 
the E.coli PBP5 is known to catalyse a weak beta-lactamase 
activity resulting in the release of penicilloic acid from 
the bound penicilloyl moiety following hydrolysis (Waxman 
and Strominger,1982). The two Bacilli enzymes do not catalyse 
this reaction, but hydrolyse the bound penicilloyl moiety 
to phenacetylglycine (Hammerstrom and Strominger,1975).
Structural and mechanistic data strongly supports the 
hypothesis that the penicillin-sensitive CPases and the 
penicillin inactivating beta-lactamases may have a common 
ancestral relationship. The evidence supporting this postulate 
include 1) N-terminal sequence homology; 2) Both CPases and 
beta-lactamases are acylated at a unique serine residue 
during catalysis and utilise a similar acyl-enzyme mechanistic 
pathway (Yocum et a^.,19 79; Cohen and Pratt,1980; Fisher 
et al.,1980); 3) Several CPases including E.coli PBP5 can
catalyse beta-lactamase activity; 4) The sequence homology 
between these two groups of enzymes has been shown to 
extend to the level of 2° structure using predictive 
methodology (Moews et al.,1980); 5) CPases are acylated by
many beta-lactam antibiotices; whether or not beta-lactamases 
can recognise the cell wall CPase substrates is as yet unknown.
In view of their common acyl-enzyme mechanism and 
involvement of an active site serine, several workers have 
noted the analogy between beta-lactamases, CPases and common 
serine proteases. Waxman and Strominger (1980) searched for 
a primary sequence homology between the two Bacilli CPases
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and serinfe proteases, but were unable to demonstrate any. 
Because in distantly related proteins, structural homology 
can occur at the 2° or 3° levels even though 1° structural 
homology is lacking, Moews et al.,(1980) compared the 
predicted 2° structure of CPases, and class A beta-lactamases 
with chymotrypsin, a serine protease. Little homology at 
the 2° structural levels was identified. The B and C 
beta-lactamase groups show little identity to those of group 
A. Several mechanistic analogies, however, between the B 
and C groups and certain CPases and serine proteases can 
be made. The B.cereus II beta-lactamase which comprises the 
B enzyme group requires a zinc prosthetic group. A CPase 
of low penicillin-sensitivity from Streptomyces albus G 
(Duez . et al.,1978) is also known to require zinc for 
catalysis, as do several proteases such as thermolysin and 
pancreatic carboxypeptidase. The class C beta-lactamases 
show little active site sequence homology to the group A 
enzymes and unlike the A group they can utilise alcohol as 
a substitute for water in the deacylation step. In view of 
these discrepancies Jaurin and Grundstrom (1981) have 
suggested that the C and A enzymes may have a different 
evolutionary origin. The two groups share the same active 
site serine and function by a similar acyl-enzyme mechanism. 
Consequently, Knott-Hunziker, Petursson, Jayatilake et al., 
(1982) have suggested that they may represent an example 
of convergent evolution. None of the serine residues in 
the AmpC beta-lactamase, a class C enzyme, is within a 
sequence with significant homology to the active site region 
of the two Bacilli CPases (Jaurin and Grundstrom, 1981) but 
a comparison with the PBP5 and 6 from E.coli has however not 
been made. Recently> Knott-Hunziker, Petursson, Waley et al., 
(1982) have shown that the class C enzymes can function as 
esterases where the analogy with serine proteases is quite 
close.
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In summary, the beta-lactamases which have' to date 
been analysed for active site and amino acid sequence, fit 
into three distinct groups. The group A beta-lactamases 
may be related to certain penicillin-sensitive CPases and 
certain mechanistic details indicate similarities between 
the three beta-lactamase groups, penicillin-sensitive CPases 
and certain serine proteases. Since the CPases are in 
general much larger proteins than the group A enzymes, it 
is doubtful that the N-terminal homology extends throughout 
the entire length of the CPase sequence. Since it is likely 
that all enzymes have derived from a small number of ancestral 
types, it can be postulated that CPases, beta-lactamases 
and perhaps even the serine proteases can be traced through 
their phylogenetic tree to a common ancestor, the differences 
between these groups reflecting their adaption to the 
different evolutionary pressures to which each was subjected.
15.4.2 The classification of the OXA-2 beta-lactamase
The OXA-2 enzyme has a molecular weight of 32,170 as 
measured by SDS-PAGE and those of the group A serine beta- 
lactamase all have similar molecular weights. The interaction 
of the OXA-2 enzyme with clavulanic acid exhibits a similar 
pattern to that shown by the TEM-2 beta-lactamase, utilising 
a similar acyl-enzyme mechanism. The identification, however, 
of an active site serine residue in the OXA-2 enzyme has as 
yet to be made. A short N-terminal amino acid sequence of 
the OXA-2 beta-lactamase was determined (section 12.6).
This sequence has been aligned with those from the group A 
beta-lactamase in figure 45. The occurrence in the OXA-2 
enzyme of a leucine-glutamine sequence at residues 5 and 6 
may indicate some degree of homology with the other beta- 
lactamases shown. On the basis of these preliminary studies, 
it may be postulated that the OXA-2 enzyme is a group A 
beta-lactamase. Presumably, there are some discrepancies 
in the active site region either in sequence, conformation or 
both, to account for the unusual substrate specificity of
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this enzyme. When further sequence data is available it 
will be interesting to compare the OXA-2 beta-lactamase with 
the N-terminal sequences of the penicillin-sensitive CPases 
discussed in the previous section. Presumably, as a group A 
enzyme it may show some homology to the CPases of E.coli and 
Bacillus species.
Anti-OXA-2 -IgG showed an immunochemical cross-reaction 
with the OXA-3 beta-lactamase. This result suggests that 
the OXA-2 and OXA-3 enzymes are related, however, the exact 
degree of homology between these two beta-lactamases is 
difficult to quantify from the experimental results. In 
view of this immunochemical cross-reaction and the similar 
chemical and physical properties displayed by these two 
enzymes, it may be the case that both enzymes have derived 
from a common bla gene. Presumably, in the case of the OXA-3 
enzyme the bla gene has undergone a deletion event which 
would account for the different electrophoretic mobility 
and lower molecular weight displayed by this enzyme.
DNA or amino acid sequencing studies will verify or 
refute this suggestion. The OXA-2 beta-lactamase has been 
designated in this study as a presumptive class A enzyme.
The similarities between the OXA-2 and OXA-3 enzymes suggest 
that the OXA-3 beta-lactamase may also be designated as 
a class A enzyme.
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Section 15.5 Isoelectric focusing studies on the OXA-2
beta-lactamase
■it
15.5.1 Charge heterogeneity .
The phenomenon of charge heterogeneity displayed by a 
broad range of purified proteins is well recognised. Many 
protein preparations considered to be homogenous in terms 
of their physico-chemical and biological properties display 
multiple forms when examined by isoelectric focusing or 
by any other technique which separates proteins purely by 
their relevant changes (Arbuthnott et al.,197'5 ; Yotis,1977)
Most purified beta-lactamase preparations examined to date 
display this charge heterogeneity and produce an isoelectric 
spectrum which usually consists of one major and several 
minor or 'satellite1 bands (Matthew,1975). The OXA-2 
beta-lactamase is no exception. It produces an isoelectric 
spectrum which consists of one main band at pH8.65 which 
represents the pi of the sample and several satellite bands 
(section 12.3). The presence of several isozymes (enzymes 
with the same physical and chemical properties but different 
pi values) within a purified preparation is caused by the 
modification of the native protein. Modification can .occur 
within the cell either during or after synthesis, or it may 
occur following the extraction of the protein during either 
purification or storage. The presence of isozymes within 
a purified preparation which originated by intercell 
modification, would be dependent upon them not being separated 
out during the purification procedure. Intercell 
modification may be caused by errors in the transcription/ 
translation system.
Such synthetic errors would produce polypeptides which 
were only slightly different from the native form. Presumably, 
any such errors would be both random and rare and 
consequently, each erroneous protein would probably be 
undetectable by techniques such as isoelectric focusing.
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If, howev'er, a considerable fraction of the protein was
synthesised erroneously, which has been predicted to occur
■\ • -
in the late stages of the growth cycle(Orgel,1976), then 
this modified fraction would be detectable. The first 
amino acid to be incorporated into a polypeptide is apparently 
always methionine. As the polypeptide matures the N-terminal 
methionine may or may not be cleaved off so that the final 
protein may or may not have methionine as its N-terminal 
residue. Errors in the removal process may result in the 
cleavage at some other residue within the N-terminal region, 
resulting in N-terminal and, concurrently, charge heterogeneity. 
Cyclisation of the N-terminal glutamine to pyroglutamic 
acid may account for some- of the charge heterogeneity 
displayed by myeloma proteins (Awdeh et al.,1970). Amino 
acid sequencing studies (section 12.6) have indicated that 
the OXA-2 beta-lactamase possesses a partially blocked 
N-terminal region which is probably due to the cyclisation 
of the N-terminal glutamine residue. The blockage may 
therefore account for some of the charge heterogeneity 
exhibited by the purified OXA-2 enzyme.
Several other modification processes have been proposed 
which may account for the charge multiformity displayed 
by a protein. Presumably, these modifications may occur 
within the cell during or after synthesis or may be 
introduced during extraction, purification or storage of 
the protein in question. Deamidation results from the loss 
of amide groups due to the differential stability of 
glutaminyl or aspariginyl residues. A variation in the 
rate of deamidation of different residues within a protein 
has been demonstrated with cytochrome C (Flatmark,1966) and 
myoglobin (Edmunson,1965). Measurement on model peptides 
has shown that the residues adjacent to an amide group can 
influence its rate of release. The conformation of a protein 
will also influence the rate of deamidation. Isoelectric
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focusing has been shown to resolve the conformational isomers 
of cytochrome C which possess the same number of amide 
groups but differ in €he relative positions of these groups 
(Flatmark and Vesterberg,1966). Williamson et al.,(1973) 
suggests that deamidation may in fact be the most common 
cause of charge heterogeneity displayed by a protein molecule. 
Other forms of chemical modification which may produce 
charge heterogeneity include oxidation of sulphydryl groups 
and phosphorylation or acetylation of amino acid side 
chains. Presumably, since the OXA-2 enzyme contains only 
one cysteine residue (section 12.4) oxidation of sulphydryl 
groups is unlikely to contribute significantly to the 
multiformity of charged species exhibited by this enzyme.
It is a well established rule that the primary sequence of 
a polypeptide chain is the sole determinant of its secondary 
and tertiary structures. Consequently, most proteins exist 
in an unique and most stable configuration. Certain proteins 
including several beta-lactamases do portray conformational 
isomerism. Conformational adjustment can lead to charge 
multiformity via the exposure or burial of charged groups 
carried on the protein molecule. The production of multiple 
banded isoelectric spectra do not always reflect the inherent 
state of the charge heterogeneity within a protein molecule. 
Certain bands may be artifacts caused by the interaction of 
the protein with carrier ampholytes within the gel matrix 
(Cann,1963). The mechanism of this interaction is not 
fully understood but it usually results in the production 
of satellite bands with lower pi values than the native 
protein.
The charge heterogeneity displayed by the OXA-2 enzyme 
may result during synthesis purification or storage. Any 
attempts to identify the modification processes which are 
responsible for this heterogeneity must be purely speculative. 
Presumably, deamidation and cyclisation of the N-terminal
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glutamine-residue may be involved. In addition, the 
possibility can not be excluded that several of the satellite 
bands produced by the OXA-2 enzyme are in fact artifacts.
244
15.5.2: Examination of the subunit structure of the OXA-2
enzyme by isoelectric focusing
A crude enzyme extract from a hybrid OXA-2/OXA-3 
strain (ie. strain producing both the OXA-2 and OXA-3 
beta-lactamases) was examined by isoelectric focusing. The 
results from these studies (section 12.4) were anomolous and 
obviously open to interpretation. On comparison of the 
isoelectric spectrum produced by the hybrid strain with 
those spectra produced by single OXA-2 and OXA-3 producers, 
two new bands were apparent which may correspond to a hybrid 
enzyme formed by the association of the subunits of the 
OXA-2 and OXA-3 enzymes. When the spectra were re-examined 
at higher protein concentrations, the two new bands' produced 
by the hybrid strain could be correlated with those bands 
produced by a crude OXA-3 and pure 0XA**2 sample, although 
the intensities of the bands in hybrid strains spectra had 
been altered considerably to those of the parent enzymes.
Several explanations of these results are possible. A
hybrid enzyme may actually be produced and in this case the 
correlation of band positions with a pure OXA-2 and crude 
OXA-3 enzyme sample may be a pure coincidence, since pi values 
are not exclusively limited to one protein type.
Alternatively, it can be argued that hybrid enzyme formation 
does not take place. If this is the case then an explanation 
of the alteration in the hybrid strain's band intensity 
must be sought. The change in band intensity may simply be 
due to the difference in the enzyme concentrations of the 
samples or it may result from post-translational modification 
of one or both of the enzyme types produced by 'the hybrid strain. 
For example, the OXA-3 enzyme may be modified by some product 
of the R46 plasmid. Alternatively, the production of two 
different enzyme types may alter the physico-chemical 
environment of the cell such that modification of one or both 
beta-lactamases results, perhaps due to an increased rate of 
deamidation.
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Brive and his coworkers (Brive et al.,1977) have examined 
a number of plasmid-mediated beta-lactamases by isoelectric 
focusing. They found that, although the position of the 
main enzyme band remains constant, the number, intensity 
and position of the satellite bands was dependent upon the 
host strain in Which the plasmid resides. Their results 
indicate that the bacterial host strain may modify the 
physical structure and activity of plasmid-mediated beta- 
lactamases. Consequently, they suggest that the identification 
of beta-lactamases and the comparison of their electrophoretic 
patterns should always be carried out using the same host 
strain. The differences in the isoelectric spectrum produced 
by the hybrid OXA-2/OXA-3 strain compared with those spectra 
produced by the parent enzymes may be due to host cell 
modification. The hybrid strain utilised was an E.coli 
J5-3 strain, whereas both the OXA-2 and OXA-3 crude enzyme 
samples were extracted from a J6-2 strain. In fact Dale 
(PhD thesis) has noted certain discrepancies in the starch 
gel electrophoretic pattern produced by the OXA-2 enzyme 
extracted from different E.coli K12 strains. The OXA-2 
enzyme produced two bands on starch gel electrophoresis at 
pH 6 when hosted by the J6-2 strain, but only one when 
mediated by the 58.161/sp strain (Meynell.and Datta,1966). 
Similarly at pH8.2, although the electrophoretic spectra 
produced by the OXA-2 enzyme extracted from both the J6-2 
and 58.161/sp host strains consisted of two bands,the 
relative positions of the bands in each spectrum were different. 
At the time, Dale attributed these discrepancies to pH 
induced modification of the enzyme. This may well be the 
case, but strain induced differences may also be accountable.
In order to establish whether the difference in the 
electrophoretic spectrum produced by the hybrid strain is 
due to concentration or strain induced effects, it should be 
possible to transfer the OXA-2 R4 6 plasmid and. the OXA-3 R55 
plasmid into the J5-3 host strain and repeat the isoelectric 
focusing experiments under the conditions of equal enzyme 
concentrations.
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Meynell & Datta (1966) refers to the E.coli K12 58.161/sp 
strain.
v,..The isoelectric focusing studies have indicated the 
marked variability of this technique which was influenced 
by a variety of parameters including the concentration, 
purity and loading positions of the samples, the activity 
of the enzyme against the nitrocefin substrate which was 
used to develop the chromatograms and the development time 
itself. Presumably, this variability may also extend to 
other electrophoretic techniques including starch gel 
electrophoresis. The demonstration (or lack of it)of 'in 
vivo' hybrid enzyme formation by isoelectric focusing may 
in fact be invalid. Further investigation into the subunit 
identity of the OXA-2 enzyme is necessary. Additional 
experiments designed to investigate this phenomenon are 
listed in section 15.7..1. These experiments are not based 
on isoelectric focusing studies.
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Section 115.6 The subunit structure of the OXA-2 and OXA-3
beta-lactamases
The proposal of a dimeric structure for the OXA-2 and 
OXA-3 beta-lactamases (Dale and Smith, 1976) was based on 
two lines of evidence:-
1) The molecular weight of both enzymes as measured by 
SDS-PAGE (Weber and Osborne, 1969), was considerably lower 
than the values obtained by sephadex gel-filtration. The 
figures obtained for the OXA-2 and OXA-3 enzymes by SDS-PAGE 
were 64% and 69% respectively, of the gel filtration value.
2) Demonstration of a presumptive 'hybrid' enzyme by starch 
gel electrophoresis.
The molecular weight of the OXA-2 enzyme as determined 
by SDS-PAGE (Laemmli and Favre,19 73) in the study was 32,170 
which is approximately 72% of the gel filtration value.
Amino acid sequencing data has indicated that the OXA-2 
enzyme has a unique N-terminal sequence which strongly 
suggests that, if the enzyme is dimeric, then the subunits 
are identical. Furthermore, a dimeric structure would 
indicate a true molecular weight of 64,000. To confirm this 
dimeric identify, attempts were made to cross-link the 
subunits of the OXA-2 enzyme with di-imidoesters. Although 
the reaction conditions were appropriate for the cross- 
linkage of the subunits of beta-lactoglobin, cross-linkage 
of the OXA-2 enzyme to produce the 64,000 dimeric protein 
was unsuccessful. This failure is surprising considering 
that Thomas (1978) has reported that only in one single case 
has the complete failure of the method been documented.
Failure may result from the absence of a suitably disposed 
lysine residue in the subunit contact regions.. Alternatively, 
it may indicate a monomeric structure. Due to certain 
ambiguities introduced by the failure of the cross-linking
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experiments, it was decided to analyse an OXA-2/OXA-3 
hybrid strain for 'in vivo' hybrid enzyme formation by 
isoelectric focusing. " The results from these experiments 
were inconclusive and obviously open to interpretation.
(section 15.5.2) .
The failure to demonstrate a subunit structure for the 
OXA-2 beta-lactamase may indicate that the enzyme is, in 
fact, a monomeric protein of molecular weight of approximately 
32,000. The OXA-2 enzyme and the beta-lactamase from 
Actinomadura R39 (Duez et al. ,1982) share several common 
properties. The Actinomadura enzyme is a member of the 
OXA-enzyme group and hydrolyses oxacillin at approximately 
3.25 times the rate of benzylpenicillin. The pattern of 
its reaction with clavulanic acid (Kelly et al.,1981) is 
very similar to that displayed by the OXA-2 enzyme expressing a 
similar* . stoichiometry of reaction (section 13.3, Table 29) .
The Actinomadura enzyme is composed of a single 15,200 
molecular weight polypeptide which displays a highly 
lasymetrical shape and, consequently, the enzyme runs at a 
molecular weight of 29,000 on sephadex filtration gels.
In view of the similarities between these two enzymes, the 
OXA-2 enzyme may exhibit a similar lasymetrical shape ■, 
especially in view of the fact that the OXA-2 enzyme does 
not run to its true molecular weight on sephadex filtration 
gels.
If both the OXA-2 and OXA-3 beta-lactamases do in fact 
possess a subunit structure, then the reasons must be 
examined as to why the two enzymes use the dimeric construction 
when all the other beta-lactamases examined to date appear 
to be monomers. Presumably, a dimer would be formed by 
the noncovalent interaction of two identical subunits 
produced by a single bla gene. Subunit structures provide 
enzyme molecules with certain advantages over their monomeric 
counterparts. An oligomeric protein can maintain a more
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favourable surface to volume ratio to shield certain 
hydrophobic regions and to achieve structural symmetry.
Self recognition of subunits in the association process 
may serve as a safe guard against errors in genetic 
translation. The most notable advantage, however, of 
polymeric enzymes, tends to be the regulation of the catalytic 
activity through the cooperation effect of subunits.
Fisher (1964) has suggested that there is a strong 
correlation between the tendency for polypeptides to 
associate and the content of their amino acids with nonpolar 
side chains. Proteins which contain more than 30% nonpolar 
amino acid residues are unable to bury their nonpolar side 
chains within the interior of the folded polypeptide chain.
The exposed nonpolar groups will therefore tend to interact 
with those from other polypeptide chains giving rise to an 
oligomeric system. Examination of the amino acid composition 
of the OXAr2 beta-lactamase (section 12.4) indicates that 
the proportion of its nonpolar amino acids is 
approximately 4 3%. It may therefore be the case that the 
polypeptide units produced by the OXA-2 bla gene tend to 
associate through their nonpolar side chain to form a 
dimeric enzyme in order to attain the most stable 
configuration possible.
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Section 1.5 . 7 Future Work
15.7.1 : The subunit .structure of the OXA-2 beta-lactamase
To date, evidence concerning the postulated enzyme 
dimeric structure is anamolous. Further investigations 
are necessary to confirm or refute this postulate. Two 
independent molecular weight determinations have been carried 
out. The molecular weight of the enzyme as determined by 
SDS-PAGE is approximately 32,000 and that determined by 
gel filtration is approximately 44,600. This discrepancy 
was one of the criteria on which Dale and Smith (1976) 
suggested the dimeric nature of the OXA-2 enzyme. A third 
molecular weight determination may help to clarify the 
situation. Density gradient centrifugation is one of the 
principal methods of molecular weight determination. The 
technique was developed by Martin and Ames (1961) as a 
simple method of measuring sedimentation coefficients in the 
preparative ultracentrifuge. Estimation of the molecular 
weight of the OXA-2 enzyme by density gradient centrifugation 
should be performed. Molecular weights can also be 
determined by gel electrophoresis. The batch method of 
Hedrick and Smith (1968) is based upon preparing a series 
of polyacrylamide disc gels of different acrylamide 
concentrations. A series of molecular weight standards are 
run on the gels and their relative migration distances (Rm ) 
are determined as the distance migrated by the protein 
divided by the distance migrated by the marker dye 
bromophenol blue. To estimate molecular weights In Rm is 
plotted against the percentage acrylamide concentration 
and the slope of this plot (K^) is then plotted against 
the log molecular weight for a series of known standards 
to produce a calibration curve. The determination of KR 
for an unknown protein then permits its molecular weight to 
be determined by reference to the calibration curve. The 
gels are generally run under anionic buffer conditions.
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Duev to the basic nature of the OXA-2 enzyme, Dale (PhD 
thesis) reported difficulties in analysing the enzyme by 
PAGE under these conditions. For efficient separation, 
buffer systems should be fixed at approximately one pH 
unit away from the pi value of the native protein. In the 
case of the OXA-2 enzyme it may be possible to run the disc 
gel batch system at pH7 with the sample run towards the 
cathode rather than the anode .
The hybridisation of variants from an oligomeric protein 
can provide information about the number of subunits in 
that oligomer. The technique depends upon obtaining two 
electrophoretically distinct variants of a subunit type and 
allowing these subunits to associate. For most proteins, 
naturally- occurring variants of a protein are not readily 
available. Occasionally, interspecies variants of a protein 
are sufficiently homologous to permit association. 
Alternatively, in the case of certain related enzyme groups, 
for example, the serine proteases, sufficient homology may 
exist between the members of the group to permit an 
association between the subunits of individual proteins.
'In vivo1 hybridisation was utilised by Dale and Smith (1976) 
in an attempt to demonstrate the subunit identity of the 
OXA-2 and OXA-3 beta-lactamases. Hybridisation studies may 
also be carried out 'in vitro' using either chemically 
modified enzymes or genetic variants. A variety of acylating 
and alkylating reagents are available for effectingchanges 
in the electrophoretic properties of a protein. Particularly 
useful are the cyclic acid anhydrides such as succinic 
anhydride (Klotz,1967), phthalic anhydride (Epstein and 
Golderberger,1964) and the c£ - halo acids such as bromoacetate 
and iodoacetate (Gurd,1967). For example, succinylation of 
aldose has been utilised to demonstrate the subunit structure 
of this enzyme (Meighen and Schachman,1970). -It may be 
possible to utilise chemical modification of the OXA-2 
enzyme to demonstrate a subunit structure for this enzyme by
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'in'f vitro' hybridisation. A disadvantage of 'in vitro' 
hybridisation is that it can only be applied to proteins which 
can be reversibly dissociated into subunits. A detailed 
investigation into the dissociation and reassociation 
properties of the OXA-2 and OXA-3 enzymes have not been 
carried out. Dissociation of an oligomeric protein is 
usually effected by such reagents as SDS, guanidine 
hydrochloride, urea or acid. The native enzyme may be 
reassociated by dialysis, dilution or, after acid treatment, 
by returning the pH to a neutral value. Weber and Kuter( 1971) have 
described a method for recovering active enzyme following 
dissociation of the subunits by SDS-PAGE. It may therefore 
be possible to apply this method to the 'in vitro' 
hybridisation of the OXA-2 and/or the OXA-3 beta-lactamases.
15.7.2 Active site labelling studies
The most valuable future investigations concerning the 
OXA-2 enzyme will be the identification of the active site 
region. Labelling of the active site should be possible 
using radio-active labelled suicide inhibitors such as 
clavulanic acid or 6 beta-bromopenicillanic acid.
Clavulanic acid is an efficient inhibitor of the OXA-2 enzyme 
In view of the enzyme-catalysed depletion of this inhibitor, 
however, it may be simpler and certainly less expensive to 
use an alternative compound. Preliminary studies with 
penicillanic acid sulphone (results not shown) indicate that 
the stoichiometry of its reaction with the OXA-2 enzyme is 
approximately 12:1. This is certainly an improvement on 
the 30:1 figure obtained with clavulanic acid. 6 beta- 
bromopenicillanic acid is a specific active site inhibitor 
of several beta-lactamases. In the case of its interaction 
with the B.cereus I enzyme, inhibition is irreversible and 
the stoichiometry of the reaction is 1:1 (Cohen and Pratt,
1980). If this interaction is mimicked by the OXA-2 enzyme, 
then 6 beta-bromopenicillanic acid would be an optimal 
choice for an active site label.
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'identification of the OXA-2 active site region may be 
achieved by peptide mapping•_ A comparison of the peptide 
maps from two enzyme samples, one treated with radio-active 
inhibitor and the other untreated, should indicate the 
labelled active site peptide. Isolation of this peptide 
followed by subsequent amino acid sequencing via Edman, 
degradation, would provide the active site sequence. DNA 
sequence data from the OXA-2 bla gene may itself indicate 
a possible active site region. The active sites of both 
the TEM-2 and the B.cereus I beta-lactamases have both been 
isolated via inhibitor labelling (Fisher et 'al.,1981);
Cohen and Pratt,1980), and their relevant positions in the 
sequence identified. A comparison of the primary sequence 
of the OXA-2 beta-lactamase following conversion of the 
DNA sequencing data, with the TEM-2 and B.cereus I enzymes may 
indicate an homologous active site region.
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15.8 • Future perspectives in beta-lactam chemotherapy
The prolific number of beta-lactam antibiotics which 
are currently available, provides the clinician with a 
confusing array of compounds at his disposal. Most of these 
compounds are modifications of a predecessor and in many 
cases the new beta-lactams offer only a slight difference 
in anti-bacterial spectra or are moderately more active 
against one or two strains. It has been estimated that 
approximately half of all the antibiotic treatment in 
hospitalised adults is inappropriate (Kunin,1978) in that the 
agent prescribed is not the drug of choice or that the 
dosage and duration of therapy is excessive.
Resistance to beta-lactam antibiotics is now relatively 
widespread. The clearest indication to date is that the 
phenomenon previously observed in the Staphylococci when 
beta-lactam therapy became established, has now extended 
to most bacterial groups. Foremost among the emerging 
resistant bacterial groups are the gram-negative rods due 
to their remarkable genetic flexibility. They tend to 
provide a source of transferable resistance determinants 
which can spread to other bacterial groups. Resistance can 
achieve epidemic proportions in both gram-positive and 
gram-negative bacteria often with serious consequences.
The spread of penicillin resistance in Streptococcus 
pneumoniae has produced a high mortality rate in children 
in certain areas (Jacobs et al.,1978).
In order to combat resistance to beta-lactam antibiotics 
the pharmaceutical industry has adopted several lines for 
future research. These include a) the development of new 
antibiotics, b) the modification of existing compounds 
and c) the development of beta-lactamase inhibitors. The 
production of novel beta-lactams will be aided greatly by 
the rapid advances which have been made in the field of
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'in'vivo' and 'in vitro' methods of genetic recombination
in the Actinomycetes (Hopwood and Charter,1980? Chater et al., ,1981
The application of these new techniques which include
protoplast fusion and recombinant DNA manipulation, not
only to the Actinomycetes but also to the filamentous fungi
and species of Bacillus, will, hopefully, provide a wealth
of new antibiotics including beta-lactams. At the present
time, the development of new beta-lactams and the
modification of existing compounds is geared to expanding
the antibacterial spectra of these compounds, with the
objective of obtaining the 'ultimate' beta-lactam which
would be effective against all of the common bacterial
pathogens. Resistance is now so widespread that achieving
this objective may be impracticable. A more logical
approach may be to change the chemotherapeutic policy from
the use of broad-spectrum to narrow-spectrum beta-lactams.
It should be possible to exploit the pre-existing limitations 
in the antibacterial spectrum of certain compounds with 
the aim of developing selective beta-lactams capable of 
limited action against specific pathogenic groups which 
may in turn help to reduce the incidence of resistance in 
certain cases. Recently, it has been claimed that temocillin, 
the new methoxy penicillin, and SQ26776, a monobactam, 
each have a reduced spectrum of activity and therefore go 
part of the way towards fulfilling a narrow spectrum policy 
(Brown et al.,1982).
Rapid advances in the field of beta-lactamase inhibitors 
have been made due to isolation and development of a novel 
group of beta-lactams which act as potent and effective 
beta-lactamase inhibitors. This group of compounds tend to 
have little intrinsic activity but their chemotherapeutic 
value lies, however, in thbir synergistic activity in 
combination with conventional beta-lactams. Clavulanic acid 
is, to date, the only member of this group which is available 
to the clinician. It is marketed in combination with 
amoxicillin under the trade name Augmentin BRL 2500.
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CliViical 'trials have reported the success of this combination 
in particular in the treatment of urinary tract (Kollarilsch 
et al.,1979) and gonococcal infections (Onedara et al.,1979) 
Future developments in this field will obviously include 
the licensing of other beta-lactamase inhibitors. Detailed 
studies into the mechanism of interaction of inhibitors 
with beta-lactamases will provide a rational basis for 
the developmentof more effective derivitives.. In addition, 
other future developments may include the application of 
the 'mutual pro-drug principle' to beta-lactamase inhibitors.
This principle would involve combining a beta-lactam 
antibiotic with a beta-lactamase inhibitor in a single 
molecule which can function as a pro-drug for both the active 
principles so that the absorption from the gastro-intestinal 
tract of both components takes place at exactly the same time 
and in a constant ratio (Baltzer et al. ,1980). This would help to ensure 
that the antibiotic and inhibitor will always be present 
at the site of infection simultaneously at the appropriate 
ratio in order to provide optimal protection of the 
antibiotic against inactivation. Pro-drugs of inhibitor- 
antibiotic combinations will, presumably, be expensive due 
to the chemical modifications necessary for their production. 
Whether the benefits in terms of efficiency will outweigh 
the disadvantages in terms of cost, have yet to be seen.
The continued development of novel beta-lactam 
antibiotics is reassuring on the basis that every 
successful improvement in drug design seems to provoke a 
successful countermove on the part of the bacteria. In 
view, however, of the misuse in antibiotic chemotherapy 
it may also be profitable to examine the existing beta- 
lactams in more detail so that we can make better use of 
what is currently available.
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